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tKKKAŒ .^^_ 
Nasal hyperreactivity can best be defined as an increased response of a 
nasal effector system to a stimulus. The clinical symptoms (increased 
response) are sneezing, hypersecretion and nasal cfcstruction. Allergens 
are the stimuli for specific nasal hyperreactivity, described as atopic 
or allergic rhinitis. Allergic rhinitis and allergic asthma occur often 
simultaneously and have a similar pathophysiology, indicating that both 
manifestations are the same hyperreactivity in the upper and Icwer 
airvrays respectively. Hyperreactivity of the Icwer airways has been 
explained by various mechanisms; the theory of Szentivanyi (1968), in 
йіісіі dysfunction of the ^-adrenoceptors has been postulated, has 
reoeived particular attention. Other studies (Barnes et al., 1980; 
Raaijmakers et al., 1984) support the imbalance of the autonomic nerve 
regulation in bronchial hyperreactivity by differences in neuroreceptor 
densities. Analogous to the bronchial hyperreactivity, nasal 
hyperreactivity may be explained by an imbalance of the autonomic nerve 
regulation. Until new, histochemical and pharmacological experiments have 
only given a general inpression of the innervation of the nasal mucosa, 
but give no any information on the characterization or localization of 
the various neuroreceptors. In contrast with the Icwer airways, only a 
few quantitative data (densities) of neuroreceptors in homogenates of the 
nasal nuoosa are available (Ishibe et al., 1983). 
In this study radioligand receptor binding and in vitro autoradiographic 
studies were performed to investigate biochemical characteristics, 
densities, sensitivities, subclasses, receptor-effector coupling or 
localization of the neuroreceptors in the nasal mucosa. Ihe rat was used 
as an experimental model, so that the restricted amount of human nasal 
mucosa was not a limiting factor. Both techniques have been applied to 
nasa] mucosa of non-allergic and allergic patients, in order to 
investigate the supposed changes in characteristics of neuroreceptors in 
nasal hyperreactivity. Ihe non-allergic group has been further subdivided 
into control, vasomotor rhinitis and chronic sinusitis patients. A 
histological study of the nasal mucosa of both groups was involved for 
the interpretation of the receptor binding studies. 
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АННЫНУТАПСМЗ 
AA = arachidonic acid 
AB/PAS = Alcian Blue/Periodic Acid Schiff 
ADP = adenosine 5 '-diphosphate 
ATP = adenosine 5 '-triphosphate 
Bmax = receptor density 
BSA = bovine serum albumin 
С = catalytic unit 
cAMP = adenosine 3'5'-cyclic monophosphate 
cGMP = guanosine S'S'-cyclic monophosphate 
00 = cycloxygenase pathway 
CYP = cyancpirriolol 
D = drug 
DG = diacylglycerol 
ШЛА = ethylenedinitrilo tetra-acetic acid disodium salt 
ER = endoplasmic reticulum 
GO/ST = G-protein with subunits 
GC = guanylate cyclase 
Gpp(NH)p = S'-guanylylimidodipho^iiate 
GTP = guanosine 5'-triphosphate 
H = agonist 
ΗΆΑ = hydroperoxide of arachidonic acid 
HEMS = 4-(2-hyàraxyethyl)-l-piperazine ethane sulphonic acid 
HEPES-PI = HEIÎS buffer with protease inhibitors 
HHSiD = hexahydrosiladifenidol 
IgE = innunoglobulin E 
IP3 = inositoltrisphosphate 
IP4 = inositoltetrakisphosphate 
Ki = equilibrium dissociation constant 
Ki = ihhibiticn constant 
ID = lipoxygenase pathway 
MC = mast cells 
PG = prostaglandin 
PI = posphatidylinositol 
PIP2 = phosphatidylinositol 4'5'-biphosphate 
PK = protein kinase 
PKC = protein kinase с 
PL = phospholipid 
FIC = phospholipase С 
PIA2 = phospholipase A2 
IMSF = рЬепуІтеа^уІзиІГо^Ійіюгіае 
QNB = quinuclidirylbenzilate 
R = receptor 
RAST = radioallergosortoent test 
SïM = standard error of the mean 
SP = substance Ρ 
th = half life time 
TOME = Να-ρ-tosyl-Lr-arginine methyl ester 
Tris = Tris (hydroxymethyl) aminraethane 
Тх = throniboxane 
ІІГ = leukcrtriene 
VIP = vasoacive intestinal polypeptide 
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снарпж ι 
шпсоиспш 
(partially published in O.R.L. 50: 32, 1988) 
1.1. Anatany and physiology of the nose. 
Ihe nose has a function in the filtration, humidification and 
thermoregulaticai of the inspired air. Ihe nasal fluid, mainly a secretory 
product of the nasal mucosa, is involved in the humidification of the 
inspired air, the removal of the inhaled pollutants and the protection of 
the underlying respiratory epithelium. The vascularization of the nasal 
mucosa has mainly a function in the warming of inhaled air and 
regulating the patency of the nasal passages (Mygind, 1978, Drettner, 
1979, Proctor, 1982, Geurkink, 1983). 
the nasal cavity is divided into two identical cavities by the nasal 
septum. In each of these cavities three regions with different functions 
can be distinguished; the vestibular, the respiratory and the olfactory. 
The vestibular regiem is restricted to a narrcw zone inside the 
nostrils. The olfactory region cctnprises the lateral and dorso-medial 
part of the nasal cavity. Ihe remaining part of the nasal cavity is 
occupied by the respiratory region, this being the aim of the study. 
In the respiratory region some conponents can be distinguished in the 
nasal mucosa; the epithelium and the lamina propria with the glands, 
blood vessels, inflaitmatory cells and nerves (Mygind, 1978; Proctor, 
1982; KLaassen et al., 1988). Ihe anatany of these structures is species 
dependent; the anatomy and physiology of the rat nasal mucosa will be 
described and the differences between the rat and human nasal mucosa. 
1.1.1. Ihe epithelium. 
In the respiratory region, the epithelium is resting on a basement 
marbrane. Ihis membrane consists of a thin continuous double membrane on 
a connective tissue marbrane (thick layer of collagen with reticulin 
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fibrils). The typical ciliated, columnar pseudostratified respiratory 
epithelium consists of 4 cell types (Rhodin, 1974; Mygind et al., 
1982a)(fig. 1.1): 
I Itie basal cells. 
Illese cells are very small and do not reach the luminal surface. The 
other cell types originate from these undifferentiated cells. 
II Goblet cells. 
Part of the goblet cells may originate from the ciliated cells and 
not from the basal cells (Bauer and Temesrekasi, 1967). Gebiet cells 
are unicellular glands, which can aggregate to form intra-epithelial 
glands. The goblet cell is characterized by a well developed Golgi 
conplex and a somewhat irregular apical part without microvilli. In 
the secretory active cells, the nucleus is pushed tcward the basal 
part of the cell by the numereous apical localized secretory 
granules. Ihe cell protrudes slightly into the lumen. After the 
extrusion of the secretory granules, the apical cell membrane 
recloses (Mogensen and Tos, 1976). 
III Non-ciliated columnar cells. 
These cells are covered with microvilli. Microvilli cannot move 
actively. They increase the surface area of the epithelial cells, 
thereby promoting the transport of substances and water between 
cells and the nasal fluid. 
IV Ciliated columnar cells. 
These cells are covered with both cilia and microvilli. Cilia are 
long thin mobile projections from the luminal surface of the cell. 
The characteristic cross section of a cilium is a ring of nine 
doublet microtubules surrounding two single central microtubules. 
Dynein arms are present on one side of each of the nine doublets. 
Dynein, with ATP-ase activity, is thought to be responsible for the 
active ciliary movement. The cilia together with the mucous layer 
have a cleansing function by moving debris and bacteria to the 
nasopharynx. 
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1.1.2. Lamina prepria. 
The lamina propria or suteucosa consists of connective tissue 
(fibroblasts, fibrocytes, histiocytes, fibrils), glands, blood vessels, 
inflammatory cells and nerves. 
1.1.2.1. The glands. 
Ihe glands of the respiratory area may be divided into goblet cells 
(secretory cells of the epithelial lining) and submucosal glands. The 
nasal fluid is mainly a secretory product of the nasal glands but it is 
also a mixture of transudate, tears, condensed water of the expired air, 
loose cells and micro-organisms (Mygind, 1978). Biochemical analysis 
revealed the presence of many chemical substances such as serum proteins, 
immunoglobulins, enzymes and glycoproteins (Widdiccmbe and Wells, 1982). 
Glycoproteins in particular are responsible for the viscosity and 
gelforming prcperties of the mucus (Clamp et al., 1978). Ihe acini of 
the glands produce the glycoproteins and it has been suggested that the 
glandular striated excretory ducts control the ion and water content of 
the secretion (Hiipps, 1981). 
Fig. 1.1: 
T r a n s m i s s i o n e l e c t r o n i c 
microsccpic diagram of the four 
ce l l types in nasal respiratory 
epithelium. 
I Non-ciliated columnar cells 
II Goblet cells 
III Basal cells 
IV Ciliated cells 
Ш = Double membrane 
CIM=Connective tissue membrane 
(Mygind, 1978; with permission) 
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Ihe submucosal glandular structures of rodents are concentrated in two 
large masses; one in the lateral wall and one in the septum (Bang and 
Bang, 1959; Bojsen-Mpller, 1964; Vidic and Greditzer, 1971, KLaassen et 
al., 1981). Two glandular parts can be distinguished with regard to 
their duct system (fig. 1.2.), although there is no clear anatomical 
boundary (KLaassen et al., 1981). The dorsal part, described as the 
maxillary glands (Bang and Bang, 1959; Vidic and Greditzer, 1971) has no 
typical intercalated or striated excretory ducts and drains by some 
simple excretory ducts into the lumen of the maxillary sinus. The ventral 
part, described as the lateral nasal gland by Vidic and Greditzer (1971), 
consists of very branched tubulo-acinous glandular tissue and many 
intercalated ducts. Fran this ventral part, one large excretory duct 
courses tcwards the vestibulum in addition to a number of smaller 
excretory ducts (KLaassen et al., 1981). Bojsen-táller (1964) considered 
this ventral part as 2 anatomically separated glands, the anterior and 
the Steno lateral glands. 
ΤΓ 
Fig. 1.2: Simple and compound multicellular glands in human (A/B) а п і 
rat (B/C) nasal mucosa. The glandular cells are black and the 
non-glandular cells are clear. A=simple acinar (alveolar) 
B=simple branched acinar (alveolar) C=campound tubulo-acinar 
(KLaassen et al., 1981; with permission). 
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Using histochemical techniques for glycoproteins three different cireas 
(ISL and L3 in the ventral part and 1^ in the dorsal part) may be 
distinguished; the dorsal part containing neutral and sulphated 
glycoproteins and the ventral part neutral and sialyted (KLaassen et al., 
1981). Ihese areas may also be distinguished by different granules in 
their acinous cells (Klaassen et al., 1982). There are also differences 
in the secretory behaviour of the histochemically different dorsal and 
ventral rat nasal glands. The ventral part has a higher sensitivity in 
glycoprotein secretion on stimulation with the cholinergic agonist 
metacholine, possibly due to differences in neural regulation (Klaassen 
and Ruijpers, 1986a) (Klaassen et al., 1987). 
The glandular tissue of the rat nasal septum contains one large gland 
with a moderate developed duct system (5 large excretory ducts) between 
the acini and may be considered as a branched tubulo-acinous gland. Two 
different areas may be distinguished on the basis of various 
glycoproteins and secretory granules in their acinar cells (Klaassen et 
al, 1981; Klaassen et al., 1982). 
large glandular systems, as present in the lateral wall of the rat nasal 
mucosa, are only found in human embryos and then regress completely 
during subsequent development (Bast, 1924). In man the submucosal glands 
may be divided into two groups; the anterior and the tubulo-alveolar 
glands. The anterior glands open into the crypts in the region of the 
internal ostium. The tubulo-alveolar glands are scattered throughout the 
respiratory area and drain by small excretory ducts which frequently end 
with a funnel-shaped opening (Bojsen-^011er, 1965; Tos, 1976). 
Ultrastructural studies reveal that striated excretory ducts are absent 
in these glands (Jahnke, 1972). Using various histochemical techniques; 
neutral, sulphated and sialyted glycoproteins have been detected in 
acinar cells of the acini (Thaete et al., 1981). 
1.1.2.2. The blood vessels. 
The vascularization of the nasal cavity has a crucial function in the 
warming of the inspired air and in the regulation of the patency of the 
nasal passages by means of venous erectile tissue. 
9 
In the rat the internal carotid artery gives off the pterygopalatine 
artery, which has two branches: a pterygoid and a palatine branch. ïtie 
artery of the pterygoid canal (vidian artery) is a continuation of the 
pterygoid branch of the pterygopalatine artery. Ihis artery runs 
forwards on the lateral surface of the internal pterygoid and enters the 
posterior nares to supply the nasopharynx and the inferior part of the 
nasal cavity. Ihe palatine portion gives off two branches; the ophthalmic 
and the sphenopalatine. The ophthalmic artery gives rise to the 
ethmoidal artery, which runs through the dorso-anterior part of the nose 
through the ethmoidal foramen. Ihe sphenopalatine artery, vrtiich supplies 
the main part of the mucosa of the septum and the lateral wall, enters 
the nasal cavity through the sphenopalatine foramen. One of its branches 
has been shewn to anastomose with the descending palatine artery by way 
of the incisive canal (Greene, 1959; Grote, 1974). 
In man the blood supply to the nasal mucosa comes from both the internal 
and external carotid artery (Dankmeyer, 1964; Osbom, 1978): 
a. f rem the external carotid artery via the sphenopalatine artery to 
the turbinates, lateral walls and inferior parts of the septum. 
b. f rem the internal carotid artery via the anterior and posterior 
ethmoidal arteries to the superior parts of the the nose. 
In both man and rat nasal mucosa the capillaries are situated at three 
levels (Mygind, 1978; Cauna, 1982): subepithelial, periglandular, 
perichondral and periosteal. Nasal fenestrated capillaries are 
characterized by the absence of an internal elastic membrane (Cauna and 
Cauna, 1975) and by the porosity of the endothelial basement membrane 
(Watanebe and Watanebe, 1980). 
Between the capillaries and the venules are interposed the cavernous 
sinusoids, localized in the basal part of the lamina propria. Ihe 
sinusoids are regarded as specialized capillaries and are normally in a 
contracted condition. Filling of the sinusoids with blood influences 
nasal patency, resulting in a congestion of the mucosa. There are also 
direct connections between arterioles and venules; the arteriovenous 
anastomoses (Cauna, 1982). 
The blood vessels can be classified according to their principal 
function into capacitance, resistance and exchange vessels (Anggârd, 
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1977; Mygind, 1978; Cauna, 1982) (fig. 1.3.)· Ihe tone of the capacitance 
vessels (mainly venous vessels and sinusoids) regulates the blood volume, 
whereas the tone of the resistance vessels (mainly small arteries, 
arterioles and arteriovenous anastomoses) regulates the blood flew. 
Transport through the wall takes place in the exchange vessels (mainly 
capillaries). 
1.1.2.3. Infiltrating cells. 
In the lamina propria many infiltrating cells are present; leucocytes, 
lymphocytes, plasma cells, macrophages and basophilic cells. The 
basophilic cells may be subdivided into blood basophilic leucocytes and 
tissue mast cells. The basophilic leucocytes have distinct granulocyte 
characteristics, including polylobed nuclei with condensed chromatin, 
cell size ranges between 7 and 10 /m with irregular blunt or thick 
surface processes, cytoplasmic glycogen and granules generally larger 
and fewer in number than those in mast cells (Galli et al., 1984). 
Two distinct types of mst cells have been identified by their 
morphologic and functional properties; the connective tissue mast cells 
and the mucosal mast cells (Bienenstock, 1988). Ihe common 
characteristics include cell size (ranges between 8 and 20 μιη), surface 
IgE receptors, numereous cytoplasmic granules (about 200), lipid bodies, 
cytoplasmic filaments and an excentric nucleus (Galli et al., 1984). 
Activation of mast cells leads to release of the mast cell mediators frcm 
Fig. 1.3.: 
Ihe vascular arrangement in the 
nasal mucosa. A-V=artericivenous 
shunt vesse l , O s u b e p i t h e l i a l 
c a p i l l a r i e s , G = P e r i g l a n d u l a r 
c a p i l l a r i e s , P = p e r i c h o n d r e a l 
c a p i l l a r i e s , S=Venous sinusoids 
(Anggârd, 1977 ; with permission). 
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the granules. Degranulation is an active secretory process requiring 
energy and Ca2+. Hie mediators nay be divided into (Robinson and 
Holgate, 1985; Wasserman, 1987): 
- vasoactive and smooth muscle mediators. 
(histamine, platelet activating factor and arachidonic acid 
metabolites; PGD2, TxA2, LTC4, ITD4 and ІЯЕ4). 
- chemotactic mediators. 
(eosinophil chemotactic factor, neutrophil chemotactic factor). 
- structural proteoglycans. 
(heparin, chondroitin sulphate). 
- granule associated enzymes. 
(chymase, tryptase, kallikrein, /3-exoglycosidase). 
The mediators of the arachidonic acid metabolites consist of the cyclo-
oxygenase products, prostaglandins (PG) and thromboxane (TxA), and of the 
lipoxygenase products, leukotrienes (UT) (Mygind, 1986). 
The mast cell release is inhibited by ^-adrenergic agonists, histamine 
and PGE2 and facilitated by α-adrenergic and cholinergic agonists and by 
PSF2a (Mygind, 1986; Warner et al., 1988). 
1.1.2.4. Nerves. 
Ihe nasal mucosa is supplied f rem the sensory and the autonomic nervous 
system (parasympathetic and sympathetic) (Christensen, 1934; Grote, 1974; 
Grote et al., 1975; Ishii and Toriyama, 1972). Ihe sensory fibres are 
thought to cerne from the trigeminal nerve. Ihe sympathetic fibres are 
derived f rem the superior cervical ganglion. The postganglionic 
sympathetic fibres run in the plexus of the carotid artery, branch off 
in the bony carotid canal and form the deep petrosal nerve. Subsequently, 
the deep petrosal nerve joins the greater petrosal nerve to form the 
vidian nerve, which reaches the nose via the pterygopalatine fossa. The 
parasyitpathetic fibres arise in the superior salivary nucleus in the 
brainstem and course to the vidian nerve as the greater petrosal nerve. 
Ihe parasympathetic fibres synapse in the pterygopalatine ganglion. 
Recently, it has been suggested that the parasympathetic pathway has its 
postganglionic neurons not only in the pterygopalatine ganglion but also 
in so-called microganglia, located within the mucosa of the inferior 
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turbinates (Galan Cortes et al., 1986). 
1.2. Sensory and autcncmic irmervaticn of the nasal mxxsa. 
The nasal mucosa is innervated by autonomic (synpathetic and 
parasympathetic) nerve fibres and also by sensory nerve fibres. The 
classical neurotransmitters noradrenaline and acetylcholine occur in the 
sympathetic (adrenergic) and parasympathetic (cholinergic) fibres. Apart 
f rem these classical neurotransmitters, peptidergic transmitters, e.g. 
vasoactive intestinal polypeptide (VIP) and Substance-P (SP), have been 
identified and localized. Other neuropeptides (avian pancreatic 
polypeptide, neuropeptide-Y, peptide histidine isoleucine) have also been 
described, but the physidLogical significance of these peptides is 
unknown (Uddman et al., 1978; Uddman and Sundler, 1979; Uddman et al., 
1980). 
The innervation pattern of the nasal mucosa has been investigated by 
histochemical, electrophysiological and denervation experiments (Anggârd 
et al., 1972; Ishii and Toriyama, 1972; Anggârd et al., 1974; Grote, 
1974; Grote et al., 1975; Cauna, 1982; Vecerina et al., 1983). 
Hiarmaoological studies have contributed to a deeper insight into the 
character of the autonomic innervation and its functional significance 
(Proctor and Adams, 1976; Eccles, 1982; Mygind, 1982a, Malm, 1983). 
1.2.1. Glands. 
Histochemistry. 
Periacinar acetylcholinesterase containing fibres have been identified in 
the nasal glands. No cholinergic fibres were found in relation to the 
excretory ducts. No adrenergic innervation of the glands could be 
demonstrated. Interconnections between the cholinergic periacinar plexus 
and the vascular plexus have been observed. 
VIP and SP immunoreactive neurons have been demonstrated in nasal 
glands. Anggârd (1983) demonstrated that the VIP-reactive neurons 
represent postganglionic parasympathetic ones and he suggested an 
interaction between the synpathetic neurotransmitter and this peptide. 
13 
Fharmacology. 
Electrical stimulation of the parasympathetic nerve supply induces nasal 
secretion, which can be ccmpletely inhibited by atropin (Eccles and 
Wilson, 1973). Parasympathcmiroetics stimulate the discharge of granules 
from rat glandular cells (KLaassen and Kuijpers, 1986a). In clinical 
trials the parasynpatholytic drug ipratropium has been used to reduce 
nasal hypersecretion (Borum et al., 1979). It has been suggested that 
α-adrenoceptors play a role in nasal secretion (Malm, 1983), however, a 
reduction of nasal secretion with α-adrenergic agonists has also been 
reported (Ehipps, 1981). Itiis controversial data nay be due to the 
technigues used and the coraplexity of origin of the nasal fluid. 
Ihe neuropeptide VIP has a stimulatory effect an the secretory activity 
of the nasal glands (Iiondberg, 1981). The effect of SP on the nasal 
glands is unknown but it is observed that SP stimulates the secretion in 
rat parotid and submandibular glands (Pemcw, 1983). 
1.2.2. Blood vessels. 
Histochemistry. 
Noradrenaline- as well as acetylcholinesterase-containing fibres have 
been found in the walls of the nasal vessels. Ihe sinusoids, especially, 
have a very dense network of both fibres, regulating the swelling and 
shrinkage of the nasal mucosa (Grote et al., 1975; Anggârd and Densert, 
1974) . 
VIP and SP containing nerve fibres have been identified in the nasal 
blood vessels (Uddman et al., 1980b; Uddman et al., 1983) 
Pharmacology. 
Parasympathomimetics provoke a vasodilatation, which may be blocked by 
atropine. Electrical stimulation of parasyirpathetic nerves also causes a 
dilatation, which is partly inhibited by atropine (Malm, 1973; Eccles and 
Wilson, 1974). Ihe atrcpine-resistant vasodilatation mic^ it be due to 
bradykinin or VIP (Lundberg, 1981). Ihe sympathetic innervation of the 
nasal blood vessels is dual, α-adrenergic agonists induce a 
vasoconstriction (Jackson, 1980), whereas /3-actrenergic agonists induce a 
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vasodilatation (Hiley et al., 1978; Malm, 1977). Ihe significance of 
α-adrenoceptors for the control of the blood volume as well as blood flow 
has been verified (Andersson and Bende, 1984; Bende, 1985), on the other 
hand ^-adrenoceptors have been suggested to be of minor functional 
inportance (Hall and Jackson, 1968; Svensson et al., 1980). Clinically 
treatment of pathological nasal congestion may be obtained with drugs 
affecting the adrenergic system (Bende, 1983). 
Both VIP and SP induce vasodilatation (lundberg, 1981; Lundblad et al., 
1983). Recently, it has been reported that neuropeptide-Y, which induces 
vasoconstriction, coexists in the sympathetic nerves (Ichimura et al., 
1988). 
1.2.3. Epithelium. 
Histochemistry. 
Hie (sub) epithelial plexus gives a weak acetylcholinesterase and 
noradrenaline reaction (KLaassen et al., 1988). Electron microscopic 
observations shew the presence of unmyelinated axons between the 
epithelial cells. Ihese axon endings are situated either superficial to 
the basement membrane or close to the airway lumen beneath the tight 
junctions (Gamse et al., 1980). 
Sub-P containing nerves have been detected beneath and sometimes within 
the surface epithelium (Uddman et al., 1983). 
Pharmacology. 
Ihe functional significance of the (sub)epithelial plexus is not yet 
elucidated. In caiparing data on this plexus in the lewer airways, it 
seems likely that one part of these axons may be considered sensory and 
the other part may be efferent adrenergic and possibly cholinergic 
(Jeffrey and Reid, 1973; Gamse et al., 1980). Ihe sensory nerves are 
involved in the nasal reflexes; respiratory, vasomotor and cardiac 
reflexes (McCaffrey, 1983). 
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1.3. Neuroreceptors. 
Intercellular communications in multicellular organisms is achieved by 
interactions of specific substances, e.g. hormones and neurotransmitters, 
released from one cell interacting with a specific receptor protein on a 
target cell. Itiis interaction results in one or more changes in the 
activity of an intracellular or plasma membrane protein in the target 
cell, which modifies physiological responses. 
It has been suggested that neuroreceptors consist of at least two 
ccnponents, the binding site and a site which translates the transmitter 
recognition into a biochemical effect (Birdsall, 1984; Levitzki, 1986; 
Nathanson, 1987). Ihe neuroreceptors have been studied in physiological, 
pharmacological, radioligand receptor binding studies and 
autoradiographic experiments (laduron, 1984). 
Different molecular models have been proposed for the interaction of the 
neurotransmitter or drug with the receptor; e.g. the occupation model, 
the rate theory, the two state model and the mobile receptor model 
(Hollenberg, 1978; Ariens et al., 1979). In this study equations based on 
the occupancy theory were used. Itiis theory assumes a bimolecular 
reaction of one drug with one receptor, at equilibrium with a 
dissociation constant (Kd) given by 
Kd = [D] [R] based on R + D > RD > E 
[RD] 
in which [D] = free concentration of drug 
[R] = free concentration of receptor 
[RD] = concentration RD-ccmplex 
E = effect 
Furthermore, the theory is based on a direct proportionality between the 
concentration of the receptor-drug-ccmplex and the pharmacological 
effect. 
In pharmaoology, the nervous system may be subdivided on the basis of 
different neurotransmitters, such as the cholinergic, adrenergic, 
histaminergic and dopaminergic system. Every system has characteristic 
neuroreceptors with a certain homogeneity; it has been suggested that 
these receptors may be derived from a common parent system (Topiol, 1987; 
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Venter et al., 1988) or common parent genes (Hall, 1987). In this chapter 
the different types of neuroreceptors and their biochemical coupling to 
the effector systems will be described. 
1.3.1. Biochemical coupling to effector systems 
In the biochemical coupling of receptors to the effector systems 
coupling proteins, G-proteins are often involved. The effector systems 
may comprise the adenylate cyclase, PI metabolism, guanylate cyclase and 
ion channels. One type of neuroreceptor can regulate more effector 
systems. The situation is even more complex, since many actions of the 
effector systems can interfere with other second messenger systems 
(Burgoyne et al., 1987). An overview of the distinct G-proteins, 
effector systems and their interactions is discussed below and 
illustrated in fig 1.4. 
1.3.1.1. G-proteins. 
G-proteins, or N-proteins, are intermediates in transmembrane signalling 
pathways. The G-proteins are heterotrimers with α-, β- and τ-subunits. 
Ihe a-subunit appears to be the primary effector of the system, it 
contains the GTP binding site and it exhibits CTP-ase activity. The 
/9.T-subunits play a role in the interaction with the receptor and 
G-protein stabilization, and are shared by various G-proteins. One 
receptor can interact with more than one G-protein (Kenakin, 1988) and 
different G-proteins are involved in different effector systems (Litosch, 
1987; Levitzki, 1987; Graziano and Gilman, 1987; Dolphin, 1987; Dunlap et 
al., 1987): 
- G
s
 and G¿ proteins are associated with adenylate cyclase activation and 
inhibition respectively. Ihe regulation of the catalytic unit by the 
two G-proteins is not symmetric; Gs is tightly bound to the unit, 
whereas G¿ has not been shown to form a conplex, and G¿ is usually 
present in much higher amounts than Gs. 
- Gp proteins are associated with activation of phospholipase C, 
resulting in an increased Pi-turnover. 
- Go proteins are associated with receptor mediated regulation of ion 
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Channels. 
- G-proteins associated with activation of phospholipase A2. 
1.3.1.2. Adenylate cyclase. 
Activation of neurotransmitter receptor sites enhance or reduce 
adenylate cyclase activity, catalysing the production of cAMP from ATP. 
In both cases the receptor signal is transmitted to the catalytic unit of 
adenylate cyclase through G-proteins (see 1.3.1.1.). The second messenger 
cAMP activates a kinase that catalyses the phosphorylation of cellular 
proteins and is converted to 5'-AMP by phosphodiesterase (Stiles et al., 
1984; Erma and Karbon, 1987). 
Ihe initial event of receptor stimulation is presumably the binding of 
the agonist (H) to the receptor (R) to forra the lew affinity HR-complex 
(fig. 1.5). Binding of this complex to G-proteins results in a ternary 
ccmplex (HRG), representing the high affinity state of the receptor. 
Hcwever, it is also possible that the receptor is firstly coupled to the 
G-protein, followed by binding of the agonist (Stiles et al., 1984; 
Levitzki, 1987; Neubig et al., 1988). 
H + R + G • HR + G 
H + RG • HRG 
The ternary complex induces a conformational change in the a-subunit, 
increasing GDP exchange for СТР. Two consequences ensue after the Mg2"1"-
dependent GTP binding to the G-protein. First, the R-G complex is 
destabilised, resulting in a conversion of the high affinity state to the 
lew affinity state, and second the G-protein is dissociated into its 
subunits. The subunit α-GTP ocmplexes probably with the effector system. 
The activated a-subunit has CTP-ase activity and beccmes deactivated when 
CTP is hydrolysed. Ihe a-GDP unit reassociates with the ß.r-unit (Stiles 
et al., 1984; Dolphin, 1987; Vauquelin et al., 1988). 
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Fig. 1.4.: 
Biochemical coupling of various neuroreceptors to effector systems. 
a=a-adrenoceptors, AA=arachidonic acid, ADP=adenosine 5'-diphosphate, ATP=adenosine 
5'-triphosphate, ß=ß-adrenoceptor, C=Catalytic unit, cAMP=adenosine S'S'-cyclic 
monophosphate, cGMP= guanosine 3'5'-cyclic monphosphate, CO=cyclooxygenase pathway, 
DG=diacylglycerol, ER=enoplasmic reticulum, G=G-protein, GC=guanylate cyclase, 
GTP=guanosine 5'-triphosphate, HAA=hydroperoxide of AA, IP3=inositoltrisphosphate, 
IP¿= inositoltetrakisphosphate, LO=lipoxygenase pathway, M=muscarinic receptor, 
PIP2=phosphatidylinositol 4'5'-biphosphate, PK=protein kinase, PL=phospholipid, 
PLC=phospholipase C, PLA2=phospholipase A2, R=receptor, +=stimulation, -=inhibition, 
ι 1 =second messenger. 
H.R.GQ^T 
high 
[ H.R.Ga/Зт ] 
GTP 
GDP 
CAMP 
Fig. 1.5: Adenylatecyclase regulation of the neuroreceptor by agonist, 
G-protein and GTP. ATP^adenosine S'-triphosfiiate, C=catalytic 
unit, сАМР=ааепо5Іпе 3'5'-cyclic monofiiosphate, Ga/0T=G-protein 
with subunits, GDP=guanosine S'-difiiosfiiate, GrP=guanosine 5'-
triphosphate, H^agonist, R=receç>tor. 
1.3.1.3. Phosphatidylinositol (PI) turnover. 
Activation of neurotransmitter receptor sites may enhance PI turnover. 
The receptor signal is transmitted to the enzyme phospholipase С through 
the Gp-protein (Cockcroft, 1987). Riospholipase С catalyses the 
conversion of PIP2 (phosphatidylinositol 4'5'-biphosphate) to IP3 
(inositoltrisphosphate) and DG (diacylglycerol). Ihe formed second 
messenger IP3 liberates Ca 2 + ions fron intracellular stores (endoplasmic 
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reticulum, calciosomes (Volpe et al., 1988)). liiere is a specific 
receptor for IP3 on the endoplasmic reticulum (ER), which mediates the 
opening of Ca 2 + channels in the ER membrane. The action of IP3 is 
terminated by dephosphorylation of the free inositol or by a kinase 
mediated phosphorylation forming IP4. IP4 may have a second messenger 
function in regulating the influx of Ca 2 + ions (Minneman, 1988b; 
Timmermans, 1988). The Ca 2 + activated Phosphorylase С may represent a 
positive feedback mechanism for Ca 2 + (Eberhard and Holz, 1988). Ihe 
second messenger DG stimulates protein kinase С and produces arachidonic 
acid metabolites, which may interact with other effector systems (see 
1.3.1.4.) (Burgoyne et al., 1987). Protein kinase C, activated by DG but 
also by Ca 2 +, modifies cellular activity by catalysing the 
phosphorylation of various substrates (Taylor and Merrit, 1986; 
Kaczmarek, 1987; Fisher and Agranoff, 1987). 
1.3.1.4. Guanylate cyclase. 
Activation of neurotransmitter receptor sites may enhance phospholipase 
A2 activity. Ihe receptor signal may be transmitted through G-proteins. 
Phospholipase A2, a calcium activated enzyme, catalyses the release of 
arachidonic acid from membrane phospholipids. Arachidonic acid activates 
phospholipase C, protein kinase С (see 1.3.1.3.) and has been shown to 
stimulate adenylate cyclase (see 1.3.1.2.) and guanylate cyclase. 
Guanylate cyclase can also be activated by Ca 2 + ions (Burgoyne et al., 
1987; Erma and Karbon, 1987) and catalyses the production of cOIP f rem 
GTP. Ihe second messenger cGMP activates a kinase that catalyses the 
phosphorylation of cell protein. 
1.3.1.5. Ion channels. 
Activation of receptors can lead to either de- or hyperpolarization, due 
to the opening or closing of ion channels. Regulation of the ion channels 
occur in different ways. The receptor may be the ion channel or distinct 
receptor and channel proteins interact with each other through 
G-proteins. The binding of the agonist at the receptor may also be 
follcwed by an alteration in the activity of an enzyme; the altered level 
of product may introduce changes in the open or closed state of a number 
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of channels throughout the cells, most probably by phosphorylation of the 
channels. Available evidence indicated a direct coupling between 
receptor, G-protein and K1" channel or Ca 2 + channels (Gomperts, 1983; 
Dunlap et al., 1987), but also an indirect activation of the ion 
channels by second messengers like protein kinase С (Christie and North, 
1988). 
1.3.2. Muscarinic acetylcholine receptors. 
The neurotransmitter acetylcholine has been shewn to act at two 
pharmaœlogically distirrct receptors, muscarinic and nicotinic receptors. 
Mjscarinic acetylcholine receptors are pharmacologically defined by their 
selectivity towards the agonist muscarine and the antagonist atropine. 
Ihese receptors mediate various types of responses in cardiac muscle, in 
numerous smooth muscles, in exocrine glands and throughout the 
peripheral and central nervous system (McKinney and Riciielson, 1984; 
Nathanson, 1987). 
Various subtypes of the muscarinic receptors have been identified over 
the past years on the basis of receptor binding and pharmacological 
experiments. Initially muscarinic receptors were subclassified on the 
basis of the selectivity profile of pirenzepine; receptors with high 
affinity for this ligand were identified as M^ subtypes, whereas the M2 
subtype was characterized by a lew affinity (Hammer et al., 1980; 
Hammer et al., 1982; Birdsall, 1984). Ihe М]^  subtype is mainly found in 
the central nervous system and sympathetic ganglia; the M2 subtype is 
found in the peripheral effector organs of the pjarasympathetic nervous 
system and also in parts of the central nervous system. M^ as well as M2 
receptors may be presynaptic muscarinic receptors involved in a negative 
feedback mechanism of the release of acetylcholine, norepinephrine or ATP 
(langer, 1981; Kilbinger, 1984; Wessler and Diener, 1987). 
After the develcpnent of several selective antagonists, it became clear 
that M^ (lambrecht et al., 1988) and N3 muscarinic receptors (Birdsall, 
1984) are not a homogeneous class. Muscarinic K^ receptors with high 
affinity for hexahydrodifenidol and hexacyclium are termed ganglionic 
Mjjj and those with lew affinity are termed hippocanpal M±
a
 (Lambrecht et 
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al., 1988). Ihe subdivision of M2 receptors has been demonstrated in 
functional and radioligand receptor binding studies by cardioselective 
antagonists, such as AF-DX-116 (Micheletti et al., 1987), gallamine 
(Clark and Mitchelson, 1976), methoctramine (Melchiorre et al., 1987) and 
by smooth muscle or gland selective antagonists luce 4-DAMP (Barlow et 
al., 1976) and hexahydrosiladifenidol (HHSiD) (Mutschler and Lambrecht, 
1984). Ihe classification of the M2 receptors is not unanimous but they 
can be divided into at least two subclasses; M2 (heart) or M2 (glands, 
smooth muscle) receptors. Ihe M2 (heart) receptors have been termed as M2
a 
(Mutschler and Lambredit, 1984) or Мгд (Eglen and Whiting, 1986) and 
M2 (gland, smooth muscle) receptors have been termed as ^β' M2B o r M3 
receptors (De Jonge et al., 1986; ladinsky et al., 1988). AF-DX-116 not 
only can differentiate between heart and glands but also displays an 
intermediate affinity for ileum smooth muscle (Hammer et al., 1986; 
Micheletti et al., 1987; Doods et al., 1987). Therefore a subdivision of 
M2 receptors into M2(heart), M3 (exocrine glands) and M4 (smooth muscle) 
has been proposed by Batink et al. (1987). Other authors demonstrated in 
ileum smooth muscle the cardiac and glandular muscarinic receptors, 
suggesting the heterogeneous presence of M2(heart) and M2(gland) subtypes 
(ladinsky et al., 1988; Giraldo et al., 1987). Recently, the 
classification scheme of M^, M2 and M3 receptors, based on differential 
affinity for selective antagonists has been generally accepted (Eglen et 
al., 1989). 
Molecular cloning studies have identified four distinct muscarinic 
receptors in the rat (Kubo et al., 1986) as well as in man (Eferalta et 
al., 1988). The pharmacological subdivision of M^ and M2 receptors is 
supported by shewing that the receptors located in the cerebral cortex 
and the heart represent distinct gene products (in rat ml and in2; in man 
HM1 and HM2). Furthermore, two additional muscarinic subtypes have been 
identified. In rat the phaimacology of these cloned subtypes (m3 and m4) 
is unknom (КідЬо et al., 1986); in man the other cloned subtypes (HM3 
and HM4) resemble the pharmacological defined Mj^  and N3 (gland) subtypes 
(Peralta et al., 1988). The receptor subtypes have also different amino 
acid sequences, although the receptors share a plasma membrane 
arrangement with seven hydrophobic transmembranal segments, a long C-
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terminal hydrophilic sequence, a shorter N-terminal hydrophilic sequence 
and a long loop between membrane segments V and VI. 
Activation of muscarinic receptors by agonists leads to various 
biochemical responses (McKinney and Richelson, 1984; Nathanson, 1987): 
- inhibition of the adenylate cyclase. 
Щ as well as M2 muscarinic receptor subtypes are coupled to the 
adenylate cyclase. 
On the basis of the agonist binding; muscarinic receptors have been 
divided into two (high and low) and sometimes into three agonist 
affinity binding sites (super high, high and low). The complex binding 
behaviour may be due to interconversion of different states of the 
receptor and/or the existence of distinct receptor subtypes (Birdsall, 
1984; Nathanson, 1987). 
- stimulation of the phosphatidylinositol (PI) turnover. 
An increased PI turnover is better correlated to the M^ subtype 
(Kunysz et al., 1988; Ashkenazi et al., 1987) but also occurs in M2 
muscarinic receptors (Noronha-Blob et al., 1988; Kunysz et al., 1989). 
- stimulation of c-GMP synthesis. 
The precise mechanism of activation of these receptors to stimulate 
guanylate cyclase has not been unequivocally established. Ca 2 + ions but 
also arachidonic acid metabolites (see 1.3.1.4.) have been suggested as 
possible mediators. 
- regulation of transmembranal ion transport (Ca2+, K1" and Na+ ions). 
Muscarinic agonists activate K*" channels in cardiac tissue, glands and 
some neurons and close those channels in many neurons. Muscarinic 
agonists increase Ca^ "1" and Na+ permeability in mammalian smooth muscle, 
seme glands and neurones, and decrease Ca 2 + permeability in cardiac 
smooth muscle and in other neurones (North, 1986; Nathanson, 1987). The 
muscarinic regulation of the ion channels is not fully understood. 
Activation of M2 (heart) receptors leads to the opening of K4" channels 
through an intervening G-protein (Oiristie and North, 1988). It is 
possible that Ca 2 + channels, coupled to M2(gland), are opened in a 
similar way (Marty, 1987). On the other hand the indirect activation 
of ion channels is caused by second messengers (see 1.3.1.5.). 
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1.3.3. Beta-adrenoceptors. 
The synpathetic neurotransmitters have been shewn to act at two 
pharmacologically distinct receptors, a- and ^-adrenoceptors. The 
/3-adrenoceptor is defined as a receptor for which the agonist 
isoprenaline is more potent than epinephrine, which again is more potent 
than rorepinephrine. Ihe /3-adrenoceptor activities are specifically 
inhibited by the antagonist propranolol (Ahlquist, 1948). 
Two pharmacologically distinct subtypes of ^-adrenoceptors, termed ßj-
and ^-adrenoceptors, have been distinguished on the basis of their 
relative affinities for the agonist epinephrine and rrarepinephrine (Lands 
et al., 1967). The /3-L-adrenoceptor binds both agonists with approximately 
equal affinity, whereas ^"Sdreno^Ptare have a 30 fold higher affinity 
for epinephrine. Subsequent to this initial classification various 
/3-adrenergic agonists and antagonists have been developed to distinguish 
between these subtypes (Minneman and Molinoff, 1980; Milavec-Krizman et 
al., 1985). The subtypes may be present in the same tissue (Minneman et 
al., 1979) but /Зз^ -adrenoceptors predominate in heart (force and rate) 
and adipose tissue (lipolysis), whereas the ^ 2 - a (i r e n o c ePt or s predominate 
in lung (relaxation), liver and smooth muscle (relaxation). Presynaptic 
ßl, as well as /^-adrenoceptors are only negligibly involved in a 
positive feedback mechanism (langer, 1981; Starke, 1987). According to 
Ariens and Simonis (1983) ^-adrenoceptors are meant for the 
neurotransmitter noradrenaline and ^2-acirenocePtors for t*16 hormone 
adrenaline. 
Recently, the primary structures of the human ßy- and /З2-adrenoceptors 
have been deduced from the cloning of their genes and/or cDNA. Certain 
amino acid sequences of the two receptor proteins are similar and both 
receptors share a plasma membrane arrangement with seven hydrophobic 
transmembranal segments (20-25 amino acids), a long C-terminal 
hydrophilic sequence, a shorter N-terminal hydrophilic sequence and a 
long loop between membrane segments V and VI (Hall, 1987). Ihe 
pharmacological subdivision of the /3^  and ^"atanoceptors is supported 
by demonstrating that the receptors are derived from different genes 
(Frielle et al., 1988). 
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Agonist stimulation of /З^ - as well as ^-adrenoceptors cause a 
stimulation of the adenylate cyclase, but they can be independently 
regulated (Donnell and Wanstall, 1987). This stimulation is mediated 
through G
s
 as well as G¿ proteins. The ability of the G¿-proteins to 
interact with a stimulatory action may be caused by changing the G¿(GDP)-
C-complex (Ocatalytic unit) for Gs (GDP) -C-cctnplex (Lsvitzki, 1986; 
Levitzki, 1987; Vauquelin et al., 1988). However, not all /3-adrenoceptors 
are able to bind with the Gg-protein but all ^-adrenoceptors induce 
conformational changes, i.e. a temporary opening of the disulphide bond 
in the receptor, in the first phase of agonist stimulation (Vauquelin et 
al., 1988). On the basis of the agonist binding 
^-adrenoceptors have been divided into high and low affinity agonist 
binding sites 
1.3.4. Alphai-adrenoceptors 
The initial subclassification of α-adrenoceptors was based on their 
localization; presynaptic o^ -adrenoceptors and postsynaptic 
a^-adrenoceptors (langer, 1974). Ihis anatomical classification appeared 
to be incorrect since a^-adrenoceptors are also located postsynaptically 
(Berthelsen and Pettinger, 1977). Subsequently the a-adrenoceptors have 
been divided into their subtypes based on their pharmacological profiles 
(Hoffman et al., 1979; Timmermans and van Zwieten, 1982; Johansson, 1984; 
Vizi, 1986). 
Alphaj-adrenoceptors are pharmacologically defined by their binding 
selectivity for the agonists phenylephrine, methoxamine, SKF89748, 
cirazoline and of the antagonists prazosin, БЕ2254 and corynanthine 
(Timmermans and van Zwieten, 1982; Hieble et al., 1986; Vizi, 1986). The 
a-j-adrenoceptors are predominantly postsynaptic sites (Starke, 1987) in 
smooth muscle, liver, heart, salivary and sweat glands, adipose tissue, 
kidney and brain. They mediate mainly stimulatory physiological actions 
(oontractioiyrelaxation, glucogenolysis, positive irrotropy/chronotropy, 
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secretion, Na+ absorption)(Timmermans, 1988). 
Recently, the presence of a^-adrenoceptors subtypes has been suggested 
because of differences in the potencies of drugs, differences in 
affecting contraction of smooth muscle, differences in second messenger 
formation in liver and brain and differences in inhibiting radioligand 
binding. The antagonist WB4101 distinguishes high, a^, and lew affinity 
binding sites, a 1 B (Morrcw and Creese, 1986; Han et al., 1987). The agent 
chlorethylclonidine was found to inactivate a^-adrenergic binding sites 
and functional responses in seme tissue. It has been suggested that the 
dilorethylclonidine-sensitive and -insensitive sites are equivalent to 
those with a lew and high affinity for WB4101 (Minneman et al., 1988a). 
Agonist stimulation of a^-adrenoceptors leads to: 
- an increased PI turn over, probably mediated by the a^-adrenoceptor 
subtype (Minneman, 1988b; Timmermans, 1988). Generally, a homogeneity 
of agonist binding to ад-adrenoceptors has been observed (Agrawal and 
Daniel, 1985; Guicheney and Meyer, 1981). Recently, several studies 
indicated high and low, GTP-sensitive agonist binding sites (Terman et 
al., 1987; Jagadeesh and Deth, 1987). 
- directly opening of Ca 2 + channels (Chiù et al., 1987) probably mediated 
by the a-uj-adrenoceptor subtype (Minneman, 1988b). 
- possible stimulation of adenylate and guanylate cyclase. These 
alternate biochemical responses have been suggested but may be indirect 
responses of the PI turnover (Minneman, 1988b). 
1.3.5. Alpha2-adrenoceptors. 
Itie a2-adrenoceptors are pharmacologically defined by their binding 
selectivity of the agonist oxymetazoline, ΒΗΓ920 and of the antagonists 
rauwolscine (stereoisomer of yohimbine), idazoxan and RX781094 
(Timnermans and van Zwieten, 1982; Vizi, 1986). Radioligand and 
functional studies indicated that o^-adrenoceptors are not a homogeneous 
group with differences in rodents and non-rodents. A definition of the 
a2-adrenergic subtypes is proposed on the base of the affinity for 
prazosin; а2д and 023 receptors having a low and a high affinity 
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respectively (Bylund, 1985; Nahorski et al., 1985). Molecular cloning 
studies have identified 2 distinct genes, which may represent the a?-
adrenoceptor subtypes. Ihe deduced amino acid sequence is roost similar to 
the cloned ^-adrenoceptors and also to the muscarinic cholinergic 
receptors (Kobilka et al., 1987). 
Postsynaptic α2-adrenoceptors have been found in vascular smooth muscle 
(vasoconstriction), platelets (aggregation), fat cells (inhibition 
lipolysis) and pancreatic islands (inhibition hyperglycemia). Presynaptic 
a2-adrenoceptors have been found in noradrenergic nerve endings (e.g. in 
the pulmonary artery, heart, vas deferens), cholinergic nerve endings 
(e.g. bladder, stomach, ileum) and serotonergic nerve endings 
(hippocampus) (Timmermans and van Zwieten, 1982). Presynaptic «2-
adrenoceptors are involved in a negative feedback of the release of the 
transmitter norepinephrine. The presynaptic receptors are called 
autoreceptors, if the noradrenergic neuron A inhibits its own 
norepinephrine (A) release; they are called heteroreceptors if the 
noradrenergic neuron В inhibits the norepinephrine release fron neuron A 
(Timmermans and van Zwieten, 1982; Timmermans, 1988). 
Agonist stimulation of 0:2 -adrenoceptors results in (Exton, 1982; 
Timmermans, 1988): 
- inhibition of the adenylate cyclase system for postsynaptic and 
probably also presynaptic o^-adrenoceptors. On the basis of the 
agonist binding, o^-adrenoceptors have been divided into two (high 
and lew) and sometimes three (super high, high and low) agonist 
affinity binding sites (Michel et al., 1980; U'Prichard et al., 
1983). 
- regulation of the transmembranal ion transport. Stimulation of 
presynaptic a2 - a (i r e n o c eP t o r s inhibits the inward current of Ca2+ ions 
via potential-sensitive permeability channels, whereas stimulation of 
postsynaptic 02-adrenoceptors promotes the influx of Ca 2 + ions. It has 
been suggested that stimulation of presynaptic a2 - ad r e n c i c eP t o r' s results 
in a promotion of K*" conductances (Tirnnermans, 1988). 
No data are available about differences in biochemical responses of the 
Q!2_adrenoceptors subtypes. 
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1.3.6. Neuroreceptors in the nasal mucosa. 
The presence of cholinergic muscarinic receptors has been demonstrated 
in homogenates of the nasal mucosa of rat (KLaassen et al., 1986b), 
guinea pig (Ishibe et al., 1985; Konno et al., 1985) and man (Ishibe et 
al., 1983; Καηηο et al., 1987a). Muscarinic receptors have been localized 
in the nasal glands after in vivo administration of 3H-1-QNB, followed by 
careful dissection and autoradiography (KLaassen et al., 1984). 
Ihe presence of adrenergic receptors has been demonstrated in 
homogenates of the nasal mucosa of guinea pig (Ishibe et al., 1985; 
Kònno et al., 1986; Konno et al., 1987a) and man (Ishibe et al., 1983, 
Kònno et al., 1987a). 
1.4. Nasal hyperreactivity. 
1.4.1. Definition, classification and terminology. 
Reactivity should ideally be expressed in terms of a stimulus-response 
curve, which is a sigmoid curve for most systems. Generally, 
hyperreactivity can be described as a shift in the stimulus-response 
curve. One of the major problems hcwever in studying nasal 
hyperreactivity is that there are no adequate methods available for 
measuring nasal responses. Hcwever, symptcms of nasal hyperreactivity 
can best be defined as an increased response of a nasal effector system 
to a stimulus (Widdicotnbe, 1983). Ihe increased responses (clinical 
nasal synptoms) are sneezing, hypersecretion and nasal obstruction 
(Mygind, 1978; Mygind, 1986). Stimuli may be specific (allergens) or 
non-specific (cold air, irritants). Allergens consist of pollen, 
microfungi, house dust mites and animal products (dander and urine). 
Ihe terms atopic and allergic rhinitis have been used for specific nasal 
hyperreactivity. Atopic Hicmgog include allergic rhinitis and allergic 
astma. Ihe atopic subjects respond to a daily exposure of minute amounts 
of allergen. In the immediate, type I anaphylactic reaction (Coombs and 
Gell, 1975) the allergens react with IgE attached to the surface of the 
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mast cells, the cells degranulate and liberate chemical mediators, 
responsible for the symptoms (Mygind, 1986). The late reaction in the 
airways are consequences of the type I reaction (Mygind, 1986). 
Allergic rhinitis can be divided into seasonal and perennial allergic 
rhinitis (Mygind et al., 1985). Seasonal allergic rhinitis is a 
generally accepted term for hay fever or pollinosis; the synçtoms being 
seasonal and the allergens pollen (Frankland et al., 1985). Perennial 
rhinitis is not so well defined; the symptoms are not always perennial, 
the predominant allergen being the house dust mite (Wihl et al., 1985). 
Ihe prevalence of allergic rhinitis in the adult general population may 
be estimated at approximately 10%; the prevalence in males being 
significantly higher than in females. Ihe symptoms may occur between the 
ages of 5-45 years, but occur especially in the 10-20 year age group 
(Wëeke et al., 1985). There is often a simultaneous occurrence of 
allergic rhinitis with asthma; about 18% of allergic rhinitis patients 
also have asthma and about 50% of asthmathic patients have allergic 
rhinitis. The short interval between the onset of the two diseases in the 
same individual strongly indicates that both are manifestations of the 
same reaction (Weeke et al., 1985). 
1.4.2. Pathophysiological mechanisms. 
Ihe kncwledge of the pathophysiological mechanism of allergic rhinitis is 
still incomplete, but clinical manifestations have been described. Many 
immunological manifestations in the immediate and late reaction have 
been observed: 
Immediate reaction 
- Elevated IgE in the serum and nasal secretions (Mygind, 1978). 
- Increase of the number of inflammatory cells; basophilic leucocytes and 
mast cells (Okuda et al., 1983; Ohtsuka et al., 1986; Ukai et al., 
1986; Gomez et al., 1986), neutrophils and eosinophils (Ukai et al., 
1986; Frick et al., 1988; Styrt et al., 1988). 
- Degranulation of mast cells (Trotter and Orr, 1973; Corrado et al., 
1985) and increasing concentrations of biochemical mediators such as 
histamine, TAME-esterase and arachidonic metabolites (prostaglandin 
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D2)(Goetzl, 1981; Naclerio et al., 1986; Brown et al., 1987; Linder et 
al., 1988). Degranulation of mast cells may cause hypersecretion (Konno 
et al., 1987b) 
late reaction 
- Increasing concentrations of the mediators histamine and TAME-esterase 
but not the irediator prostaglandin D2, suggesting that basophils are 
partly responsible for the late response (Naclerio et al., 1985 ; 
Norman, 1985). 
Besides the immunological manifestations neurological manifestations 
have also been observed: 
- Cholinergic hypersensitivity. 
(Kaliner et al., 1982; Corrado et al., 1986; Devillier et al., 1988) 
- ^ -adrenoceptor hyposensitivity. 
(Kaliner et al., 1982; Shelhamer, 1983) 
- Autoantibodies against /3-adrenoceptors. 
(Venter et al., 1980; Kaliner et al., 1982) 
- Histamine hypersensitivity. 
(Eccles, 1983; Corrada et al., 1986; Ukai et al., 1986) 
- Sensory hypersensitivity. 
(Payan e t a l . , 1984; l^nessen e t a l . , 1988) 
These data suggest a m u l t i f a c t o r i a l pathogenesis of nasal 
hyperreactivity. Specific and non-specific nasal hyperreactivity may be 
due to (Mygind, 1982b): 
1. an increase in the epithelial permeability. 
Mygind (1982b) proposed a hypothesis for the pathogenesis of immediate 
allergic rhinitis. Allergen exposure to the sensitised nasal mucosa 
increases the number of basophilic leucocytes and mast cells. 
Histamine, released from these cells, increases epithelial 
permeability and prenotes allergen penetration and contact with other 
mast cells. Other authors suggested an increase of epithelial 
permeability by an increase in the number of eosinophils, which 
destruct the mucociliary apparatus (Frigas and Gleich, 1986; Frick et 
al., 1988). Histamine also increases vascular permeability and dilates 
blood vessels mainly via a direct effect on vascular H^ and H2 
receptors. Itching, sneezing and hypersecretion are caused by 
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histamine effects on nervous H^ receptors; hypersecretion being 
mediated via a parasyirpathetic reflex in the trigeminal and vidian 
nerve. 
2. an increased sensitivity of the sensory nerves 
According to Payan et al. (1984), non-specific stimuli may increase 
the release of SP fron the sensory nerves. The immediate effects of 
SP would be vasodilatation and activation of mast cells. The mast cell 
mediators could then amplify the initial inflammatory response. 
3. a changed modulation of the afferent impulse. 
No data are available to support this hypothesis. 
4. an increase in the number or sensitivity of receptors on effector 
cells, resulting in an imbalance of the autonomic nerve regulation. 
Qiolinergic hyperresponsiveness and ^-adrenergic hyporesponsiveness 
have been observed in allergic patients in comparison with controls 
(see neurological factors). Hyper- and hypo-responsiveness have been 
explained in terms of changes in neuroreceptor numbers in the lower 
airways of asthmatic patients (Szentivanyi, 1968; Barnes et al., 
1980). Changes in the numbers of neuroreceptors in the nasal mucosa of 
allergic patients in comparison with chronic sinusitis patients have 
been reported (Ishibe et al., 1983). 
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1.5. Outline of the thesis. 
Ihe present study deals with the biochemical and autoradiographic 
analysis of neuroreceptors in the nasal mucosa in order to elucidate the 
supposed changes in the distribution pattern of the neuroreceptors in 
nasal hyperreactivity. Radioligand receptor binding and in vitro 
autoradiographic assays were developed for studying the biochemical 
characteristics, densities, sensitivities, subclasses, receptor-effector 
coupling and localization of neuroreceptors in the nasal mucosa. In the 
first instance, the rat was used as an experimental model, so that the 
restricted amount of human nasal mucosa was not a limiting factor. 
The pharmacological characterization of muscarinic receptors in 
homogenates of rat nasal mucosa has partly been described (Rodrigues de 
Miranda et al., 1985; Klaassen et al., 1986b). In chapter 2, the 
muscarinic subclasses and the agonist binding to muscarinic receptors 
will be described. An in vitro autoradiographic assay was developed to 
localize the muscarinic receptors in the rat nasal mucosa and is 
described in chapter 3. The pharmacological characterization and 
localization of the ^-adrenoceptors in rat nasal mucosa is described in 
chapter 4. Ihe characterization of the a^- and a2-a|irenocePtors in 
homogenates of rat nasal mucosa is described in chapter 5 and 6 
respectively. Until now, it was not possible to locate these receptors. 
Radioligand receptor binding and in vitro autoradiographic experiments 
were applied to human nasal mucosa. Bicpsies were taken from patients 
with either an allergic or non-allergic rhinitis. The non-allergic 
patients were further subdivided into a control, a vasomotor rhinitis and 
a chronic sinusitis group (chapter 7). Bicpsies were studied 
histologically to investigate the constituents of the biopsies used for 
the biochemical studies and for possible changes in nasal 
hyperreactivity (chapter 8). Ihe pharmacological characterization and 
localization of the muscarinic and adrenergic receptors in the nasal 
mucosa of non-allergic and allergic patients will be described in chapter 
9 and 10 respectively. 
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CHAPTER 2 
ШЗСАКШГС АСЕГ¥І£НОІЛНЕ НВСЕРИЖЗ IN HCMDGENÄTES OF RAT NASAL MJOOSA. 
Y.J.B, van Megen1, A.B.M. KLaassen1, J . F . Rodrigues de Miranda2 , R.lï i .R. 
Wentges1 and C.A.M, van Ginneken2. 
Departments of Otorhinolaryngology1 and Pharmacology2, Un ive r s i ty of 
Nijmegen, I h e Nether lands . 
2.1. Abstract 
Muscarinic acetylcholine receptors have been demonstrated in homogenates 
of rat nasal mucosa (Rodrigues de Miranda et al., 1985; KLaassen et al., 
1986). The relatively high Kd-value and the extraordinary homogeneous 
agonist binding sites reported in that study might be due to proteolysis. 
In this study the Kd-value of the 3H-1-QNB binding was significantly 
lewer and the competition of the agonist for the antagonist binding 
demonstrated 25+7% high affinity sites after the addition of protease 
inhibitors. In the presence of guanine nucleotides a monophasic 
inhibition curve was obtained. 
The M2 subtype selective antagonists AF-DX-116 and HHSiD inhibited 
3H-1-QNB with lew and high affinity respectively, indicating that the M2 
receptors in rat nasal mucosa are of the M2 (gland) or M3 subtype. 
2.2. Introducticn 
Physiological and neurohistochemical experiments have demonstrated that 
the parasyrpathetic nervous system plays an essential role in the 
regulation of the vasomotor and secretory activities of the nasal mucosa 
(Grote et al., 1975; Anggârd, 1977; Malm, 1983; Vecerina et al., 1983). 
Radioligand receptor binding studies have already demonstrated 
cholinergic muscarinic receptors in homogenates of rat nasal mucosa 
(Rodrigues de Miranda et al., 1985; KLaassen et al., 1986). Specific 
binding of 3H-1-QNB (Quinuclidinylbenzilate), a cholinergic antagonist, 
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to rat nasal mucosa honogenates occurs to an homogeneous class of binding 
sites, with a dissociation constant of 0.06±0.02 riM and a receptor 
density of 8±2 pmol/g tissue (Klaassen et al, 1986). Ihis binding is 
stereoselectively inhibited by benzetimide enantiomers, demonstrating the 
muscarinic character of the receptors. Ihe agonists methyl furtrethonium 
and methacholine inhibit 3Н-1-С2ГО binding at high concentrations, 
pointing to the presence of an hcniogeneous population of lew affinity 
agonist binding sites in 4 out of 6 experiments (Rodrigues de Miranda et 
al., 1985; Klaassen et al., 1986). This is rather exceptional because 
heterogeneity of agonist binding has been a predominant feature of 
muscarinic receptors in a variety of tissues (Birdsall, 1984; McKinney 
and Richelson, 1984; Nathanson, 1987). 
Muscarinic receptors were subclassi f ied on their selective profile of 
pirenzepine (Hammer et al., 1980; Birdsall, 1984). Pirenzepine displaces 
Зн-І-ОМВ binding with lew affinity (5xl0-6 M) in rat nasal mucosa, 
classifying the muscarinic binding sites as M2 receptors (Rodrigues de 
Miranda et al., 1985; Klaassen et al., 1986). After the development of 
selective antagonists, it became clear that M2 muscarinic receptors are 
not an homogeneous class. The subdivision of Mj receptors in 
M 2 (heart) (^а^гд)
 a n t i
 M2 (gland) (^/f^B"*^) subtypes has been 
demonstrated in functional and radioligand receptor binding studies by 
cardioselective antagonists such as AF-DX-116 and by glandselective 
antagonists such as Hexahydrosiladifenidol (HHSiD) (Mutschler and 
lantorecht, 1984; Eglen and Whiting, 1986; Micheletti et al., 1987; 
ladinsky et al., 1988). Ihe pharmacological subdivision of M2 receptors 
has been supported by molecular cloning studies (Kubo et al., 1986; 
Peralta et al., 1988). 
In this study the muscarinic acetylcholine receptors were further 
characterized in honogenates of rat nasal mucosa with respect to the 
presence of M2 muscarinic subclasses and their extraordinary agonist 
inhibition. In earlier studies inclusion of the protease inhibitors IMSF 
and EDIA during honogenization and incubation did not affect the binding 
parameters of the antagonist and agonist binding (Rodrigues de Miranda et 
al., 1985). In this study, the effect of the inclusion of other protease 
inhibitors, leupeptin and pepstatin, during honogenization and irœubation 
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was investigated. 
2.3. Materials and methods 
3H-1-QNB (Quinuclidinylbenzilate) (spec. act. 33.1 Ci/mmol) was purchased 
from New England Nuclear, Doom, Ihe Netherlands. AF-DX-116 was a gift 
from Dr. Karl Ihomae QnbH; HHSiD and 1-<2NB were gifts from Dr. G. 
Lambrecht, Wolfgang Goethe University, Frankfurt, West-Germany. 
Methylfurtrethonium was synthesized in our laboratory according to known 
procedures. PMSF (phenylmethylsulfonylfluoride), Gpp(NH)p (5·-
guanylylimidodiphosphate), leipeptin, pepstatin and HEEES were cijtained 
from Sigma, Chemical Company, St. Louis, M.O., U.S.A. All other chemicals 
were of analytical grade. 
The nasal mucosae from Wistar rats (about 200g body weight) were 
dissected, immediately frozen (acetone/CC^ bath) and stored at -80oC. Ihe 
tissue weis homogenized in icecold Tyrode buffer (pH 7.4) or HEPES-PI 
buffer (20 nM HEEES, 120 irM NaCl, 10 mM MgO^, 1 irM IWSF, 1 irti EDTA, 0.01 
πΜ leupeptin and 0.01 nM p^statin) with an Ultraturrax for 2x10 sec. Ihe 
homogenate was centrifuged at lOOOxg for 5 min. The supernatant was 
collected and centrifuged at 100,000xg for 1 hour (40C). The pellet was 
resuspended by Potter homogenization in Tyrode or HEPES-PI buffer. 
Radioligand receptor binding studies were carried out in conical plastic 
centrifuge tubes, containing 40 μΐ 3H-1-QNB, 40 μΐ Tyrode or HEPES 
buffer and 320 μΐ tissue homogenate (12.5 mg/ml Tyrode or HEPES-PI 
buffer). Non-specific binding was determined in the presence of 12 μΜ 
1-QNB. The honogenates were incubated for 90 min. at З ^  under rotation 
(10 rpm) and centrifuged for 15 min. at 18,000xg. Aliquots (250 μΐ) of 
the supernatants were mixed with 10 ml of scintillation fluid (Aqua Luma, 
lumac) for determining free concentrations of radioligand. The remaining 
supernatant was removed by suction. Ihe tips of the centrifuge tubes were 
mixed with 10 ml Aqua luma and the samples were counted in a liquid 
scintillation counter. Ihe binding parameters were calculated by 
subjecting the data to a non-linear least squares curve fitting procedure 
using the Gauss Newton algorithm (Fletcher and Pcwell, 1963). Inhibition 
curves were analysed according to a one or two binding sites model. 
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2.4. Results 
Specific 3H-1-QNB binding to muscarinic receptors in homogenates of rat 
nasal mucosa in the presence of protease inhibitors (EMSF, EDTA, 
leupeptin, pepstatin) was saturable with a dissociation constant (Kd) of 
0.04±0.02 nM and a receptor density (Btax) of 9.0±2.6 pmol/g tissue (n=5) 
(fig. 2.1). The Kd-value of the 3H-1-QNB binding with protease inhibitors 
was significantly lower than the Kd-value (0.06±0.02 nM) determined in 
the absence of protease inhibitors (Rodrigues de Miranda et al., 1985 ; 
Klaassen et al., 1986). All other experiments were performed in the 
presence of these inhibitors to be certain that maximal precaution was 
taken. 
bound ' H - l - Q N B I p m o l / g l -
bound/free 
0 5 Го 15 20 
"H-I-QNB free (nM) 
Fig. 2.1: Specific 3H-1-QNB binding to homogenates of rat nasal mucosa 
in the presence of the protease inhibitors FMSF, EDTA, 
leupeptin and pepstatin. Total binding (O) and non-specific 
binding (Δ) wer« determined in the absence and presence of 
1-QNB. Ihe line without points represents the specific 
3H-1-QNB binding. Inset: Scatchard plot of the specific part 
of the binding. Data shown are the means of triplicates from 
a representative experiment. 
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Inhibition of the full agonist methylfurtrethonium displayed a biphasic 
character (Ki^.310.1 μΜ and КІ2=7.0±0.5 μΜ) indicating the presence of 
25+7% Ыф affinity agonist binding sites (n=3) (fig. 2.2). In the 
presence of 10 - 4 M Gpp(NH)p the agonist inhibition curve was monophasic 
(Ki=8.9 iM), suggesting a conversion of the Ыф. into the 1см affinity 
agonist binding sites. 
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Fig. 2.2: 
Inhibition of the specific 
3H-1-QNB binding to haroogenates 
of rat nasal mucosa by the 
agonist methy furtrethonium in 
absence (0) and presence (·) of 
IO-4 M Gpp(NH)p. The curve in the 
absence of Gpp(NH)p could 
significantly better fitted by a 
two binding sites model, whereas 
the curve in the presence of 
Gpp(NH)p could adequately be 
fitted by a one binding site 
model. Data shown are the means 
of triplicates. 
Fig. 2.3: 
Inhibition of specific 3H-1-QNB 
binding to homogenates of rat 
nasal mucosa by the antagonists 
AF-DX-116 (·) and HHSiD (0). The 
curves could adequately be fitted 
by a one binding site model. Data 
shown are the means of 
triplicates frem a representative 
experiment. 
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Itie subtype selective antagonists AF-DX-116 (heart selective) and HHSiD 
(gland selective) were used to investigate muscarinic receptor subclasses 
in rat nasal mucosa. The inhibition curves of AF-DX-116 (Ki=0.98±0.13 μΜ; 
n=3), as well as HHSiD (Ki=0.025±0.003 μΜ; n=3) were monophasic, 
suggesting the presence of an homogeneous population of M3 receptors in 
rat nasal mucosa (fig. 2.3). 
2.5. Discussicn 
Specific 3H-1-QNB binding to muscarinic receptors in homogenates of rat 
nasal mucosa has been described elsewhere (Rodrigues de Miranda et al., 
1985; KLaassen et al., 1986). In that study the binding was of high 
affinity with Kd-value of 0.06±0.02 riM. Ihis Kd-value appeared to be 
somewhat higher than described in other rat tissues (Watson et al., 1986; 
Batra, 1986; Gies et al., 1987). The agonist inhibition curve appeared to 
be monophasic in 4 out of 6 experiments. Ihis is rather exceptional 
because heterogeneity of agonist binding has been a predominant feature 
of muscarinic receptors in a variety of tissues (Birdsall, 1984; 
Nathanson, 1987). Proteolysis of muscarinic receptors has been described 
in electrophoresis (Birdsall et al., 1979) and radioligand binding 
studies (Aronstam and Greenbaum, 1984; Batra, 1986). Ihe higher Kd-value 
and the extraordinary hcroogeneous agonist binding sites demonstrated in 
earlier studies may be due to proteolysis and therefore FMSF and EDTA, 
serine and metalloprotease inhibitors respectively, were included during 
antagonist and agonist binding. Нслге ег, inclusion of the protease 
inhibitors did not affect the binding parameters of antagonist and 
agonist binding (Rodrigues de Miranda et al., 1985). 
In this study pepstatin and leupeptin, inhibitors of carboxyl and 
thiolproteases respectively, were included in addition to FMSF and EDTA 
during homogenization and incubation. The Kd-value (0.04±0.02 nM) of the 
3H-1-QNB binding to homogenates of rat nasal mucosa was significantly 
lewer in the presence of the four protease inhibitors in comparison with 
the Kd-values determined in the presence of MSF and EDTA alone. The 
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present results shew that in homogenates of rat nasal mucosa the agonist 
inethylfurtrethonium binds to high (25±7%) and low affinity agonist 
binding sites. The Ki-values were in agreement with those described in 
bovine (Beld et al., 1980) and human tracheal smooth muscle (van Koppen 
et al., 1985). It has been accepted that the high affinity complex 
consists of agonist, receptor and guaninenucleotide binding protein 
(Birdsall, 1984; Nathanson, 1987). In the presence of 1СГ4 M С£р(Ш)р a 
monophasic inhibition curve was observed. This complete conversion of the 
high into the low affinity agonist binding sites has been demonstrated in 
other tissues (Birdsall, 1984; Nathanson, 1987), but incomplete 
conversion has also been observed (Vanderheijden et al., 1987; Rinner et 
al., 1988). 
Ihe M2 (heart) and M2 (gland) selective antagonists AF-DX-116 and HHSiD 
inversely inhibited the 3H-1-QNB binding in membranes of rat nasal 
mucosa. AF-DX-116 showed only low affinity, whereas HHSiD showed only 
high affinity for the 3H-1-QNB binding sites, suggesting an homogeneous 
population of M2 (gland) subtypes, also described as M3 receptors, in rat 
nasal mucosa. The Ki-values of AF-DX-116 inhibition were in agreement 
with those determined in rat submandibular glands (Martos et al., 1987) 
and in rat pancreas (Waelbroeck et al., 1987) ; the Ki-values of HHSiD 
inhibition were in agreement with those reported in rat submaxillary 
glands (Baudière et al., 1987) and in rat pancreas (Waelbroeck et al., 
1987). Ihe presence of M2 (gland) subtypes in rat nasal mucosa is 
supported by in vivo and in vitro autoradiography (KLaassen et al., 1984; 
van Megen et al., 1988). Ihe autoradiograms demonstrated specific 
3H-1-<2NB labelling of muscarinic receptors in rat nasal glands. 
In further experiments, agonist and antagonist binding will be performed 
in the presence of protease inhibitors in human nasal mucosa to study the 
supposed changes in the distribution pattern of receptors vinder 
pathological conditions such as nasal hyperreactivity. 
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CHftPTER 3 
АШШАЕШХКЫШС ANAI^SIS OF MUSCARINIC НЕХЗШЖБ IN RAT NASAL GLANDS. 
Y.J.B. van M e g e n 1 ' 2 , M.J. Teunissen 1 , A.B.M. Klaassen 1 and J . F . Rodrigues 
de Miranda 2 . 
Departments of Otortiinolaryngology·1- and Fharmacology2, U n i v e r s i t y of 
Nijmegen, P h i l i p s van Ifi i jdenlaan 15, 6500 HB Nijmegen, I h e Nether lands . 
(published i n Eur. J . Fharmacol. 145: 7, 1988) 
3.1. Abstract 
An in vitro method was developed for the biodiemical and autoradiographic 
demonstration of low muscarinic receptor densities in peripheral tissue. 
Histological criteria point clearly to the necessity for fixation to 
preserve tissue quality. 3H-1-Quinuclid:inyibenzilate bound specifically 
to a hcmogeneous class of binding sites in 0.5% glutardialdehyde-fixed 
cryostat sections (10 /an) of rat nasal glands with high affinity 
(ка=0.47±0.0б nM) and with a receptor density (йпах) of 41+1 fmol/mg 
protein. Ihis binding was linearly dependent on the thickness of the 
sections. Kinetic experiments resulted in a Kd-value of 0.19 riM. Binding 
weis stereoselctively inhibited by benzetimide enatiomers. Autoradiograms, 
generated after incubation with 0.6 nM 3H-1-Quinuclidinylbenzilate and 
dipping in nuclear K2 emulsion, shewed specific labelling of glandular 
acini and excretory ducts. These in vitro observations provide conclusive 
evidence for the presence of acetylcholine receptors in the nasal glands 
of the rat. 
3.2. Introduction 
Ihe parasympathetic nervous system plays an essential role in the 
regulation of the vasomotor and secretory activities of the nasal mucosa. 
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Physiological experiments in animals have demonstrated the presence of 
acetylcholine receptors in nasal vessels and glands. Metacholine causes a 
vasodilatation, which can be blocked by atropine (Malm, 1983). Electrical 
stimulation of parasympathetic nerves in the nasal glands provokes 
secretion which can be inhibited by atropine (Eccles and Wilson, 1973; 
Anggârd, 1974; 1977). Neurohistodiemical investigations also point to the 
existence of a well developed parasympathetic nervous system in the 
respiratory part of the nasal mucosa (Ishii and Toriyama, 1972; Grote et 
al., 1975; Vecerina et al., 1983). The innervation of the nasal glands 
appears to consist of acetylcholinesterase-containing fibres. Ihe 
vascular structures, especially the sinusoids, also shew a very dense 
network of these fibres. 
Padioligand receptor binding assays could provide more quantitative data 
on the density and biochemical characteristics of the receptors involved. 
Muscarinic acetylcholine receptors have been described in the nasal 
mucosa of the rat (Rodrigues de Miranda et al., 1985), guinea pig (Ishibe 
et al., 1985; Konno et al., 1985) and man (Ishibe et al., 1983) with the 
help of the anatagonist 3H-1-QNB (3H-1-Quinuclidinylbenzilate). Ihese 
investigations were performed on homogenates of the nasal mucosa and do 
not give any information about the localization of the receptors. In 
vitro autoradiography seems a suitable technique for the localization of 
receptors (Young and Kuhar, 1979; Wamsley, 1983; Nonaka and Moroji, 1984; 
Palacios, 1984). 
Precautions have been taken to minimize diffusion of the ligand from the 
receptor when autoradiographic techniques are applied. This would exclude 
the autoradiographic dipping technique (Wamsley, 1983). High affinity 
radioligands are now available and the technique of dipping the slides 
into liquid emulsion seems to be applicable. Ihe present study was 
designed in an attempt to develop an in vitro autoradiographic technique 
for the localization of muscarinic receptors in rat nasal glands. In 
principle, three methods of covering the tissue sections with a 
photographic sensitive layer are compared. Furthermore, it is necessary 
that this in vitro technique should also be applicable for the 
pharmacological identification of the receptors involved. 
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3.3. Materials and methods 
Tissue preparation 
Wistar rats (about 200 g body weight) were used throughout this 
investigation. After decapitation, the nasal glands were carefully 
dissected and rapidly frozen using iscpentane cooled in liquid nitrogen. 
Cryostat sections were thaw-mounted on glass slides coated with 
gelatin/chrome-alum. Ihe sections were air dried and stored at -80oC. 
Before incubation the sections were dried again at room temperature and 
fixed at 40C in 0.5 or 2% glutardialdéhyde in Tyrode buffer for 30 or 45 
min dependent on the thickness of the section. Subsequently, the 
sections were rinsed in buffer at 40C for 30 min and further processed 
for either radioreceptor assays or autoradiography. Alternatively, 
instead of this fixation, inhibitors of proteolysis (1 mM HEF, 5 пМ 
ЕША, 0.01 пМ Lsupeptin, 0.01 пМ Pepstatin) were included during the 
incubation procedure as described below. 
Several non-mounted parallel sections were collected for protein 
determination according to Irwry et al. (1951) with bovine serum albumin 
as a standard. Protein determination was performed after solubilization 
of the sections in 0.1 N NaOH at 100oC (boiling water-bath) for 15 min. 
Parallel sections, taken at various stages of the incubation procedures 
were stained with methylgreen pyronin (1%) for histological verification 
of tissue quality. 
Radioreceptor assay on cryostat sections. 
Ihe tissue sections were overlayed with 150 μΐ 3H-1-QNB (specific 
activity 33.1 Ci/itmol, NEN, Doom, The Netherlands) in Tyrode buffer at 
various concentrations ranging frem 0.04-8.0 nM. Subsequently, the 
sections were incubated at З ? ^ for 90 min in a humid atmosphere. Non­
specific binding was measured in parallel incubations in the presence of 
12 μΜ L-ora (gift fron Dr. G. lambrecht, Johan Wolfgang Goethe 
Univeritát, Frankfurt/m, West-Germany) under the same conditions. After 
the incubatie»! 75 μΐ of the incubation buffer was mixed with 10 ml Aqua 
Duma (Ifcckard) to determine the concentration of radioligand. Ihe 
remaining incubation buffer was removed by rinsing the sections in fresh 
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buffer. Ihe slides with the sections were then placed in counting vials, 
containing 1 ml Soulene-350 (Packard). The vials were warmed to ЗТ'-'С 
overnight. Instagel/0.5 N HCl (9:1) 18 ml, was added and the samples were 
then counted in a liquid scintillation counter (1215 Rackbeta, Ы Ш ) . The 
binding parameters were calculated by subjecting the data to a non-linear 
least squares curve fitting procedure with the Gauss-Newton algorithm. 
Identical results were obtained with this droplet incubation method and 
with the incubation of sections on slides in jars (Young and Kuhar, 
1979). 
Autoradiography. 
Following the method described above, 10 μη sections of rat nasal glands 
were incubated with 0.06 nM 3H-1-QNB at 370C. Adjacent sections were 
incubated with 12 μΜ Ir-QNB in addition to 3H-1-QNB to determine the non­
specific binding. After incubation, the sections were rinsed in Tyrode 
buffer (room temperature) then briefly in distilled water to remove the 
buffer salts. The specimens were coated with 0.5% gelatirychrome-alum. 
Three methods were used for covering the slides with photographic 
sensitive layer and further processing: (a) The slides were air-dried and 
dipped in liquid emulsion (nuclear K2 emulsion, Ilford) diluted with 
distilled water (1:1). After an exposure time varying between 14 days and 
3 months at 40C the autoradiograms were developed in amidol (180C, 8 
min.), rinsed in distilled water, fixed in sodium thiosulphate (30%) at 
Ιβ^ for 1-3 min, thoroughly washed in distilled water (15 min) and 
stained with 1% methylgreen pyronin. (b) Several sections were covered 
with Kodak AR-10 stripping film swollen in distilled water (room 
temperature) for 2-3 min. After an exposure time ranging from 1-3 months 
at 40C, the autoradiograms were developed in Kodak D19 developer, rinsed 
briefly in clean water (IS^) and fixed in a solution prepared according 
to Kodak formula F-24. Ihe slides were then extensively washed in 
deionized water, air-dried and stained with 1% methylgreen pyronin. (c) 
Autoradiograms were generated by apposition to emulsion (nuclear K2 
emulsion, Ilford)-coated ooverslips according to the method previously 
described by Young and Kuhar (1979). After an exposure time ranging from 
1-3 months, development of the autoradiograms was carried out according 
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to method (a) after the coverslips had been gently bent away from the 
tissue sections. 
3.4. Results 
Histological tissue integrity and characteristics of the acetylcholine 
receptor involved were examined before autoradiographic experiments were 
performed. 
Histological experiments. 
Ihe nasal glands of the rat are of the tubulo-acinar type. Acinar cells 
and striated excretory ducts were observed, all embedded in connective 
tissue. 
Methylgreen pyronin stains the nuclei green-blue and the acinar cytoplasm 
purple-red. There was no essential difference in staining reaction with 
methylgreen pyronin whether the tissue sections were fixed in 0.5% or in 
2% glutardialdehyde. Omitting fixation in the absence or presence of 
inhibitors of proteolysis during incubation resulted in a loss of 
staining reaction, many cytoplasmatic vacuoles and a diffuse appearance 
of the nuclei. 
Biochemical experiments. 
Tissue sections of the nasal glands fixed in 0.5% glutardialdehyde were 
used throughout these experiments since lack of fixation led to a marked 
loss of tissue integrity. Figure 3.1 represents a typical experiment on 
the binding of 3H-1-QNB to 10 μιη cryostat sections of rat nasal glands. 
The specific part of the binding was saturable with a receptor density 
(Etnax) of 39 fmol/mg protein and a dissociation constant (Kd) of 0.43 nM. 
The Scatchard plot (inset) points to the presence of a homogeneous class 
of binding sites. The non-specific binding was relatively lew. Both Kd 
and Etnax varied slightly between experiments and a Kd of 0.47±0.06 ПМ and 
a Bmax of 41±1 fmol/mg protein was calculated from the mean of three 
experiments. There was no difference in binding parameters between 
3H-1-ÇNB binding in 10 or 20 μια cryostat sections. The binding of 
3H-1-QNB was linearly dependent on the thickness of the sections. 
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Fig. 3.1: Binding of 3H-1-QNB to 0.5 % glutardialdehyde fixed cryostat 
sections (10 μπι) of rat nasal glands at З ^ . Total binding 
(0) and non-specific binding (Δ) which was determined in the 
presence of 12 μΜ unlabelled QNB. ihe line without points 
represents the specific 3H-1-<?JB binding. The dissociation 
constant was 0.43 nM and the receptor density 39 fmol/mg 
protein. Inset: Scatchard plot of the specific part of the 
binding. 
Kinetic experiments, in which bound radioligand was determined as a 
function of time, indicated that equilibrium was reached after 90 min at 
a ligand concentration of 0.4 nM (fig. 3.2). Dissociation of the ligand-
receptor complex proceeded slowly with a half-life of approximately 90 
min. The association rate constant was 4.1xl07M_1.min-1. The dissociation 
rate constant was 0.0076 min-1. Consequently, the calculated kinetic Kd 
was 0.19 riM. Ihere was no difference in the kinetics of 3H-1-QNB binding 
between to 10 and 20 μτη sections. 
Ihe binding of 3H-1-QNB (1.3 nM) to muscarinic receptors in sections of 
rat nasal glands was inhibited stereoselectively by stereoisomers of the 
antagonist benzetimide. Dexetimide was 1500 times as effective in 
displacing 3H-1-QNB f rem its binding sites as levetimide (Ki=8.3xl0~9 
and Ki=1.2xl0-5 M, respectively). 
In all these binding studies incubations were terminated by rinses in 
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fresh buffer. It appears from fig. 3.3 that rinses of 3x4 min reduced the 
non-specific binding of the radioligand to the sections and resulted in 
an optimal ratio of specific to non-specific binding. Rinses of 3x10 min 
were sufficient to obtain the same ratio of specific to non-specific 
binding in 20 /m sections. 
Bound 3H-I-QNB in fmoi/mg protein -
20-
- i 1— 
20 60 100 U 0 180 220 
time in m m 
Fig. 3.2: 
Time dependent binding of 
3H-1-QNB (0)(0.4 nM) to 0.5% 
glutardialdehyde-f ixed cryostat 
sections (10 μιη) of rat nasal 
glands. Ihe non-specific (Δ) 
binding was relatively low. 
Dissociation of the radioligand 
receptor binding complex was 
initiated by the addition of an 
excess of unlabelled ligand (12 
m (ο) · 
Fig. 3.3: 
Ihe influence of the rinsing time 
on the dissociation of the 
radioligand receptor canplex. 
Fixed tissue sections were 
incubated with 0.9 riM 3H-1-QNB 
for 90 min. at 310C. The slides 
were then rinsed in fresh buffer 
for times varying frcm 4 to 60 
min. Total binding (Ο), specific 
binding (Ο), non-specific binding 
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Fig. 3.4: 
Autoradiograitts of 0.5% glutardialdehyde-fixed cryostat sections (10 μπι) 
of rat nasal glands after incubation with 0.6 nM 3H-1-QNB (A) or with an 
excess of 1-QNB in addition to the radioligand (B) followed by dipping in 
liquid nuclear emulsion. The autoradiograms shew specific labelling of 
the glandular acini and the excretory ducts (x800). Staining with 
methylgreen pyronin (1%). 
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Autoradiographic experiments. 
After 3 months exposure the autoradiographs showed labelling of the 
glandular acini with 3H-1-QNB (fig. 3.4A). The excretory ducts also 
shewed slight labelling, whereas the connective tissue was devoid of 
silver grains. Autoradiographs made f rem sections incubated with an 
excess of unlabelled ligand in addition to 0.6 nM 3H-1-QNB, showed only a 
very faint homogeneous labelling of the glandular tissue (fig. 3.4B). 
These autoradiograms were generated by means of the dip-method. The most 
relevant disadvantage of the other two autoradiographic techniques was 
the appearance of high background levels, making difficult the detection 
of small amounts of specific binding. 
3.5. Discussicn 
Most reports on the autoradiographic localization of different receptors 
deal with the high receptor densities found in the brain (Young and 
Kuhar, 1979; Wamsley, 1983; Palacios, 1984) and only a few deal with 
lewer recepitor concentrations (Barnes et al., 1983; Summers et al., 
1984). The droplet incubation using a small amount of radioligand in 
combination with the dip method offers the possibility of characterizing 
and localizing рвгірйіегаі muscarinic receptors at low receptor 
concentrations. 
A well preserved histology is necessary for accurate localization of the 
silver grains. Ihe ccmnonly used fixatives such as glutardialdehyde are 
generally recctnmended because they do not interfere with the 
autoradiographic technique (Pearse, 1980). Fixation with glutardialdehyde 
appeared to be indispensable because the absence of fixation resulted in 
deformation of the incubated glandular tissue. Unfortunately, this 
implies that it is inpossible to perform control experiments to check the 
influence of the fixatives on ligand receptor binding in cryostat 
sections. Young and Kuhar (1979), suggested on the basis of in vivo 
experiments that low concentrations of formaldehyde do not result in a 
loss of opioid receptors in rat brain. The concentration of 
glutardialdehyde (0.5%) used in the present study was also low since no 
difference in histology of the nasal glands was observed after fixation 
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with either 0.5 or 2% glutardialdehyde. 
The receptor binding studies showed that 3H-1-QNB binds to a homogeneous 
class of muscarinic receptors in both 10 and 20 μιη sections of rat nasal 
glands. Ihe binding was saturable and of high affinity. The muscarinic 
nature of the receptors was confirmed by the inhibition of 3H-1-QNB 
binding by the enantiomers of benzetimide. Hie receptor density (41+1 
fmol/mg protein) in rat nasal glands was 1см in contrast with the 
density of 2000 fmol/mg protein in rat striatum cryostat sections (10 
μια) (Nonato and Moroji, 1984). Comparing our findings with data f rem 
studies on homogenates reveals that the receptor density found in the 
present study agrees well with the density of nasal glandular hemogenates 
(55 fmol/mg protein) (KLaassen et al., in press) and is lewer than the 
density in the submandibular gland (214 fmol/mg protein) (Costa and 
Murphy, 1985). The Kd-value (0.47±0.06 hM) agreed well with the value 
found for 3H-1-QNB binding in cryostat sections of the rat striatum 
(0.36 riM) (Nonato and Moroji, 1984), but contrasts with the value found in 
ferret lung (0.06 hM) (Barnes et al., 1983). Nonato and Moroji (1984) 
demonstrated a difference in Kd-values between 10 and 20 /лп cryostat 
sections and suggested a dependence of the Kd value upon receptor 
density. Ihis suggestion is not supported by the binding and kinetic 
experiments of the present study. There are slight differences between 
values for 3H-1-QNB binding to cryostat sections and those for 
hemogenates of rat nasal mucosa (Κα=0.06 nM) (Rodrigues de Miranda et al., 
1985) and of rat nasal glands (Kd=0.11 nM) (KLaassen et al., 1987). Such 
discrepancies have already been reported (Gilbert et al., 1979 ; Nonato 
and Moroji, 1984), but Barnes et al. (1983) found identical Kd-values for 
3H-1-QNB binding to cryostat sections and homogenates of the ferret lung. 
If methodological aspects are left out, these discrepancies should be due 
to the inability of the radioligand to penetrate the sections (Wamsley et 
al., 1981; Nonato and Moroji, 1984). However, the binding of 3H-1-QNB 
appeared to be linearly dependent on the thickness of the sections, 
whereas the Kd-value was independent of the thickness of the sections. 
Alternatively, the affinity of the ligand for the receptor in more or 
less intact membranes of cryostat sections could be different from that 
in hemogenized membrane fragments. 
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After an exposure time of 3 months, the autoradiographs of 10 μιη sections 
showed specific labelling of the acini with 3H-1-<2NB. Ihis observation 
provides evidence for the presence of muscarinic acetylcholine receptors 
in rat nasal glands. The findings Eire also in agreement with in vivo 
autoradiographic results (KLaassen et al., 1984), and with results of 
histochemical studies on the cholinergic innervation of the nasal mucosa 
(Grote et al., 1975) and of physiological experiments (KLaassen and 
Kuijpers, 1986). In addition to the findings in previous studies, the 
autoradiographs also suggest a slight specific labelling of the striated 
excretory ducts. The striated ducts of the salivary gland control the ion 
and water content of the secretions (Schneyer et al., 1972), and the 
striated ducts of the nasal glands could have a similar function (Phipps, 
1981). It can be deduced free the present data that this function is 
under parasympathetic control. 
The best autoradiographic results were obtained from the dipping 
technique. In contrast to this method, the slides covered with Kodak 
stripping film shewed increased background levels after longer exposure 
times. The increased background levels interfered with the detection of 
small amounts of silver grains above the section. Floating the stripping 
film on a sugar solution of bromide (10 mg/ml) may suppress the high 
background levels (O'Callaghan et al., 1969). The Ilford K2 emulsion-
coated coverslip method also showed such increased background levels. 
Rogers (1973) has already reported that pressure causes latent images of 
such films. A disadvantage of the dipping technique, however, is that it 
gives no reliable quantitative data on grain density because dipping does 
not guarantee a uniform thickness of the emulsion layer (Rogers, 1973). 
Many other problems can also be encountered in quantitative receptor 
mapping (Rogers, 1973; Ruhar and Unnerstal, 1985; Kuhar, 1985). 
The technique now presented, that involves incubation of the sections 
with a small amount of 3H-1-QNB and covering the slides with 
iphcrtographic emulsion, seems a suitable method for the localization of 
lew receptor densities in human nasal mucosa and for studying the 
presumed changes in the distribution psattem of receptors under 
pathological conditions such as nasal hyperreactivity. 
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CHAPTER 4 
BIOCHEMICAL AND AUTORADIOGRAFHIC ANALYSIS OF -^AERENOCEPTORS IN RAT NASAL 
MUCOSA 
Y.J .B. van Megen 1 ' 2 , C.J.B.M. van Rat ingen 1 , A.B.M. KLaassen1, J . F . 
Rodrigues de Miranda2 , C.A.M, van Ginneken2 and R.lti.R. Wentges1 
Departments of Otorhinolaryngology1 and Fharmacology2, Un ive r s i ty of 
Nijmegen, H i i l i p s van leydenlaan 15, 6500 HB Nijmegen, The Nether lands . 
( p a r t i a l l y publ ished in NeuroSci. L s t t . 90: 75, 1988). 
4 . 1 . Abstract 
The specific binding of 1 2 5i- (-) -cyancpindolol to homogenates and 
cryostat sections of rat nasal mucosa was saturable, stereoselective and 
of high affinity (Kä=5.0±0.4 pM, ЕПвх=204±12 fmol/mg protein and 
Kä=7.2±0.7 pM; Впазе=15±1 fmol/mg protein respectively). Ihe subtype 
selective antagonists 1^203-030 a n d ICI118 551 inhibited specific 
125I-(-)-CYP binding, in both homogenates and cryostat sections, 
according to a two binding sites model indicating the presence of ß^- and 
/32-adrenoceptors. Competition of isoprenaline for the antagonist binding 
to hcsnogenates demonstrated 30% high affinity agonist binding sites. In 
the presence of guanine nucleotides a steepening of the curve was 
observed. 
In vitro labelling of cryostat sections of rat nasal mucosa was corabined 
with autoradiography. The autoradiographs, generated after incubation 
with 20 pM 125I-(-)-CYP, showed specific labelling of the epithelium and 
glandular excretory ducts. It appeared from autoradiographs generated 
with subtype selective antagonists in addition to the radioligand that 
ßj- and ^ -adrenoceptors were present in both structures. 
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4.2. Introduction 
ñiysiological and morphological experiments have shown that especially 
the nasal vascular structures are innervated by sympathetic (adrenergic) 
nerves (Anggârd and Densert, 1974; Grote et al., 1975; Malm, 1977; 
Vecerina et al., 1983). Stimulation of the sympathetic nerves results in 
a release of noradrenaline, which activates a- and ^-adrenoceptors. 
Although it is well established that α-adrenoceptors predominate in nasal 
vessels, the opinion of the presence of /3-adrenoceptors is controversial. 
Hall and Jackson (1968) could not demonstrate /3-adrenoceptors in the 
nasal blood vessels of the dog. On the other hand, these receptors have 
been demonstrated in nasal resistance or capacitance vessels in the cat 
and the dog (Malm, 1977; Hiley et al., 1978). No evidence for adrenergic 
innervation of the nasal glands has been obtained. However, some 
physiological experiments suggested an influence of adrenergic agonists 
on the secretory activities of the nasal mucosa (Phipps, 1981; Malm et 
al., 1983). 
Clinical pharmacological investigations point to the anti-allergic effect 
of j3-adrenergic agonists by inhibiting histamine release from mediator 
cells, suggesting a role of these receptors in mediator release (Kaliner 
and Austen, 1975; Svensson et al., 1980). Quantitative data on 
biochemical characteristics and localization of the /3-adrenoceptors are 
necessary to get more insight in the physiological role of these 
receptors in the nasal mucosa. In this study radioligand binding 
techniques were applied for the biochemical characterization of 
/3-adrenocepïtors in homogenates and in cryostat sections of rat nasal 
mucosa, using the antagonist 125I-(-)-cyanopindolol (125I-(-)-CYP). The 
/3-acJrenocep>tors were characterized in regard to affinity, receptor 
density, stereoselectivity, subclassification in βγ- and /З2-
adrenocepftors and the inhibitory pattern of the antagonist binding by the 
agonist isoprenaline. Ihe in vitro labelling of the cryostat sections was 
ccmbined with autoradiography for the localization of /3-adrenoceptors in 
rat nasal mucosa. 
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4.3. Materials and methods 
125I-cyanopindolol [125I-(-)-CYP] (spec. act. 2200 Ci/imrol) was purchased 
from Amersham International, England. ІСІцд 551, (-)- and 
(±)-propranolol were gifts from ICI Ltd, Alderly Park, England, 
(±)-isoprenaline and ЬКзоз-озо ^1^111 Boehringer Ingelheim, ERB and Sandoz, 
Basel, Switzerland respectively. (+)-propranolol was purchased from Sigma 
Chemical Company, St. Louis, МЭ, USA. 
Radioligand receptor binding assay for homoqenates 
The nasal mucosae from Wistar rats (about 200 g body weights) were 
dissected, immediately frozen (acetone/OC^ bath) and stored at -800C. The 
tissue was homogenized in icecold Tyrode buffer (pH 7.4) with an 
Ultraturrax for 2x10 sec. The homogenate was centrifuged at 1000 g for 5 
min Hie supernatant was collected and centrifuged at 100,000 g for 1 hr 
(40C). Ihe pellet was resuspended by Potter homogenization in buffer. 
Radioligand receptor binding studies were carried out in glass tubes 
containing 40 μΐ 125I-(-)-CYP, 40 μΐ Tyrode buffer with 0.1% BSA and 320 
μΐ tissue homogenate corresponding with a final concentration of 2 mg/ml 
tissue. Non-specific binding was determined in the presence of 2 μΜ 
(±)-propranolol. Ihe homogenates were incubated for 2 hrs at 370C. 
Incubations were terminated by rapid dilution with 2x2 ml ice cold buffer 
and filtration through Whatman GF/C filters under vacuum, followed by 3x5 
ml rinses of the filter with ice cold buffer. Radioactivity collected on 
each filter was measured in a gammacounter (NE1612, MEN) at 78% counting 
efficiency. In order to obtain free radioligand concentration total 
concentration was corrected for bound concentration. Ihe binding 
parameters were calculated by subjecting the data to a non-linear least 
square curve fitting procedure using the Gauss-Newton algorithm (Fletcher 
and Pcwell, 1963). Inhibition curves were analysed according to a one or 
two binding sites model. Ihe half life time (t^ ) for equilibration was 
calculated by the equation (Graafana et al., 1988) : 
t^ = 2.3 1оа(А+ЗП with Ar=RcH-DofKi, B=Ro.Do and С=(А2-4В)^ 
с.kl (A+C) DcF=initial ligand concentration 
RCF=total receptor concentration 
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Radioreceptor binding assay for cryostat sections. 
Itie nasal mucosae from Wistar rats were carefully dissected and rapidly 
frozen using isopentane cooled in liquid nitrogen. Cryostat sections (10 
μια) were thaw-mounted on 1% gelatin/chrcmte-alum coated glass slides. 
Several non-mounted parallel sections were solubilized in 0.1 N NaOH at 
1000C (boiling-waterbath for 15 min) for protein determination according 
to Inwry (1951) with Bovine Serum Albumine (BSA) as a standard. The 
sections were dried and stored at -800C. Before the incubation, sections 
were dried again at room temperature (r.t.) and fixed in 0.5% 
glutardialdehyde in Tyrode buffer for 30 min (40C) followed by rinsing 
in buffer (2x15 min; 40C). The tissue sections were dried and overlayed 
with 150 μΐ 125I-(-)-CYP in Tyrode buffer (with 0.01% BSA) at various 
concentrations radioligand. Subsequently, the sections were incubated at 
370C for 2 hrs in an humid atmosphere. For the measurements of the non­
specific binding, parallel incubations were performed in the presence of 
2 μΜ (±) -propranolol at the same conditions. After the incubation, 75 μΐ 
of the incubation buffer was counted to determine the free concentration 
radioligand, the remaining incubation buffer was removed by rinsing the 
sections in fresh buffer (r.t.) during 4x15 min Ihe slides were broken, 
transferred to vials and the radioactivity in the sections was counted by 
gamma counting (NE1612 gammacounter, NEN). Ihe binding parameters were 
calculated as described above. 
In vitro autoradiocrrarhv. 
Incubations on cryostat sections were performed as described above using 
0.02 nM 125I-(-)-CYP. After washing the slides in buffer (r.t.), they 
were rinsed in distilled water (r.t.) to remove salts. The specimens were 
coated with 0.5% gelatin/chrome alum, air dried and dipped in liquid 
emulsion (Nuclear K2 emulsion, Ilford) diluted with distilled water 
(1:1). After 2 months exposure (40C) the autoradiographs were developed 
in amidol (180C, 8 min), rinsed in distilled water, fixed in sodium 
thiosulphate (30%) at 180C for 1-3 min, thorou^ily washed in distilled 
water (15 min) and stained with 1% methylgreen pyronin. 
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4.4. Results 
Characterization of 125I-(-)-CYP binding to homoqenates of rat nasal 
mucosa. 
Specific binding of 125I-(-)-CYP to membranes of rat nasal mucosa was 
saturable and of high affinity (fig. 4.1). Ihe Scatchard plot (inset) 
points to the presence of a homogeneous class of binding sites. Analysis 
of the data demonstrated a mean dissociation constant (Kd) of 5.0 ± 0.4 
pM and a receptor density (Bmax)of 5.1 ± 0.3 pmol/g tissue corresponding 
with 204 ± 12 fmol/mg protein (n=10). 
Bound ,25l-|-)-CYP (pmole/gl 
Bound/lree 
25 50 75 
'"M-I-CYP tree (pM| 
Fig. 4.1: Specific 125I-(-)-CYP binding to homogenates of rat nasal 
mucosa. Total binding (0) and non-specific binding (Δ) were 
determined in the absence and presence of 2 μΜ 
(±)-propranolol. The line without points represents the 
specific ^^-(-J-CYP binding. Inset: Scatchard plot of the 
specific part of the binding. Data shewn are the means of 
triplicates frem a representative experiment. 
12:>I-(-)-CÏP binding to rat nasal mucosa was linearly dependent on 
tissue oonoentration between 0.5 and 20 mg/ml at a free ligand 
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concentration of 0.02 riM. Itie time dependent association and dissociation 
fron /3-adrenergic receptors in rat nasal mucosa was studied in the 
presence of 3 fM 125І-(-)-С ГР (fig. 4.2). Binding of 125I-(-)-CYP at 
370C readied equilibrium at 120 min The association rate constants (1^), 
determined in two experiments, were 1.80 and 1.57 nM"l min-^·. The 
dissociation rate constants (k^) were 0.0022 and 0.0024 min-1. 
Consequently, the calculated Kd-values (Kä=]c_1/k1) were 1.2 pM and 1.5 pM 
respectively. The halflife tiroes of reaching equilibrium were 35 and 39 
min respectively. 
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Fig. 4.2: 
Time course of association and 
dissociation of 125I-(-)-CYP 
binding to homogenates of rat 
nasal mucosa. Incubations were 
performed with 3 pM 
125 I-(-)-CYP 37 0C. at 
Dissociation was induced by 
addition of 2 μΜ (±)-propra­
nolol after 90 min incubation. 
Total binding ( о ) , non­
specific binding ( Δ ) and 
dissociation (O) · Data shewn 
are the means of triplicates. 
Fractional specific 
Fig. 4.3: 
I n h i b i t i o n of s p e c i f i c 
1 2 5 I - ( - ) - C Y P binding by the 
antagonists 1^203-030 (0) a n d 
I C I 118 551 ( · ) · Homogenates of 
nasal mucosa were incubated a t 
370C for 120 min a t 16 pM 
1 2 5 I-(-)-CYP in the presence or 
absence of competing agents. Data 
shown a r e t h e means of 
t r i p l i c a t e s f r o m a 
representative experiment. 
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Table 4.1: Inhibition constants of ^-adrenergic antagonists for 
125I-(-)-CYP (16 pM) binding to hanogenates and cryostat 
sections of rat nasal mucosa. 
Antagonist 
Homocienates 
(-)-propranolol 
(+)-propranolol 
^203-030 
ICI118,551 
Cryostat sections 
(-)-propranolol 
(+)-propranolol 
^гоз-озо 
ICI118,551 
КІ! (nM) 
0.75/ 0.76 
120 / 90 
42 ± 11 
0.9 ± 0.3 
0.49/ 0.78 
260 / 320 
24 ± 1 
7 ± 4 
Ki2 (μΜ) 
-
-
17.5±3.9 
0.01+0.02 
_ 
-
48±14 
0.26±0.10 
%01 
50±4 
63±4 
43±11 
45±5 
η 
n=2 
n=2 
n=3 
n=3 
n=2 
n=2 
n=3 
n=3 
Ihe binding of 125I-(-)-CYP (16 pM) to ^ -adrenoceptors in hanogenates of 
rat nasal mucosa was stereoselectively inhibited by stereoisomers of the 
antagonist propranolol. (-)-propranolol appeared to be a 140 fold more 
potent than (+)-propranolol in competing for 125I-(-)-CYP binding sites 
(table 4.1). Conpetition curves could adequately be fitted with a one 
binding site model. 
Ihe subtype selective ^-adrenergic antagonists 1^203-030 (ßi-selective) 
and leine 551 (^-selective) were used to define the relative 
preportions of /Si and ^-adrenoceptors in rat nasal mucosa homogenates 
(table 4.1/fig. 4.3). Both conpetition curves were shallow and could be 
fitted with a two binding site model. Inhibition of 125I-(-)-CYP by 
1^203-030 a s well as ICIll8 551 demonstrated the presence of a 
heterogeneous /J-adrenoceptor population in rat nasal mucosa, ІК2ОЗ-ОЗО 
detected 50+4% ^-adrenoceptors and ІСІцз
 5 5 1 detected 63±4% ß^-
adrenoœptors. 
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Inhibition curves of the full agonist isoprenaline displayed a biphasic 
character indicating the presence of high (30±3%) and lew affinity 
agonist binding sites in the rat nasal mucosa (table 4.2). In the 
presence of 5.10-4 M Gpp(NH)p a steepening of the isoprenaline inhibition 
curve was observed. However, no complete conversion of high affinity 
binding sites into lew affinity binding sites could be obtained. 
Table 4.2: Inhibition constants of the /3-adrenergic agonist iso­
prenaline for 125I-(-)-CYP binding to homogenates of rat 
nasal mucosa. 
- Gppmp 
+ Gpp(NH)p 
Κίχ (μΜ) 
0.02710.006 
0.14 ±0.06 
КІ2 (μΜ) 
0.60±0.07 
1.3 ±0.4 
% RH 
30±3 
50±18* 
η 
3 
3 
* ЯН: A different set of affinity states with a lower agonist 
affinity than the high affinity state determined 
without Gpp(NH)p. 
Characterization of 125I-(-)-CYP binding to sections of rat nasal 
mucosa. 
The specific binding of 125I-(-)-CYP to 10 цт cryostat sections of rat 
nasal mucosa is saturable (fig. 4.4). Ihe Scatchard plot (inset) points 
to the presence of a hemogeneous class of binding sites with high 
affinity (ка=7.2±0.7 pM) and mean density of 15±1 fmol/itg protein (n=5). 
Ihe time dependent binding of 125I-(-)-CYP at a free concentration of 7 
pM indicated that it took 5 hours of incubation to reach equilibrium. 
Equilibration time could be reduced to 2 hours by increasing the ligand 
concentration to 18 pM. 
The binding of 125I-(-)-CYP (16 pM) to /3-adrenoceptors in sections of rat 
nasal mucosa was stereoselectively inhibited by stereoisomers of 
propranolol, (-)-propranolol having 460 times greater affinity than 
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(+)-propranolol in displacing 125I-(-)-CYP from its binding sites (table 
4.1). 
Bound ,z5I-(-)-CYP [fmole/mg) 
Bound/lree ι 
l-(-)-CYP free IpM) 
Fig. 4.4: Specific 125I-(-)-CYP binding to cryostat sections of rat 
nasal mucosa. Total binding (0) and non-specific binding (Δ) 
were determined in the absence and presence of 2 μΜ (±)-
propranolol. Inset: Scatchard plot of the specific part of the 
binding. Data shewn are the means of triplicates from a 
representative experiment. 
Inhibition of 125I-(-)-CYP by ІК203-0ЗО a n i ICI118 551 demonstrated the 
presence of a heterogenecus ^ -adrenoceptor peculation, 1^203-030 detected 
43±11% and ICI 1 1 8 55! 45±5% ^ -adrenoceptors respectively (fig. 4.5). 
In all binding and oraipetition experiments incubations were terminated by 
rinses in buffer. It appears that rinses of 4 χ 15 min reduce the non­
specific binding of the radioligand to the sections and result in an 
optimal ratio specific to non-specific binding. 
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Fig. 4.5: 
I n h i b i t i o n of s p e c i f i c 
1 2 5I-(-)-CYP binding by the 
antagonists IK203-030 (0) a n d 
I C I 1 1 8 , 5 5 1 ( · ) · Cryostat 
sections of r a t nasal mucosa 
were incubated a t 370C for 120 
min with 20 pM 1 2 5I-(-)-CYP in 
the presence or absence of 
competing agents. Data shewn 
are the means of t r i p l i c a t e s 
f r o m a r e p r e s e n t a t i v e 
experiment. 
-12 -10 -8 -6 -U -2 
Log cone antagonist (M) 
Autoradiography. 
After 2 months exposure the autoradiographs showed a dense labelling of 
the nasal epithelium and the glandular excretory ducts (fig. 4.6 A and 
4.7 A) with 12^I-(-)-CYP. Autoradiographs made from sections incubated in 
the presence of 2 μΜ (±)-propranolol in addition to the radioligand 
shewed only a faint homogeneous labelling of the nasal mucosa (fig. 4.6 
В and 4.7 B). The glandular acini shewed a very slight labelling, which 
hardly could be distinguished frcm the non-specific labelling, whereas 
the connective tissue and the blood vessels were devoid of silver grains. 
In order to localize /3-adrenoceptor subtypes, series of consecutive 
sections were incubated with 20 pM 125I-(-)-CYP, in the presence of 2 μΆ 
(±)-propranolol; 0.1, 0.5 or 1.0 /iM ICI 1 1 8 55·^ or in the presence of 5, 
30 or 55 μΆ 1^203-030· ^ 6 autoradiograitis generated with high 
concentrations ICI 1 1 8 5 5 1 (1.0 μΜ) and 1*203-030 (
30 а П | 3 5 5
 ^
1) w e r e 
indentical to those obtained with 2 μΆ (±)-propranolol. Ilie 
autoradiograms generated with a lew concentration ІСІцв 551 (0.1 μΜ) 
were similar to those obtained with 125I-(-)-CYP alone. In 
autoradiograms obtained with 0.5 μΜ ІСІцз 553^  or 5 μΜ IK203 030 ^ Г" o r 
/?2 -adrenoceptors were labelled preferentially. Ihose autoradiograms 
shewed a reduction of specific labelling in both epithelium and striated 
Fractional specific — 
, 2 5 l-(-)-CYP binding 
10-
0 8 -
06 
04 
02 
-.-8-, 
•x 
V 
• 0·~ο 
χ 
L
-//-I 1 1 1 1 1 1 1 Τ 1 C 
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excretory ducts indicating that both βγ- and /?2-adrenoceptors are present 
in these structures. 
4.5. Discussici 
Radioligand receptor binding studies with the antagonist 125I-(-)-CYP 
have been used to demonstrate ^-adrenoceptors in homogenates of many 
tissues (Stiles et al., 1984). In this study binding studies were 
performed to homogenates but also to cryostat sections of rat nasal 
mucosa. This in vitro labelling of the sections combined with 
autoradiography give the opportunity to localize the /Q-adrenoceptors. 
Until now, in vitro autoradiography has been mainly applied to the 
localization of high receptor densities in the brain (Palacios and 
Kuhar, 1982) or in the lewer airways (Carstairs et al., 1985). Recently, 
an in vitro method has been developed to localize low muscarinic 
receptor densities in the rat nasal glands (van Megen et al., 1988a). 
This method was applied to localize /3-adrenoceptors in rat nasal mucosa. 
Specific 125I-(-)-CYP binding to j9-adrenoceptors in homogenates or in 
cryostat sections of rat nasal mucosa was saturable and of high affinity. 
The Kd-values of the binding to homogenates (5.0±0.4 pM) and cryostat 
sections (7.2+0.7 pM) were similar to those determined in other tissues 
(Stiles et al., 1984; Carstairs et al., 1985; van Koppen et al., 1987). 
No differences between Kd-values for 125I-(-)-CYP binding to homogenates 
or cryostat sections have also been observed in rat kidney (Summers et 
al., 1985) and human lung (Carstairs et al., 1985). Ihe /9-adrenoceptor 
density per mg protein is higher in homogenates (204±12 fmol/mg protein) 
than in sections (15.2±0.4 fmol/mg protein). This discrepancy may be due 
to differences in protein contents; homogenates consist of a relatively 
pure membrane fraction, whereas sections contain all tissue contituents. 
Ihe presence of jS-adrenoceptors in honogenates of nasal mucosa of guinea 
pig (Ishibe et al., 1985; Kònno et al., 1987) and man (Ishibe et al., 
1983; Konno et al., 1987) has been demonstrated earlier using the 
antagonist 3H-DihydrOalprenolol. Hie present study conprises also 
pharmacological characteristics of the 125I-(-)-CYP binding and the 
distrihution of /3-adrenooeptor subtypes in rat nasal mucosa. 
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Fig. 4.6: 
Autoradiograms of 0.5% glutardialdehyde fixed cryostat sections (10 m) 
of rat nasal mucosa after incubation with 20 pM :C25I-(-)-CYP (A) or with 
2 μΜ (±) -propranolol in addition to the radioligand (B). Ihe 
autoradiograms shew specific labelling of the nasal epithelium. Staining 
with methylgreen pyronin (1%) χ 800. 
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Fig. 4.7: 
Autoradiograms of 0.5% glutardialdehyde fixed crvpstat sections (10 μπι) 
of rat nasal mucosa after incubation with 20 pM ^25!- (-) -СУР (A) or with 
2 μΜ (±)-prcpranolol in addition to the radioligand (B). The 
autoradiograiDS show specific labelling of the nasal glandular excretory 
ducts. Staining with methylgreen pyronin (1%) .x800. 
81 
The time dependent 125I-(-)-CYP (3 pM) binding to homogenates indicated 
that equilibrium was reached after 120 min incubation, which is in 
agreement with the th (about 35 min). In cryostat sections equilibrium 
was only reached after 5 hours using a low concentration of 125I-(-)-CYP 
(7 pM). As expected by increasing the 125I-(-)-CYP concentration to 18 
pM, the equilibrium time was reduced to 2 hours. The lower association 
rate of 125I-(-)-CYP in cryostat sections in comparison with homogenates 
may be due to a slow diffusion of the radioligand in and out the 
sections. Unexpectedly, the Scatchard plot of the specific binding was 
linear after 2 hours incubation and the Kà value was in agreement with 
that determined in homogenates. For the in vitro autoradiographic 
experiments a concentration of 20 pM 125I-(-)-CYP was used. Ihis 
concentration ensured a rapid equilibration, 80% saturation of the 
binding sites and a favourable specific to non-specific ratio. 
The presence of ^-adrenoceptors has been connected with adrenergic 
innervation. According to Ariéns and Simonis (1983) β^-adrenoceptors are 
meant for the neurotransmitter noradrenaline and 02-adrenoceptors for the 
hormone adrenaline. Inhibition experiments with 1^203-030' reported to 
have a 500-1000 fold /S^ -^selectively (Milavec-Krizman et al., 1985), 
demonstrated a heterogeneous population of /Э-adrenoceptors consisting of 
50% and 43% β ^-adrenoceptors in homogenates and cryostat sections of rat 
nasal mucosa, respectively. The Ki-values correspond well with those 
reported in homogenates of rat kidney (Taylor et al., 1984; Milavec-
Krizman et al., 1985). Ihere was a slight discrepancy in the distribution 
of /3-adrenoceptors measured by the ^-selective antagonist ІСІцд 55^. 
Ihe ^^-adrenoceptor peculation in cryostat sections (45%) was in 
agreement with that determined with ІК20З-ОЗО (43%) but the β^-
adrenoceptor peculation in homogenates (63%) was somewhat higher than 
that determined with ІК2ОЗ-ОЗО (50%) · Ihis apparent discrepancy may be 
due to the low selectivity (65-fold) of ICI 1 1 8 55! (Milavec-Krizman et 
al., 1985). Ihe Ki-values of the inhibition of 125I-(-)-CYP binding with 
KI-lis 551 were in agreement with those reported in homogenates of rat 
kidney (Milavec-Krizman et al., 1985) and in sections of human lung 
(Carstairs et al., 1985). 
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The present results show that in homogenates of rat nasal mucosa the 
/S-adrenergic agonist isoprenaline binds to tvro different states, a high 
(30±3%) and low affinity agonist state. Ihe Ki-values were in agreement 
with those described in other tissues (Kent et al., 1980; Brodde, 1982; 
Stiles et al., 1984). It has been accepted that the high affinity complex 
consists of agonist, receptor and guaninenucleotide binding protein 
(Harden et al., 1982; Stiles et al., 1984; Levitzki, 1986). 
Guaninenucleotides appeared to convert the high affinity states into low 
affinity states of the receptor (Brodde, 1982; Stiles et al., 1984; 
Seveme et al., 1987). 
In the presence of 5.10_4 M Gpp(NH)p a steepening of the inhibition 
curve, but no complete conversion of high into low affinity states was 
observed. Since the protease inhibitor H1SF had no effect on the 
inhibition curves, proteolytic activity is not responsible for the 
incomplete conversion. Furthermore, the two inhibition curves in the 
absence and presence of Gpp(NH)p were analysed simultaneously as a pair 
according to two models: 
a) a model with the restriction that the affinity constants for the 
high and lew affinity state were equal in the absence or presence 
of Gpp(NH)p, while the fraction receptors in the high affinity 
state was optimized independently for both situations. 
b) a model with no restrictions i.e. the affinity constants as well as 
the fraction receptors in the high affinity state were optimized 
independently in the absence or presence of Gpp(NH)p. 
In the second analysis the residual sum of squares was significantly 
lower (F-test; p<0.05) indicating that no simple conversion of receptors 
from the high to the lew affinity state occurred but rather a transfer 
fron one set of high and low affinity states to another set of high and 
lew affinity states accompanied by an overall lewer affinity. Complete 
conversion has neither been demonstrated in rat liver (Dax et al., 1986) 
in tradiea smooth muscle (van Koppen et al., 1987) and in rat heart 
(Qirist et al., 1988). 
After an exposure time of two months the autoradiographs of 10 дт 
sections of the rat nasal mucosa shewed specific 125i-(-)-CYP labelling 
of the epithelium. This finding was in agreement with a histochemically 
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weak positive noradrenalin reaction (KLaassen et al., 1988). Beta-
adrenoceptors have also been demonstrated in the epithelimn of the 
trachea (Davis et al., 1979; Agrawal et al., 1987) and lung (Carstairs et 
al., 1985). It has been suggested that these receptors in airway 
epithelium play a role in the mucociliary transport, active iontransport 
or the production of epithelium derived relaxatory factors (Davis et al., 
1979; Carstairs et al., 1985; Agrawal et al., 1987). 
Ttie autoradiographs shewed also a specific "^^l-^-CíP labelling of the 
striated excretory ducts of the nasal glands as described before (van 
Megen et al., 1988b). The presence of /3-adrenoceptors in striated 
excretory ducts has also been demonstrated in the salivary glands, where 
they control the ion and water content (Schneyer et al., 1972). It has 
been suggested that the striated excretory ducts of the nasal glands have 
a similar function (Phipps, 1981). 
The autoradiographs demonstrated a slight labelling of the nasal 
glandular acini. No evidence for adrenergic innervation of the acini 
could be observed in histochemical experiments (Grote et al., 1975 ; 
Vecerina et al., 1983). A small population of ^-adrenoceptors has been 
demonstrated in submucosal glands of the human lung (Carstairs et al-, 
1985). 
Frcm these and previous experiments (van Megen et al., 1988a; van Megen 
et al., 1988b) it may be concluded that the production of glycoproteins 
by the acini is mainly under parasympathetic control, whereas the 
regulation of the ion and water content of the nasal fluid by the 
excretory ducts is under both sympathetic and parasympathetic control. 
In this study, the autoradiographs did not show specific labelling of 
^-adrenoceptors in nasal blood vessels. TTiis finding is in agreement with 
several physiological studies (Hall and Jackson, 1968; Anggârd and 
Densert, 1974; Svensson et al., 1980). However, other physiological 
studies demonstrated ^-adrenoceptors in resistance (Malm, 1974) and 
capacitance vessels (Malm, 1974; Hiley et al., 1978). 
Clinical pharmacological studies refer to the anti-allergic effects of β-
adrenergic agonists by inhibiting histamine release frcm mast cells 
(Kaliner and Austen, 1975). Botana (1987) demonstrated /3-adrenoceptors on 
pleural and peritoneal mast cells. However, only a few mast cells were 
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present in rat nasal mucosa. No specific 125I-(-)-CYP labelling in these 
cells could be observed. 
Ihe radioligand receptor binding studies and in vitro autoradiography 
suggested the presence of a mixture of ß^- and ß2-a.arenoceptor 
populations in the nasal epithelium and in the glandular excretory ducts. 
Ihe coexistence of /3-adrenoceptors subtypes has also been observed in rat 
kidney (Summers et al., 1985). In human lung epithelium, a homogeneous 
/^"adrenoceptor population was observed. However, the authors suggested 
that the epithelium was probably contaminated with smooth muscle 
consisting of pure ^ -adrenoceptors (Carstairs et al., 1985). 
In summary, /3-adrenoceptors have been demonstrated and characterized in 
homogenates as well as in cryostat sections of rat nasal mucosa. 
Furthermore, the in vitro labelling on cryostat sections was combined 
with autoradiography. The radioligand receptor binding experiments and 
the in vitro autoradiography demonstrated both ß^- and ^ 2-a<irenocePtors 
in the epithelium and glandular excretory ducts. In the future, both 
techniques will be applied to human nasal mucosa for studying the 
supposed changes in the distribution pattern of receptors under 
pathological conditions sudi as nasal hyperreactivity. 
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CHftPTER 5 
ПИСЫЭПЖПСИ OF AIHaj^-AERENOCEETCKS Ш RÄT NASAL MUCOSA. 
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R.lh.R. Wentges1 and C.A.M, van Ginneken2. 
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Hospital, ENT Researcii Laboratory, Hiilips van Lsijdenlaan 15, 6500 HB 
Nijmegen, The Netherlands. 
(published in Journal of Receptor Research 9: 221, 1989) 
5.1. Abstract 
3H-Prazosin was used to demonstrate α^-adrenoceptors in rat nasal 
mucosa. Specific binding is saturable and occurs to a homogeneous class 
of binding sites with high affinity (Kd=0.07+0.01 riM) and with a receptor 
density of 0.36+0.02 pmol/g tissue or 14+1 fmol/mg protein. Kinetic 
experiments resulted in a Kd-value of 0.03 hM. Ihe binding is 
stereoselectively inhibited by epinephrine enantiomers. Ihe antagonist 
prazosin inhibits 3H-Prazosin binding with high affinity, in contrast to 
yohimbine, classifying the binding sites as aj-adrenoceptors. Inhibition 
experiments with WB4101 indicated the presence of a l a- (31+9%) and 
a^-adrenoceptor subtypes in the rat nasal mucosa. The order of 
potencies of agonists determined in competition experiments was 
(-)epinephrine > (+)epinephrine > (-)phenylephrine. 
5.2. Introduction 
Physiological experiments have demonstrated that adrenergic receptors are 
involved in the vasomotor activities of the nasal mucosa (Eccles and 
Wilson, 1974; Grote et al., 1975; Jackson, 1979; Jackson, 1980; Ichimura 
and Jackson, 1984). Although nasal secretion has been proven to be mainly 
under parasympathetic control, it has been suggested that 
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a-adrenoceptors play a role in the regulation of nasal secretory 
activity (Malm et al., 1983). 
Neurohistochemical studies also point to the presence of a dense 
adrenergic innervation of nasal blood vessels, especially the sinusoids, 
regulating the swelling and shrinkage of the nasal mucosa (Grote et al., 
1975; Anggârd and Densert, 1974; Vecerina et al., 1983). Radioligand 
receptor binding studies give the opportunity of investigating the 
biochemical characteristics, densities and subclasses of adrenoceptors. 
Ihe a-adrenoceptors have been divided into a^- and a2-acirenocePtors 
based on their pharmacological profiles (Berthelsen and Pettinger, 1977; 
Hoffman et al., 1979). In this study we have demonstrated the presence of 
a^-adrenoceptors in the rat nasal mucosa with the radioligand binding 
technique using the selective antagonist 3H-Prazosin (Timmermans and van 
Zwieten, 1981; Johansson, 1984) . Recently, the presence of 
a^ -adrenocepítor subtypes have been reported (Monxw and Creese, 1986; Han 
et al., 1987; Minneman et al., 1988). It appeared that the antagonist 
WB4101 distinguishes two o^-adrenoceptor binding sites, one high (ala) 
and one lew (ацэ) affinity binding site. Vte used this antagonist to 
demonstrate the presence of a-L-adrenoceptor subclasses in rat nasal 
mucosa. 
5.3. Materials and methods 
Chemicals 
3H-Prazosin was purchased f rem New England Nuclear (spec, activity: 18.8 
Ci/mmol), Doom, Ihe Netherlands. (+) and (-) epinephrine bitartrate were 
gifts frcm Sterling Winthrop, Haarlem, Ihe Netherlands. Prazosin was a 
gift frcm Pfizer, New York and pjhentolamine from Ciba-Geigy, N.J. 
Yohimbine-HCl and (-) phenylephrine were obtained frcm Sigma Chemical 
Co., St. liDuis, МЭ, USA and WB4101 from Amersham International, England. 
All other chemicals were of analytical grade. 
Membrane Preparations 
Nasal micosae of Wistar rats (body weight about 250 g) were carefully 
dissected, irtmediately frozen (acetone/cr^ bath) and stored at -80°C. Ihe 
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tissue was hanogenized in ice-cold Tris/HCl buffer (50 irM Tris; 120 mM 
NaCl; 5 irM KCl; 2 irM СаС12; 1 ігМ МЭСІ2/ рИ 7.4) with an Ultraturrax for 
2x10 seconds. The hctnogenate was centrifuged at lOOOxg for 5 min, the 
supernatant was collected and centrifuged at 50,000xg for 15 min (4°С). 
Ihe resulting pellet was washed 3 times in ice-cold Tris/HCl buffer by 
resuspension and cerrtrifugation (50,000xg, 15 min). The final pellet was 
resuspended by Potter homogenization in buffer. Protein determination was 
performed according to Lowry using bovine serum albumin as a standard. 
Radioligand Receptor Binding Assay 
Receptor binding studies were carried out in glass tubes containing 40 μΐ 
3H-Rrazosin, 40 μΐ Tris/HCl buffer and 320 μΐ tissue homogenate 
corresponding to a final concentration of 25 mg/ml tissue. Instead of the 
buffer, phentolamine was added to a final concentration of 12 μΜ for the 
determination of the non-specific binding. The homogenates were 
incubated at 25°C for 40 min. Incubations were terminated by rapid 
dilution with 2x2 ml ice-cold buffer and filtration through Whatman GF/C 
filters under vacuum, follcwed by 3x5 ml rinses of the filter with 
buffer. Radio-activity collected on each filter was determined by liquid 
scintillation counting after the addition of 10 ml Aqua luma (lumac). Ihe 
binding parameters were calculated by subjecting the data to a non-linear 
least square curve fitting procedure using the Gauss-Newton algorithm 
(Fletcher and Powell, 1963) comparable with the LIGAND program (Munson 
and Rodbard, 1980). Inhibition curves were analysed according to a one 
or two binding sites model. 
5.4. Results 
Specific binding of 3H-Prazosin to rat nasal mucosa membranes was 
saturable and of high affinity (fig. 5.1). A Scatchard representation 
(insert) points to a harogeneous population of binding sites. Analysis of 
the data fron 6 experiments results in a mean equilibrium dissociation 
constant (Kd) of 0.07+0.01 nM and a total receptor density (Bmax) of 
0.36+0.02 Txx>l/q tissue. Tissue protein content of the homogenates has 
been determined in 4 out of 6 experiments, resulting in 25±4 mg 
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proteiiVg tissue. With this converting factor the receptor density has 
been expressed in fmol/mg protein (йпаэс=14+1 fmol/mg protein). 
Fig. 5.1: Specific binding of 3H-Prazciein to rat nasal mucosa membranes 
(25 mg/ml). Total binding (0) and non-specific binding (Δ), 
determined in the presence of 12 μΜ phentolamine. The line 
without points represents the specific 3H-Prazosin binding. 
Inset: Scatchard plot of the specific part of the binding. 
3H-Prazosin binding was linear with tissue concentrations in the range 
of 15-45 mg/ml. If a tissue concentration belcw 10 mg/ml was used 
specific binding could hardly be demonstrated. Using a tissue 
concentration of 25 mg/ml reproducible specific binding was obtained. 
Furthermore, non-specific binding could be reduced to a level of 50% at 1 
riM 3H-Prazosin applying filtration instead of centrifugation after the 
incubation. Extending the wash-procedure of the membrane pellets (4 
washes instead of one wash) resulted in a 10 % reduction of the 
non-specific binding. 
As illustrated in figure 5.2, the specific binding of 3H-Prazosin to rat 
nasal mucosa was rapid, 95% equilibrium being reached in approximately 40 
min. Specific binding was reversible icon addition of 12 μΜ phentolamine. 
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The association (kj_) and dissociation (k_i) rate constants were 0.50+0.13 
109 M-1!!^-1 and 0.016+0.002 min-1 (n=3). Ihe corresponding kinetic Kd 
(k.l/k!) value of 0.03 hM was somewhat lewer than the equilibrium 
Kd-value. 
Bound 3H-Prazosin in pmole/g 
10 20 30 ¿0 60 60 70 80 90 
time in mm 
Fig. 5.2: Time course of association and dissociation of 3H-Prazosin 
binding to rat nasal mucosa. Incubations were performed with 
0.1 hM 3H-Prazosin at 25°C. Dissociation was induced by 
addition of 12 μΜ phentolamine after 40 min incubation. Total 
binding (O), non-specific binding (Δ), dissociation (O) · 
Adrenergic antagonists carpeted for the 3H-Prazosin binding sites in rat 
nasal mucosa with an order of potencies clearly indicative of 
^-specificity (fig. 5.3). Prazosin (Ki=0.11 and 0.19 riM) was 1000 times 
more potent than yohimbine (Ki=0.11 and 0.14 juM). Inhibition experiments 
with the antagonist WB4101 shewed shallow inhibition curves (fig. 5.3). 
The curves could best be fitted with a two binding sites model 
(Ki^.18+0.15 hM; КІ2=5.3+0.6 riM) and indicated the presence of a l a-
(31+9%) and aj^-adrenoceptors. The adrenergic agonists competed for the 
3H-Prazosin binding sites in the follcwing order of potency: 
(-)epinephrine (Ki=1.9 and 2.8 nM), (+)epinephrine (Ki=52 and 71 hM), 
(-)phenylephrine (Ki=2.8 and 5.4 μΜ) (fig. 5.4). All agonist inhibition 
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curves displayed a normal slope (one binding site). Ihe JH-Prazosin 
binding is stereoselectively inhibited by the enanticmers of 
epinephrine, (-) epinephrine having 23 times greater affinity than 
(+)epinephrine. 
Fractional specific 
3H-Prazosin binding 
-12 -10 -8 -6 -4 -2 0 
Log cone antagonist m mol/l 
Fig. 5.3: 
I n h i b i t i o n of s p e c i f i c 
3H-Prazosin binding by the 
a n t a g o n i s t s prazos in (O) / 
yohimbine (0) and WB4101 (Δ). 
Nasal mucosa membranes were 
incubated a t 25°C for 40 min 
with 0.2 nM 3H-Prazosin in the 
absence o r p r e s e n c e of 
oonpeting agents. Data shewn 
are the means of t r i p l i c a t e s 
f r o m a r e p r e s e n t a t i v e 
experiment. 
Fig. 5.4: 
I n h i b i t i o n of s p e c i f i c 
3 H-Prazosin binding by the 
agonists (-) epinephrine ( Δ ), 
( + ) e p i n e p h r i n e ( О ) and 
(-)phenylephrine (0) . Nasal 
mucosa membranes were incubated 
a t 25°C for 40 min with 0.2 rM 
3H-Prazosin in the absence or 
presence of competing agents. 
Data shewn are the means of 
t r i p l i c a t e s fron a representative 
experiment. 
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5.5. Discussier! 
Appropriate conditions, especially a tissue concentration above 10 
mg/ml, were essential to observe specific 3H-Prazosin binding to 
a^-adrenoceptors in rat nasal mucosa. This may be due to the 
unfavourable ratio specific to non-specific binding. Notably, the 
a^-adrenooeptor density (14 fmol/rag protein) was low in contrast with 
the density of 200 fmol/mg protein in rat cerebral cortex (Diop et al., 
1987) or 177 fmol/mg protein in rat mesenteric arteries (Agrawal and 
Daniel, 1985). 
Specific binding of 3H-Prazosin to rat nasal mucosa was of high affinity 
with a Kd-value of 0.07+0.01 nM (ΓΪ=6) . The binding occurs to a 
homogeneous class of binding sites with a receptor density of 0.36+0.02 
pmol/g tissue or 14+1 fmol/mg protein. The Kd-values in the present 
study are in agreement with those found in other tissues of the rat 
(Guicheney and Meyer, 1981; Agrawal and Daniel, 1985; Rattigan et al., 
1986; Diep et al., 1987). 3H-Prazosin binding was demonstrated in nasal 
mucosa of guinea pig (Kd=0.37 hM (Ishibe et al., 1985) and Kd=2.63 hM 
(Kbnno et al., 1986)) and man (10=0.31 nM (Ishibe et al., 1983)). The 
Kd-values reported were higher than those found in this study. To rule 
out a possible species difference we determined the dissociation constant 
of 3H-Prazosin binding in guinea pig nasal mucosa, which appeared to be 
similar. As we applied the receptor assay method of Ishibe et al. (1983; 
1985) only small differences in methodology, like the use of glass 
instead of plastic incubation tubes, can account for the discrepancy in 
dissociation constant. 
Ihe saturability, stereoselectivity, reversibility and kinetics of the 
3H-Prazosin binding indicated that 3H-Prazosin binds to a^-adrenoceptors 
in rat nasal mucosa. Competition experiments confirmed the a^-adrenergic 
characteristics of the binding sites since 3H-Prazosin was 1000 times 
more potent than yohimbine (Timmermans and van Zwieten, 1981; Johansson, 
1984). Competition experiments with WB4101 indicated the presence of 
α
ΐ 3- (31±9%) and a^-adrenoceptors. The Ki-values for WB4101 at the Ыф 
(aia) аіхі t* 1 6 1<:w (alb) affinity binding sites were in agreement with 
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those in heart, cortex and kidney (Morrow and Creese, 1986; Minneman et 
al., 1988). It has been suggested that ala-adrenoceptors mediate opening 
of the Ca2+-channels, whereas the a^j-adrenoceptors stimulate the 
inositol phospholipid metabolism (Morrcw and Creese, 1986; Han et al., 
1987; Minneman et al., 1988). The relative potency of agonists was in 
agreement with those of other studies (Barnes et al., 1979; Snavely and 
Insel, 1982). The competition curves of the 3H-Prazosin binding followed 
a sigmoid shape. Ihis is in agreement with the homogeneity of agonist 
binding sites observed in other tissues (Barnes et al., 1979; Guicheney 
and Meyer, 1981; Agrawal and Daniel, 1985; Rattigan et al., 1986). 
Hcwever, several studies have demonstrated biphasic agonist competition 
curves, indicating heterogeneous agonist binding sites (Adams et al., 
1986; Hieble et al., 1986; Jagadeesh and Deth, 1987). 
Physiological and histochemical experiments have provided evidence for 
the presence of α^-adrenoceptors in smooth muscles of nasal blood 
vessels which mediate vasoconstriction (Anggârd and Densert, 1974; Grote 
et al., 1975; Vecerina et al., 1983; Idiimura and Jackson, 1984). In 
studies of the lewer airways it has also been suggested that these 
receptors are present on mast cells, where they regulate mediator release 
(Kònno et al., 1986). Autoradiographic experiments will be needed to 
localize these ^ H-Prazosin binding sites. 
This study may contribute to a better understanding of the mechanisms of 
clinically used drugs. Commonly used nasal decongestants stimulate both 
a^- and 02 -adrenoceptors. Hcwever, Andersson and Bende (1984) 
demonstrated that a^-acting drugs, in contrast to o^-acting drugs, did 
not reduce the nasal blood flew. Itierefore, a nasal decongestant with 
only an ai-adrenoceptor stimulating effect might be preferable to a drug 
which also acts on oc -adrenoceptors, provided that the decongestive 
effects are similar. It has been reported that the nasal decongestant 
Abbott-57219 mediates selective αι-vasoconstriction but not constriction 
of the resistance vessels (Kyncl et al., 1987). 
In the present study a radioreceptor assay has been adapted for the 
demonstration and characterization of a^-adrenoceptors in rat nasal 
mucosa. This assay will be applied to human nasal mucosa in order to 
study the supposed changes in the distribution pattern of receptors under 
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pathological conditions such as nasal hyperreactivity. 
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6.1. Abstract 
The specific binding of 3H-Rauwolscine to membranes of rat nasal mucosa 
was saturable, stereoselective and of high affinity. In 7 out of 14 
experiments the Scatchard plot points to an homogeneous population of 
binding sites (Κ3=3.6±0.6 nM; йпах=5.1+0.7 pmol/g). In the other 
experiments 3H-Rauwolscine binding was significantly better fitted 
according to a two binding sites model with hicpi (Kd=0.20±0.08 nM; 
unax=0.5+0.1 pnol/g) and lew affinity binding sites (Kd=17±6 nM; 
Bmax=ll±5 pmol/g). Investigation of the non-specific and filter binding 
suggested that the appearance of two binding sites may be an artefact of 
an inappropriate definition of the specific binding due to non-linear, 
non-specific binding. 
Inhibition of 3H-Kauwolscine binding with the subtype selective 
antagonist prazosin suggested the presence of a2-adrenoceptor subclasses 
in rat nasal mucosa. All full agonist inhibition curves demonstrated high 
and lew affinity agonist binding sites. In the presence of guanine 
nucleotides a monophasic (-)-epinephrine inhibition curve was obtained. 
6.2. Introducticn 
itiysiological and morphological experiments have shewn that the nasal 
vascular structures are innervated by syirpathetic (adrenergic) nerves 
(Anggârd and Densert, 1974; Eccles and Wilson, 1974; Grote et al., 1975; 
Idiimura and Jackson, 1984; Vecerina et al., 1983; Berridge and Roach, 
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1986). Although nasal secretion has been proven to be mainly under 
parasympathetic control, it has been suggested that adrenoceptors play a 
role in the regulation of the nasal secretory activity (Malm et al., 
1983). 
Clinically used nasal decongestants points to the presence of 
α-adrenoceptors in human nasal mucosa (Andersson and Bende, 1984). 
Radioligand receptor binding studies can be used to investigate the 
biochemical characteristics, densities and subclasses of adrenoceptors. 
Ihe α-adrenoceptors have been divided into cty and (^-adrenoceptors based 
on their pharmacological profiles (Berthelsen and Pettinger, 1977; 
Hoffman et al., 1979). The a^-adrenoceptors have already been 
demonstrated and characterized in homogenates of rat (van Megen et al., 
1989) and guinea pig nasal mucosa (Ishibe et al., 1985). No quantitative 
data of o^-adrenoceptors in rat nasal mucosa are available. In this study 
we have demonstrated the presence of аз-adrenoceptors using the 
selective antagonist 3H-Rauwolscine as radioligand (Timmermans and van 
Zwieten, 1982; Johansson, 1984). Alpha2-adrenoceptor subtypes have been 
proposed on the basis of the affinity for prazosin; азд- and a2B~ 
adrenoceptors having low and high affinity respectively (Bylund, 1985; 
Nahorski et al., 1985). In this study, the characteristics of the 
a2-adrenoceptors in regard to affinity, receptor density, 
stereoselectivity, classification into their subtypes and the inhibitory 
pattern of the antagonist binding by agonists have been demonstrated. 
6.3. Materials and methods 
3H-Rauwolscine was purchased fron New England Nuclear (spec, activity 
73.5 Ci/mmol), Doom, The Netherlands. (+)- and (-)-epinephrine 
bitartrate were gifts from Sterling Winthrop, Haarlem, The Netherlands. 
Prazosin was a gift from Pfizer, New York and phentolamine from Ciba-
Geigy, N.J. Yohiitibine-HCl, Clonidine, oxymetazoline and Gpp(NH)p (51-
guanylylimidodiphosphate) were obtained from Sigma Chemical Co., St. 
Ixxiis, M.O., U.S.A. All other chemicals were of analytical grade. 
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Membrane preparations 
Ihe nasal mucosae from Wistar rats (body weight about 250 g) were 
carefully dissected, immediately frozen (acetone/CC^ bath) and stored at 
-80oC. The tissue was homogenized in ice-cold Tris/EDTA buffer (50 πΜ 
Tris, 1 ігМ EDIA) with an ultraturrax for 2x10 sec. The hcînogenate was 
centrifuged at lOOOxg for 5 min, the supernatant was collected and 
centrifuged at 100,000xg for 60 min (40C). Ihe resulting pellet was 
resuspended by Potter homogenization in buffer. Protein determination was 
performed according to lorry using bovine serum albumin as a standard. 
Receptor binding studies. 
Receptor binding studies were carried out in glass tubes, containing 40 
μΐ 3H-Rauwolscine, 40 μΐ Tris/EDTA buffer and 320 ßl tissue homogenate 
corresponding to a final concentration of 10 mg/ml. Instead of the 
buffer, phentolamine was added to a final concentration of 12 μΜ in 
buffer for the determination of the non-specific binding. Ihe hcmiogenates 
were incubated at 250C for 20 min. Incubations were terminated by rapid 
dilution with 2x2 ml ice-cold buffer and filtration through Whatman GF/C 
filters vinder vacuum followed by 3x5 ml rinses of the filter with buffer. 
Radioactivity on each filter was determined by liquid scintillation 
counting after the addition of 10 ml Aqua luma (Dumac). Ihe binding 
parameters were calculated by subjecting the data to a non-linear least 
squares curve fitting procedure using the Gauss Newton algorithm 
(Fletcher and Powell, 1963). Antagonist binding and inhibition curves 
were analysed according to a one or two binding sites model. 
6.4. Results 
Specific binding of 3H-Rauwolscine to membranes of rat nasal mucosa was 
saturable and of high affinity (fig. 6.1). Analysis of the data 
demonstrated a mean dissociation constant (Kd) of 4.1+0.5 nM and a 
receptor density (йпах) of 5.9+0.5 тдвюі/д tissue corresponding with 
236±32 finol/mg protein (n=14). 
The 3H-Rauwolscine (0.5 ιίΜ) binding to rat nasal mucosa was linearly 
dependent on tissue concentration between 5-45 mg/ml. 
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Bound 'H-Rauwolscme [pmol/g] 
üound/lfee 
3H-Rauwolscine free (nM) 
Fig. 6.1: Specific binding of 3H-Rauwolscine to rat nasal mucosa 
membranes (25 mg/ml). Total binding (O) and non-specific 
binding (Δ), determined in the presence of 12 μΜ phentolamine. 
The line without points represents the specific 3H-Rauwolscine 
binding. Inset: Scatchard plot of the specific binding. 
Bound 3 H-Rauwolscine (pmol/g) 
06 
SO 6 0 
time in mm 
Fig. 6.2: Time course of association and dissociation of 3H-Rauwolscine 
binding to rat nasal mucosa membranes. Incubations were 
performed with 0.5 riM 3H-Rauwolscine at 250C. Dissociation was 
induced by addition of 12 μΜ phentolamine after 25 min 
incubation. Total binding (O) non-specific binding (Δ) 
dissociation (O) · 
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Ihe time dependent association and dissociation frcm a^-adrenoceptors in 
rat rasai mucosa is illustrated in fig. 6.2. The specific binding of 
3H-Rauwolscine (0.5 hM) was rapid, 95% equilibrium being reached in 
approximately 20 min. Specific binding was reversible upon addition of 12 
μΜ phentolamine. If ln(Bt/Beq) was plotted versus time, the dissociation 
reaction followed first order kinetics, indicating the presence of an 
homogeneous class of binding sites. Ihe association (k^ ) and dissociation 
(k-l) constants were 0.02310.003 nM~1min"1 and 0.032±0.008 min-1 
respectively; the calculated Kd-value (Kd=k_1/k1) of 1.4±0.3 riM (n=3) 
was somewhat lewer than the equilibrium Kd-value. 
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Зн-Inhibition of the specific -Ή-
Rauwolscine binding by the 
antagonists phentolamine (·), 
yohimbine (0) and prazosin (Δ). 
Nasal mucosa membranes were 
incubated at 250C for 20 min 
with 8 nM 3H-Rauwolscine in the 
absence or presence of 
competing agents. Ihe curve of 
prazosin could significantly 
better fitted according to a 
two binding sites model 
whereas the curves of 
phentolamine and yohimbine 
could adequately be fitted 
according to a one binding 
site model. Data shown are the 
means of triplicates fron a 
representative experiment. 
The subtype selective antagonist prazosin was used to define the 
proportion of 02-adrenoceptor subtypes. Ihe inhibition curve was shallow 
and could be significantly better fitted according to a two binding site 
model, suggesting the presence of «^-adrenoceptor subclasses (table 6.1; 
fig. 6.3). Adrenergic antagonists competed for the 3H-Rauwolscine binding 
sites in rat nasal mucosa with the follcwing order of potency; 
phentolamine > ychirribine > prazosin (low affinity) (table 6.1; fig. 6.3). 
Irihibiton curves of the partiell agonist Clonidine displayed a monophasic 
character, whereas the full agonist oxymetazoline displayed a biphasic 
103 
character, demonstrating 52+5% high affinity states (table 6.1; fig. 
6.4). Inhibition curves of the full agonists (-)-epinephrine and 
(+)-epinephrine displayed also a biphasic character, indicating the 
presence of 54±3% and 63±7% high affinity binding sites respectively 
(table 6.1; fig. 6.4). The binding of 3H-Rauwolscine to a^-adrenoceptors 
was stereoselectively inhibited by the stereoisomers of epinephrine. In 
the presence of 5.10-4 M Gpp(NH)p the (-)-epinephrine inhibition curve 
became monophasic (Ki=0.46±0.03 juM, n=3, fig. 6.5). 
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Fig. 6.4: 
Inhibition of the specific 3H-
Rauwolscine binding in rat 
nasal mucosa membranes by the 
full agonists oxymetazoline 
(Δ), (-)-epinephrine (O) and 
(+) -epinehrine (·). All curves 
could be significantly better 
fitted according to a two 
binding sites model. Data shewn 
are the means of triplicates 
from a representative 
experiment. 
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Fig. 6.5: 
Inhibition of the specific 3H-
Rauwolscine binding in rat nasal 
mucosa membranes by the agonist 
(-) -epinephrine in the absence 
(O) and presence (·) of 5.10~4 M 
Gpp(NH)p. Itie inhibition curve in 
the presence of Gpp(NH)p could 
not be significantly better 
fitted according to a two 
binding sites model. Data shown 
are the means of triplicates f rem 
a representative experiment. 
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Table 6.1: Inhibition of a2-adrenergic agonists and antagonists for 
3H-Rauwolscine (8 riM) binding to rat nasal mucosa membranes. 
Agent 
Antaqonists 
yohimbine 
phentolamine 
prazosin 
Acfonists 
Clonidine 
oxymetazoline 
(-) -^ )inej*irine 
(+) -^linephrine 
Ki (μΜ) 
0.037 ±0.010 
0.013 ±0.006 
0.0012/0.0009 
0.033±0.009 
0.006/0.012 
0.11 ±0.03 
2.5 ±0.6 
Ki (μΜ) 
0.33/0.36 
0.62/0.44 
2.12+0.26 
125 ± 50 
%RH 
36/45 
52/56 
54±3 
63±7 
η 
3 
4 
2 
3 
2 
3 
3 
Further analysis of the 3H-Rauwolscine binding to rat nasal mucosa 
indicated that in 7 out of 14 experiments the Scatchard plot pointed to 
an homogeneous class of binding sites (Rd=3.6±0.6 riM; anax^S.1+0.7 
pnol/g). In the other experiments the Scatchard plot of the 
3H-Rauwolscine binding was curvilinear and the binding could be 
significantly better fitted according to a two binding sites model 
assuming high affinity binding sites with Kc%j=0.2010.08 nM and 
ûnax=0.5±0.1 рпюі/q tissue and lew affinity binding sites with KdL=17±6 
riM and EhB3C=ll+5 pmol/g. 
The non-specific binding was identical, when determined in the presence 
of 12 μΜ phentolamine or 1 μΜ (-)-epinephrine. In the first experiments 
(n=14) the non-specific binding values were determined with phentolamine 
for two concentrations of radioligand. In 7 additional experiments, the 
non-specific binding values were determined for every concentration of 
the radioligand. In all these experiments the non-specific binding 
appeared to be non-linear (fig. 6.6). Neglecting the non-linearity of 
the non-specific binding, the specific 3H-Rauwolscine binding was 
significantly better fitted according to a two binding sites model (fig. 
6.6 A and 6.6 C) in 2 out of 7 experiments. However, the specific 
binding could adequately be fitted aooording to a one binding site model 
105 
if the non-specific binding values, fitted according to a saturation 
curve, were subtracted fron the total binding in these 2 experiments 
(fig. 6.6 В and 6.6 D). 
Bound 3H-Rauwo[scine[pmol/g) 
Bound (pmol/g) 
Fig. 6.6: Specific binding of 3H-Rauwolscine to c^-adrenoceptors in rat 
nasal mucosa membranes. Total binding (·) and non-specific 
binding (Δ), determined in the presence of 12 μΜ phentolainine. 
If in 2 out of 7 experiments the non-specific binding was 
fitted linearly (A), the specific binding (C; Scatchard plot) 
could be significantly better fitted according to a two 
binding sites model. If in these 2 experiments the non­
specific binding was fitted according to a saturation curve 
(B), the specific binding (D, Scatchard plot) could adequately 
be fitted according to a one binding site model. 
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6.5. Discussion 
Specific binding of 3H-Rauwolscine to rat nasal mucosa was saturable and 
of high affinity. Careful analysis of the 3H-Rauwolscine binding 
indicated that the binding occurs to an homogeneous class of binding 
sites with а Ш value of 3.6±0.6 nM and a receptor density of 5.1+0.7 
pnol/g tissue or 204±28 fmol/mg protein in 7 out of 14 experiments. Ihese 
Kd-values are in agreement with those of 3H-Rauwolscine binding to other 
rat (Bylund, 1985; Adams et al., 1986; Pettibone et al, 1987) and human 
tissues (Muller and Noack, 1988). Surprisingly, in the other experiments 
the 3H-Rauwolscine binding was significantly better fitted according to a 
two binding sites model, indicating high affinity binding sites with 
Väif=O.2O±0.08 nM and unax=0.5±0.1 pnol/g tissue and lew affinity binding 
sites with KdL=17±6 nM and Bniax=ll±5 pmol/g. The total receptor density 
(11.5 pmol/g tissue), determined by a two binding sites analysis was 
higher than the density (5.1 pmol/g tissue) determined by a one binding 
site analysis. Ihis discrepancy may be due to an overestimation of the 
number of binding sites in the analysis according to a two binding sites 
model and to scatter of the data points. A few studies reported 
curvilinear Scatchard plots with 3H-Rauwolscine binding to other tissues 
(Diop et al., 1983; U'Prichard, 1984; Periyasamy and Somani, 1985; 
Convents et al., 1989a). Ihe % and the KL values determined in this 
study are in agreement with those reported for 3H-Rauwolscine binding to 
rat and bovine brain cortex (Diop et al., 1983; U'Prichard, 1984) and 
human platelets (Periyasamy and Scmani, 1985). Many interpretations of 
sudi binding data were given; binding to several a^-adrenoceptor 
subclasses with different affinities, negative cooperative interactions 
among a2-adrenergic binding sites (Periyasami and Somani, 1985), 
3H-Rauwolscine binding to serotonergic sites (Broadhurst et al., 1988; 
Convents et al., 1989b), or an inappropriate definition of the non-
specific binding (Convents et al., 1989a). Differences in the non-
specific binding determined in the presence of phentolamine or 
(-)-epinephrine have been reported (Convents et al., 1987; Convents et 
al., 1989a). In calf retina phentolamine should be used to define the 
non-specific binding since specific 3H-Rauwolscine binding comprises 
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binding to 02-adrenoceptors and non-adrenergic sites, when 
(-)-epinephrine is used for the determination of the non-specific binding 
(Convents et al., 1987). On the other hand, in human and rabbit cortical 
membranes (-)-epinephrine should be used to define the non-specific 
binding since specific 3H-Rauwolscine binding comprises binding to 
02-adrenoceptors and non-receptor sites, when phentolamine is used for 
the determination of the non-specific binding (Convents et al., 1989b). 
In this study the non-specific binding was identical when determined in 
the presence of 12 μΜ phentolamine or 1 μΜ (-)-epinephrine. Non-linear 
non-specific binding has been reported in calf retina (Convents et al., 
1987) and human and rabbit cortical membranes (Convents et al., 1989a), 
irrespective as to whether phentolamine or (-) -epinephrine were used to 
define non-specific binding. In this study, the non-specific binding 
appeared to be non-linear, when the non-specific binding values were 
determined for every concentration of the radioligand in 7 additional 
experiments. This non-linear non-specific binding may be due to filter 
binding since in most experiments non-specific binding consists of 85% 
and 50% filter binding at lew and high concentrations radioligand, 
respectively. Neglecting the non-linearity of the non-specific binding 
the specific binding could adequately be fitted according to a one 
binding site model in 5 experiments, but could be significantly better 
fitted according to a two binding sites model in the other 2 experiments. 
If the non-linear, non-specific binding values for every concentration 
radioligand were subtracted from the total binding, the specific binding 
could adequately be fitted according to a one binding site model in these 
2 experiments. Ihis investigation of the non-specific binding suggested 
that the appearance of two 3H-Rauwolscine binding sites are probably an 
etrtefact of an inappropriate definition of the specific binding due to 
non-linear non-specific binding. Ihe irregular 3H-Rauwolscine filter 
binding may be responsible for the non-linear, non-specific binding. 
Ihe kinetic experiments and competition experiments with yohimbine in our 
study also pointed to the presence of an homogeneous class of 
3H-Rauwolscine binding sites. 
Apart fron the artificial appearance of a second 3H-Rauwolscine binding 
site, the peculation of 02-adrenoceptors as labelled by 3H-Rauwolscine 
108 
has been divided into subtypes on the basis of the affinity for prazosin 
(Bylund, 1985; Nahorski et al., 1985). The inhibition curve of 
3H-Rauwolscine with prazosin suggested the presence of a-¿-adrenoceptor 
subclasses in rat nasal mucosa. The Ki-values of the high and low 
affinity binding sites were in agreement with those observed in rat lung 
(Bylund, 1988), rat submandibular gland (Bylund, 1985; Bylund, 1988) and 
human brain (Betrash and Bylund, 1986). In this study the Ki-value of 
prazosin for the high affinity sites was of the same magnitude as the Kd-
value for 3H-Prazosin binding to the a^-adrenoceptors in rat nasal mucosa 
(van Megen et al., 1989). However, the aj-adrenoceptor density (0.36 
pmol/g tissue) in rat nasal mucosa determined with 3H-Prazosin is lewer 
than the receptor density expected from these experiments (approximately 
2.9 ріюі/g tissue). Other studies demonstrated an homogeneous class of 
a-¿-adrenoceptors with low affinities for prazosin (Neylon and Summers, 
1985; Hamilton et al., 1988; Convents et al., 1989a). 
All full agonist inhibition curves of 3H-Pauwolscine binding displayed 
high and lew affinity agonist states. Ihe Ki-value of the high affinity 
state of (-) -epinephrine is scmewhat higher than described in other 
tissues, but a wide range of Ki-values has been reported (Michel et al., 
1980; Brodde et al., 1982; Murphy and Bylund, 1988; Convents et al., 
1989a). It has been accepted that the high affinity complex consists of 
agonist, receptor and G-protein (Michel et al., 1980; U'Prichard, 1984). 
In the presence of 5.10-4 M Gpp(NH)p a monophasic (-)-epinephrine 
inhibition curve was obtained. The Ki-value was in between the high and 
the lew affinity Ki-values, probably due to a residual peculation of 
high affinity states, suggesting an incomplete conversion of the high 
into the lew affinity binding sites. Ccmplete conversion has neither been 
demonstrated in rat renal cortex (Snavely and Insel, 1982), human 
platelets (Scìiloos et al., 1987) and calf retina (Convents et al., 
1989a). The Ki-values of oxymetazoline were in agreement with those 
determined in other studies (Rouot et al., 1982; Murphy and Bylund, 
1988). Oxymetazoline and Clonidine are clinically used nasal 
decongestants and have been reported to act mainly on the capacitance 
vessels, regulating the blood volume, but also on the resistance vessels 
decreasing the blood flow (Andersson and Bende, 1984; Ichimura and Chow, 
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1988). Riysiological experiments in animals have also demonstrated the 
presence of o^-adrenoceptors in nasal blood vessels (Idiimura and 
Jackson, 1984 ; Berridge and Roach, 1986). Autoradiographic experiments 
will be needed to localize these 3H-Rauwolscine binding sites. 
In the present study a radioreceptor assay has been developed for the 
demonstration and characterization of o^-adrenoceptors in rat nasal 
mucosa. This assay will be applied to human nasal mucosa in order to 
investigate the supposed changes in the distribution pattern of receptors 
in nasal hyperreactivity. 
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СД РПК 7 . 
СНАНАСГЕКІЯПСЗ OF NCN-ALUKGIC AND MlfBGIC РАИИЯ5 
7.1. Introduction 
Nasal hyperreactivity can best be defined as an increased response of a 
nasal effector system to a stimulus (Widdicombe, 1983). In specific nasal 
hyperreactivity or allergic rhinitis the specific stimuli are allergens 
(pollen, microfungi, house dust mites, animal products -dander and 
urine). Ihe nasal synptoms (responses) are sneezing, hypersecretion and 
nasal obstruction (Mygind, 1978; Passali, 1983; Norman, 1985; Mygind, 
1986). These symptoms in nasal allergy may be due to changes in the 
pharmacological characteristics of neuroreceptors (Mygind, 1982). Ihe 
clinical picture and classification of patients is essential in the 
investigation of this hypothesis by radioligand receptor binding and in 
vitro autoradiographic studies of human nasal mucosa. In this study 
patients were classified into non-allergic and allergic individuals on 
the basis of clinical parameters. The heterogeneous non-allergic group 
was subdivided into control, chronic sinusitis and vasomotor rhinitis 
patients. 
7.2. Materials and methods 
Patients, f rem whom we received a biopsy, were characterized on the basis 
of the following parameters (according to Mygind, 1978): nasal symptoms, 
family history, sinus X-rays, serum IgE, blood and nasal eosinophilia, 
PAST and skin-tests. Patients were classified into a non-allergic and 
allergic group. Hie non-allergic group was subdivided into control 
individuals, chronic sinusitis and vasomotor rhinitis individuals. 
The control group consisted of patients with a history of nasal trauma, 
deviations of the septum and cosmetic problems and were characterized by 
lew serum IgE values (<90 U/ml), a low eosinophil count in the blood 
(<225.106 cells/ml) or in the nose (<2%) and negative RAST and skin-
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tests. The sinus X-rays were normal. 
The sinus X-rays of the chronic sinusitis patients demonstrated a mucosal 
change but other characteristics were similar to the control group. 
Ihe pathophysiology of the vascmotor rhinitis group resembles the 
pathophysiology of the allergic group, but an allergic component can be 
excluded. All these patients had nasal obstruction and the other 
characteristics were similar to the control group. 
Allergic rtiinitis was diagnosed on high IgE values (>150 U/ml), an 
elevated eosinophil count in the blood (>320.106 cells/ml) and/or in the 
nasal mucosa (>5%) and a positive RAST and/or skin-test for house dust 
mites, pollen and/or dander. 
7.3. Results and discussion 
Patients were characterized on the basis of the parameters described 
above, and classified into a non-allergic and allergic group (table 7.1 
and 7.2). Furthermore, the heterogeneous non-allergic group was 
subdivided into controls, chronic sinusitis and vasomotor rhinitis 
patients. The patients should be diagnosed on the basis of the 
combination of parameters, since not all parameters of allergic patients 
differed from those of controls. Not all parameters could be obtained 
fron all the patients, especially in the non-allergic group where RAST 
and skin-tests were rarely performed. Fourty-one out of 221 patients, 
from whom we received a biopsy, were left out of the study, because no 
clear distinction between allergic and non-allergic could be made. 
Another group of 114 patients was not involved in this study because of 
the limited amount of tissue received. 
Ihe clinical parameters of serum IgE, blood and nasal eosinophils were 
sometimes determined on two different points of time and the values were 
within the same order of magnitude with 85%, 76% and 66% reliability 
respectively. Mygind (1978) reported a 71%, 82% and 88% reliability of 
an increased number of eosinophils in the nose, an increased serum IgE 
content and a positive skin-test respectively in allergic patients. 
This study comprises 26 allergic and 40 non-allergic individuals. The 
control group consisted of 28 individuals with a mean age of 31±11 years, 
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13 males and 15 females, 16 smokers and 5 individuals with medication. 
Ihe chronic sinusitis group consisted of 9 patients with a mean age of 
44±15 years, 5 males and 4 females, 2 smokers and 4 patients with 
medication. Ihe vasomotor rhinitis group was a small group with 3 
patients (mean age 37±24 years), 1 male and 2 females, 2 smokers and 2 
patients with medication. Ihe allergic group consisted of 26 patients 
with a mean age of 24+9 years, 16 males and 10 females, 4 smokers. Fifty 
percent of the patients were on medication and 38% also had asthma. The 
skin-test showed a positive reaction in 20 of the 26 patients with pollen 
(n=18), house dust mites (n=17) and/οτ dander (n=18). Ihe RAST was 
positive in 5 out of 26 patients with pollen (η=4), house dust mites 
(n=5) and/or dander (n=2). Ihe RAST and the skin-test both indicated a 
positive reaction in 3 out of 3 patients. None of the allergic patients 
demonstrated an acute clinical manifestation of allergic rhinitis. 
In conclusion, only 30% of the biopsies could be used for biochemical 
studies since a clear distinction could not always be made between 
allergic or non-allergic patients antyOr because of the limited amount 
of tissue. 
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Table 7 .1 : Characteristics of non-allergic pat ients . 
Biopsy 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
birth-date 
621008 
650308 
590907 
541011 
401017 
460215 
450506 
510625 
220611 
670905 
420518 
610612 
420401 
310101 
560906 
540212 
580710 
390903 
630715 
540817 
640920 
650426 
650426 
510827 
240611 
230808 
521222 
550416 
670730 
420725 
721215 
690721 
430920 
580414 
620203 
540405 
470726 
690621 
401211 
220309 
IH/f 
f 
f 
f 
f 
m 
m 
f 
f 
m 
m 
f 
f 
f 
m 
m 
f 
m 
m 
m 
m 
f 
m 
m 
m 
f 
m 
f 
f 
f 
f 
m 
f 
f 
m 
f 
m 
m 
f 
m 
f 
ooeration 
turb 
nr 
turb 
sr 
sr 
str 
revision 
sr 
sr 
polyp 
turb 
turb 
turb 
turb 
turb 
sr 
sr 
sr 
nr 
nr 
sr 
sr 
sr 
sr 
sr 
sr 
sr 
sr 
sr 
turb 
sr 
str 
str 
str 
str 
str 
turb str 
sr 
polyp 
sr 
sr 
sr 
turb 
sr 
sr 
str 
polyp 
date 
840807 
840813 
840910 
841102 
841121 
841210 
841212 
850125 
850124 
850308 
851107 
850918 
851002 
851118 
860313 
860405 
860502 
860605 
860625 
860627 
860704 
860711 
860711 
861014 
861112 
870114 
870206 
870213 
870316 
870431 
870702 
870708 
870820 
870824 
871005 
871211 
880208 
870728 
870728 
881004 
medication 
Vi, Τ 
none 
none 
none 
none 
Te 
Bi, Pa 
none 
Be 
none 
Be, Ot 
Be 
Be 
none 
none 
none 
none 
none 
none 
none 
none 
none 
none 
none 
Au 
none 
Lo 
none 
none 
Syn 
none 
none 
none 
none 
none 
none 
none 
none 
none 
la 
smoker 
2 
10 
3 
10 
11 
10 
25 
no 
no 
no 
no 
no 
no 
no 
3 
25 
20 
8 
8 
15 
no 
no 
no 
no 
no 
7 
no 
no 
5 
25 
no 
10 
no 
10 
no 
no 
8 
no 
25 
no 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
c/d 
asthma 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
no 
no 
yes 
no 
child 
child 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
Au=Auginentine, Be=Beconase, Bi=Bisolvon, c^osntrol, c/d=cigarettes/day, 
chilcNasthma in childhood, Da=dander, Ec>=Eosincçhils, HM=house dust 
mites, La=Lanoxin, Ir»=]x»nudal, neg=negative, ND=not determined, nr=nose 
r e sec t i on , Ob=Obstruction, Ot=Otrivin, Pa=paracetarool, Po=pollen, 
polyp=polypectcjmy, pos=positive, RhFRhinorhoe, rv=rtiinitis vasomotoria, 
s=chronic s inus i t i s , s(ρ)=chronic s inus i t i s with polype, Sn=sneezing, 
sr=septum resection, Syn=Syntaris, TXTriludan, Te^Tetracycline, Tr= 
trauma, turb-turbinectcmy, turb str= stripping turbinates,Vi=Vibramycine. 
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Table 7.1: continued 
Biopsy 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
date 
param. 
840821 
ND 
831086 
841120 
861210 
821216 
ND 
850219 
710514 
841019 
850722 
850930 
850129 
860425 
ND 
ND 
860623 
860610 
ND 
860402 
861007 
ND 
851223 
860709 
ND 
790514 
861106 
860829 
860910 
870202 
ND 
871117 
870901 
870910 
ND 
880120 
870313 
ND 
ND 
ND 
IgE 
(U/itui 
22 
ND 
7 
6 
ND 
ND 
ND 
28 
ND 
10 
49 
96 
27 
14 
ND 
ND 
54 
34 
ND 
44 
10 
ND 
6 
149 
ND 
73 
32 
15 
102 
86 
ND 
2 
51 
119 
ND 
10 
23 
ND 
ND 
ND 
Eo blood 
fxlO6 c/ml) 
110 
ND 
120 
65 
70 
70 
ND 
50 
226 
90 
120 
180 
125 
150 
ND 
ND 
265 
220 
ND 
80 
80 
ND 
165 
45 
ND 
273 
110 
ND 
300 
12 
ND 
60 
80 
215 
ND 
50 
135 
ND 
ND 
ND 
Eo nose 
m 0 
ND 
0 
0 
70 
0 
ND 
0 
ND 
3 
0 
0 
0 
0 
ND 
ND 
5 
5 
ND 
0 
0 
ND 
0 
0 
ND 
25 
0 
ND 
5 
2 
ND 
0 
0 
0 
ND 
0 
0 
ND 
ND 
ND 
septum-
deviation 
neg 
pus 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
pos 
neg 
neg 
neg 
neg 
neg 
pos 
pos 
pos 
pos 
pos 
риь 
pos 
pos 
pos 
neg 
pos 
pus 
neg 
neg 
pus 
neg 
pus 
neg 
pos 
pos 
neg 
neg 
pus 
neg 
neg 
X-ray 
(date) 
neg(831117) 
ND 
neg(831026) 
neg(840315) 
pos(841108) 
pos(860312) 
pos(841129) 
pns(841024) 
pos(830314) 
neg(840000) 
neg(850227) 
ND 
pos(850129) 
pos(850925) 
ND 
ND 
neg(860110) 
neg(850827) 
ND 
neg(860404) 
neg(801112) 
ND 
neg(860204) 
neg(860709) 
pos(861103) 
ND 
neg(861204) 
neg(860926) 
ND 
neg(870223) 
pos(831101) 
neg(870321) 
риь 
ND 
ND 
neg(871026) 
neg(870623) 
ND 
neg(880330) 
neg(780720) 
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Table 7 .1 : continued 
opsY 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
Skin-test 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
neg 
neg 
ND 
neg 
neg 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
neg 
ND 
ND 
ND 
ND 
ND 
ND 
neg 
ND 
ND 
Po, 
ND 
ND 
ND 
ND 
(710514) 
(841019) 
(850000) 
(860515) 
(790514) 
(630125) 
Da (540410) 
RAST-test 
neg (831222) 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
neg (860910) 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
neg (870602) 
ND 
ND 
ND 
Sn 
neg 
ND 
neg 
ND 
pos 
ND 
ND 
ND 
ND 
ND 
poa 
pos 
pus 
ND 
ra 
neg 
neg 
pos 
ND 
neg 
ra 
neg 
риь 
neg 
ND 
pos 
neg 
ND 
ND 
pos 
neg 
pus 
neg 
ND 
ND 
ND 
ND 
neg 
ND 
pos 
Ш 
neg 
ND 
pos 
ND 
pos 
pos 
neg 
neg 
neg 
pus 
pus 
pus 
pus 
pus 
neg 
neg 
neg 
pos 
ND 
pos 
pus 
pus 
neg 
neg 
pos 
pos 
neg 
neg 
pos 
neg 
neg 
pos 
pus 
neg 
neg 
pos 
pos 
neg 
pos 
pos 
Ob 
pos 
pos 
pus 
pus 
pos 
pos 
pos 
pus 
pus 
pus 
pus 
pus 
pus 
pus 
pus 
pus 
pos 
pos 
pos 
pus 
pos 
pus 
pus 
pus 
ra 
pos 
pos 
pos 
pos 
pos 
pus 
pus 
pos 
ND 
pos 
pos 
pos 
pus 
pos 
pos 
Tr J 
neg 
pos 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
pos 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
pos 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
pos 
neg 
pos 
neg 
neg 
neg 
neg 
neg 
Diacmosis 
rv 
с 
с 
с 
s 
s 
с 
s 
s 
с 
с 
rv 
Ξ 
s 
с 
с 
с 
с 
с 
с 
с 
с 
с 
с 
s 
rv 
с 
с 
с 
с 
s(p) 
с 
s(p) 
с 
с 
с 
с 
с 
с 
с 
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Table 7.2: Characteristics of al lergic rh in i t i s pat ients . 
Biopsy 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
birth-date 
580928 
641014 
650714 
620708 
640716 
590619 
520807 
640110 
730809 
610711 
570703 
631106 
611124 
690427 
641203 
691031 
440201 
711220 
370114 
580101 
651116 
700107 
621201 
640315 
590730 
800128 
m/f 
m 
f 
f 
f 
m 
m 
m 
m 
m 
m 
f 
f 
f 
m 
m 
f 
f 
m 
f 
m 
m 
m 
m 
m 
f 
m 
operation 
sr 
turto 
turto 
sr 
sr 
sr 
nr 
sr 
str 
str 
turto str 
turto 
sr 
sr 
sr 
sr 
turto 
turto 
turto 
turto 
turto 
turto 
turto 
sr 
sr 
sr 
turto 
turb 
str 
str 
str 
str 
str 
str 
str 
str 
date 
840809 
841008 
841210 
841210 
850103 
850218 
850219 
850304 
850509 
850730 
860223 
860415 
860623 
860702 
860908 
861031 
861219 
870105 
870227 
870728 
871112 
871228 
880114 
880115 
880307 
880915 
medication 
none 
Be 
none 
none 
Be 
Ve 
none 
Me 
Ro, Pe 
Be 
none 
Be, Lo 
Be, Meth 
none 
none 
Ti 
none 
none 
Be 
The 
Ve 
Syn 
none 
none 
none 
In, Ve 
smoker 
no 
no 
ND 
25 
no 
no 
3 
no 
no 
no 
no 
no 
25 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
25 
no 
no 
c/d 
c/d 
c/d 
c/d 
asthma 
no 
yes 
no 
yes 
yes 
no 
child 
no 
no 
yes 
no 
yes 
yes 
no 
no 
no 
no 
no 
no 
child 
yes 
yes 
yes 
no 
no 
yes 
a r = a l l e r g i c r h i n i t i s , Be=Beconase, c=control , c / d=c iga re t t e s /day , ch i ld= 
asthma i n childhood, Da=dander, Eo=Eosinophils, HM=house dus t mi t e s , 
Lo=l£Hnudal, Me=Methyrit, Meth=Ifethadon, neg=negative, ND=not determined, 
nr=nose r e s e c t i o n , ObObst ruc t ion , param. =paraineters, Pe=Pen ic i l l i n , 
Po=pollen, polyp=polypectcimy, pos = pos i t i ve , Rh=Rhinorhoe, Ro=Ronnisol, 
s=chrOnic s i n u s i t i s , s(p)=chronic s i n u s i t i s with po lyps , Sn=sneezing, 
sr=septum r e s e c t i o n , SyTt=Syntaris, Ih&^nieoline, Ti=Tinset , Tr=trauma, 
t u r b = t u r b i n e c t o m y , turto s t r = s t r i p p i n g t u r b i n a t e s , Ve=Ventolin, 
vr=vasomotor r h i n i t i s . 
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Table 7.2: continued 
Biopsy 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
date 
param. 
830419 
841023 
841031 
830118 
850118 
841011 
840727 
850329 
ND 
ND 
860317 
ND 
860702 
861208 
860917 
ND 
860618 
860120 
870515 
ND 
871123 
870224 
880127 
880603 
880324 
890109 
IgE 
(U/mll 
ND 
155 
ND 
2090 
2880 
566 
ND 
1235 
ND 
ND 
468 
ND 
107 
940 
142 
ND 
578 
226 
168 
ND 
2120 
4650 
mo 
720 
440 
ND 
EO blonri 
(xlO6 c/ml) 
34 
60 
410 
320 
255 
405 
1320 
480 
ND 
ND 
100 
ND 
105 
575 
165 
ND 
465 
685 
170 
ND 
330 
ND 
286 
435 
200 
1900 
Eo nose 
f%) 
0 
2 
30 
50 
0 
90 
50 
0 
ND 
ND 
0 
ND 
0 
10 
5 
ND 
5 
5 
10 
ND 
2 
ND 
0 
60 
15 
2 
septum-
deviation 
neg 
put, 
ND 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
ND 
neg 
роя 
neg 
pos 
neg 
neg 
X-ray 
(date) 
neg(830503) 
neg(841023) 
pos 
neg(830201) 
ND 
neg(841012) 
ND 
ND 
neg(840501) 
cele(850730) 
neg(860102) 
ND 
neg(860424) 
ND 
neg(860624) 
neg(861006) 
neg(860805) 
pos(860217) 
neg(861008) 
ND 
neg(870617) 
pos(870702) 
ND 
neg(880208) 
ND 
neg(880808) 
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Table 7.2: continued 
Biopsy 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
Skin-test 
yuü 
pos 
pos 
pos 
pos 
pos 
ND 
pos 
ND 
pos 
pus 
ND 
ND 
pos 
pos 
pus 
pos 
ND 
pos 
pos 
ND 
pos 
pus 
pos 
pos 
pos 
Po, 
Po, 
Po, 
Po, 
Во, 
Po, 
PD, 
Po, 
Po, 
Po, 
Po, 
HM 
Po, 
Po, 
Po, 
Po, 
Po, 
Po, 
HM 
PO, 
HM, 
Da 
HM 
HM, 
HM, 
HM, 
HM, 
HM, 
HM, 
HM, 
HM, 
Da (830607) 
(860403) 
(841013) 
Da 
Da 
Da 
Da 
Da 
Da 
Da 
Da 
(860000) 
Da 
Da 
HM, 
HM, 
HM, 
HM, 
(840619) 
(850228) 
(841113) 
(840000) 
(840000) 
(820102) 
(870217) 
(860624) 
(860805) 
(620309) 
Da 
Da 
Da 
Da 
(870000) 
HM, Da 
(860000) 
(870702) 
(830000) 
(861202) 
(880000) 
RAST-test 
ND 
ND 
pus 
ND 
ND 
ND 
ND 
ND 
Po, 
ND 
ND 
Po, 
HM, 
HM 
Da 
HM(860000) 
ND 
ND 
Po, 
ND 
ND 
ND 
ND 
ND 
ND 
Po, 
ND 
ND 
ND 
ND 
HM 
HM, Da 
Sn 
pos 
pos 
pos 
pos 
pos 
pos 
neg 
pos 
pos 
pos 
pos 
ND 
neg 
pos 
ND 
pos 
pos 
pos 
neg 
neg 
ND 
pus 
pos 
pos 
pus 
neg 
Ш 
pus 
pus 
ND 
pus 
pus 
pos 
pus 
pos 
neg 
neg 
pos 
pos 
pus 
pos 
pos 
pos 
neg 
pos 
neg 
neg 
pos 
pos 
pos 
pos 
neg 
neg 
Ob 
pos 
pos 
ND 
pus 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pus 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
pos 
at . 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
pos 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
neg 
Diagnosis 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
ar 
7.4. References 
Mygind, N., Nasal allergy, Blackwell Scientific Publications, Oxford, 
1978. 
Mygind, N., Mediators of nasal allergy, J. Allergy Clin. Immunol. 70: 
149, 1982. 
Mygind, N., Essential allergy, Blackwell Scientific Publications, 1986. 
Norman, P.S., Allergic rhinitis, J. of Allergy and Clin. Immunol. 75: 
531, 1985. 
Bassali, D., Screening of allergic rhinitis, Rhinology 21: 321, 1983. 
Widdicombe, J.G., Introduction. In: P. van Cauweberge and J.J. Grote 
(Eds.), Nasal hyperreactivity, p. 1-12, 1983. 
121 

СИАРГЕК 8 
HISIOIOGICAL CHANOS IN ΊΗΕ NASAL MKJDSA OF АІІЕНБІС РАТГЕЖБ IN 
GCHPARISCN WITH NCN-AIXERGIC PATUNES. 
Y.J.B, van Megen1, A.B.M. Klaassen 1 , J . F . Rodrigues de Miranda 2 , C.A.M. 
van Ginnèken2 and R. lh .R. Vfentges1. 
Departments of Otorhinolaryngology1 and Pharmacology2, Un ive r s i ty of 
Nijmegen, The Nether lands . 
8.1. Abstract 
A histological study of the nasal mucosa of non-allergic patients and 
allergic patients (allergic rhinitis) was performed. Ihe non-allergic 
graup was subdivided into control and chronic sinusitis patients. 
Specimens were embedded in glycolmethacrylate, stained with Toluidine 
blue and Alcian blue/Periodic acid Schiff and examined by light 
microscopy. In most specimens, various tissue components were present; 
epithelium and the lamina propria with glands and blood vessels, ihe 
AB/PAS staining indicated the presence of neutral as well as acidic 
glycoproteins in goblet cells and in the tubulo-alveolar glands. In 
contrast with the control individuals, chronic sinusitis patients showed 
granulocytes in the respiratory epithelium suggesting infection. In 
specimens of patients with allergic rhinitis basophilic cells were 
observed in the epithelium, whereas no basophilic cells could be observed 
in control individuals. More basophilic cells were observed in the lamina 
propria of allergic patients in comparison with controls. 
8.2. Introducticn 
In the last decade the structure of the nasal mucosa from both control 
individuals and fron patients with allergic rhinitis has been studied 
with light, scanning and electron microscopy (Jahnke, 1972; Mygind et 
al., 1974; Tos and Mogensen, 1977; Okuda et al, 1983; Kawabori et al., 
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1983). Histological changes in epithelium, basal membrane and glands 
have been observed in allergic patients. Most histological studies were 
performed on nasal scrapings or blown secretion and only a few studies 
deal with biopsies fron the nasal mucosa. In this study we present a 
blind histological investigation of plastic embedded biopsies of nasal 
mucosa f rem controls, from patients with chronic sinusitis and from 
patients with allergic rhinitis. 
8.3. Materials and methods 
Biopsies of human nasal mucosa from behind the inferior turbinate were 
obtained during sinus and septal surgery. Nasal allergy or chronic 
sinusitis was diagnosed on the basis of the following parameters; nasal 
symptoms, family history, sinus X-rays, blood and nasal eosinophils, 
serum IgE, RAST and skin-tests. Patients were classified into a non-
allergic group, subdivided into control individuals and chronic sinusitis 
patients, and an allergic (allergic rhinitis) group, the study comprises 
12 control patients (6 males and 6 females) with ages ranging from 20 to 
50 years (mean age 34.5 years), 2 chronic sinusitis patients (1 male and 
1 female, 17 and 47 years respectively) and 7 patients with allergic 
rhinitis (4 males and 3 females) ranging from 18 to 52 years (mean age 29 
years). All allergic patients had a positive RAST and/or skin-test for 
house dust mites, whilst 4 patients had a positive test for pollen. None 
of the allergic patients shewed an acute manifestation of allergic 
rhinitis. 
Ihe biopsies were immediately washed in 0.9% NaCl and fixed in 2.5% 
glutardialdehyde in 0.1 M phosphate buffer (pH 7.0) for 24 hours at 40C. 
Specimens with bone were decalcified in 10% EDIA (pi 7.3) for 14 days. 
For embedding in glycolmethacrylate (GMk, JB-4 embedding kit, 
Polysciences Inc., Warrington PA, USA), the specimens were dehydrated in 
ethanol (from 70 to 100%) and impregnated with catalysed solution A (100 
ml solution A with 0.9 g catalyst) overnight at 40C. Subsequently, the 
specimens were placed in moulding cups and embedded in a mixture of 25 ml 
catalysed solution A and 0.9 ml solution В in a vacuum for 15-30 min at 
4QC to avoid air interference with the polymerization process. Ihe 
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plastic moulding ctçe were sealed with melted paraffin. Polymerization 
was continued at 0oC for 30 min and thereafter at 250C for 60 min. Itie 
blocks were stored at 40C. 
JB-4 sections (2 μια), made with a glass knife, were floated on distilled 
water, containing 2-4 drops NH4OH per 200 ml. Ihe sections were picked up 
on glass slides and the slides were slightly warmed until wrinkles 
disappeared. Ihe sections were stained with Toluidine blue or Alcian 
blue/Periodic acid Schiff and mounted in DPX-xylol. 
Staining procedures. 
Toluidine blue (ТВ) 
Sections were stained in 2.5% ТВ (C.I. 52040) in 2.5% anhydrous 
sodiumcarbonate for 2 min, rinsed in distilled water until the excess of 
stain is removed and dried in air. 
Alcian blue - Periodic acid Schiff (AB-PAS) 
Sections were stained in AB solution (1% AB 8GX, С.1.74240) in 3% acetic 
acid, pH 2.6) for 90 min and rinsed in distilled water. Subsequently, the 
specimens were treated with 1% periodic acid for 15 min, rinsed in 
distilled water for 5 min and stained in Schiffs reagent for 60 min. 
Schiffs reagent was prepared by boiling distilled water, followed by the 
addition of 1% basic fuchsin (C.I. 42500). The solution was cooled to 
50oC, filtered and 10% HCl (Ш) was added. Ihe solution was then cooled 
to 250C, before 1% sodiummetabisulphite was added. After 1 day storage 
in the dark, the light brown solution was bleached with 2% bone charcoal 
and filtered. After staining in Schiffs reagent, the sections were 
rinsed 3 times for 10 min in fresh sulphurous acid (1.2% 
sodiummetabisulphite in 0.05 N HCl), repeated rinsing in tap water for 10 
min and stained in Mayer's Hemalum for 10 min, followed by rinsing in tap 
water and dried in air. 
8.4. Results 
Controls 
Most specimens (8 out of 12) contained pseudostratified ciliated 
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epithelium, whereas other specimens contained stratified respiratory 
epithelium (table 8.1). In 5 specimens squamous epithelium was present in 
sane areas. Ihe epithelium is resting on a basement membrane, which 
consists of a PAS-positive membrane with underneath a connective tissue 
membrane. In the pseudostratified columnar respiratory epithelium of most 
specimens, 4 cell types could be distinguished; basal cells, ciliated 
and non-ciliated columnar cells and goblet cells. The goblet cells 
stained with PAS and/or AB, indicating the presence of neutral and/or 
acidic glycoproteins. Hyperplasia, transudate and intra-epithelial glands 
were only occasionally observed. Infiltrating cells were not present in 
the epithelium. 
Ihe glandular tissue in the lamina propria, is of the tubulo-alveolar 
type. Acini are scattered throughout the respiratory region, surrounded 
by connective tissue, and drain by small unbranched excretory ducts. Ihe 
glands stained with PAS and/or AB. Blood vessels were present in biopsies 
of human nasal mucosa; the sinusoids, large venous erectile tissue, were 
only present in a few specimens (table 8.2). Infiltrating cells, sudi as 
granulocytes, plasma cells and basophilic cells (PAS-positive and TB-
positive) were present in the lamina propria. 
Chronic sinusitis 
The histological structure of the nasal mucosa of 2 patients with chronic 
sinusitis was comparable with the structure of controls. Many 
granulocytes were present in the respiratory epithelium of 1 patient, 
whereas respiratory epithelium could not be observed in the other patient 
(table 8.1, table 8.2). 
Allemic rhinitis 
Generally, the histological structure of the nasal mucosa of 7 patients 
with allergic rhinitis was comparable with the structure of the mucosa of 
the control individuals. Hcwever, basophilic cells (mast cells) were 
observed in the epithelium of the nasal mucosa of allergic patients, 
whereas none were observed in the epithelium of the controls. Ihe number 
of basophilic cells in the lamina propria was also increased in allergic 
patients in comparison with controls. 
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Table 8.1: Histology of the epithelium of nasal biopsies of non-allergic 
(control individuals, chronic sinusitis) and allergic 
rhinitis patients. 
Control individuals 
nr. 
16 
17 
18 
19 
24 
28 
29 
30 
32 
35 
37 
40 
m/f 
f 
m 
m 
m 
m 
f 
f 
f 
f 
f 
m 
m 
Stratified 
stratified 
pseudostr. 
stratified 
stratified 
pseudostr. 
pseudostr. 
pseudostr. 
pseudostr. 
pseudostr. 
pseudostr. 
stratified 
pseudostr. 
Squamous 
0 
NO 
0 
0 
NO 
0 
NO 
NO 
NO 
NO 
NO 
0 
GC 
NO 
О 
NO 
О 
О 
О 
О 
NO 
0 
0 
0 А 
О 
CNC 
NO 
О 
NO 
0 
0 
0 
О 
NO 
О 
О 
О 
О 
ВС 
NO 
О 
N0 
О 
0 
0 
0 
N0 
0 
О 
0 
0 
ш 0 
0 
N0 
0 
0 
0 
0 
N0 
0 
0 
0 
0 
НН 
NO 
0 
NO 
NO 
NO 
0 
0 
NO 
NO 
NO 
0 
NO 
INF 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
m NO 
NO 
NO 
NO 
NO 
NO 
0 
NO 
NO 
NO 
0 
NO 
Chronic sinusitis 
13 f stratified О NO NO NO 0 NO NO NO 
31 m pseudostr. NO О 0 0 0 NO GR NO 
Allergic rhinitis 
56 
58 
59 
60 
63 
64 
65 
f 
m 
f 
m 
m 
m 
f 
pseudostr. 
pseudostr. 
pseudostr. 
stratified 
pseudostr. 
pseudostr. 
stratified 
0 
NO 
0 
N0 
NO 
0 
0 
О 
0 
0 
О* 
0 
NO 
0 
0 
0 
О 
О 
0 
0 
0 
0 
0 
0 
о 
0 
0 
о 
0 
0 
0 
0 
0 
0 
0 
о 
N0 
N0 
О 
N0 
N0 
0 
MC, GR 
MC 
MC 
MC 
MC 
MC 
MC 
0 
NO 
NO 
N0 
N0 
NO 
N0 
BOBasal c e l l s , Ш=Ваза1 membrane, CNOCiliated and non-ciliated 
ce l l s , GOGoblet ce l l s , GI^Glands, GR=Granulocytes, H№=Hyperplasia, 
I N F = I n f i l t r a t e , MC=mast c e l l s , NO=Not observed, 0=Observed, 
TIfc=Transudate, *=foming intra-epithel ia l glands. 
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Table 8.2: Histology of the lamina propria of nasal biopsies of non-
allergic (control individuals, chronic sinusitis) and 
allergic rhinitis patients. 
Control individuals 
Nr. 
16 
17 
18 
19 
24 
28 
29 
30 
32 
35 
37 
40 
Infiltrate 
MC, GR 
MC, PC 
FEW MC 
FEW MC 
FEW MC, 
MC, PC 
MC, GR 
MC, GR 
MC, GR, PC 
MC, GR 
MC 
MC, GR 
Glands falvcooroteins) 
PAS 
POS 
POS 
POS 
POS 
POS 
POS 
POS 
POS 
POS 
POS 
NO 
POS 
AB 
ND 
ND 
ND 
ND 
POS 
POS 
POS 
POS 
POS 
POS 
NO 
POS 
AND NEG 
AND NEG 
AND NEG 
AND NEG 
AND NEG 
AND NEG 
AND NEG 
Blood vessels 
Sinusoids 
О 
MANY 
NO 
NO 
0 
0 
0 
NO 
0 
0 
NO 
NO 
Others 
0 
0 
0 
0 
MANY 
0 
0 
0 
0 
0 
NO 
0 
Chronic sinusitis 
13 
31 
FEW MC, GR, PC 
MC, PC 
POS 
NO 
ND 
NO 
NO 
NO 
0 
0 
Allergic rhinitis 
56 
58 
59 
60 
63 
64 
65 
MANY MC, GR, PC 
MANY MC, PC 
MANY MC, GR, PC 
MC, GR, PC 
MC, GR, PC 
MC, GR, PC 
MC, GR, PC 
POS 
POS 
POS 
POS 
POS 
POS 
POS 
POS AND NEG 
POS AND NEG 
POS 
POS 
POS 
POS 
POS 
AND NEG 
AND NEG 
AND NEG 
AND NEG 
AND NEG 
NO 
MANY 
0 
0 
NO 
NO 
0 
MANY 
0 
0 
0 
0 
0 
0 
AB=Alcian blue, Gt^Sranulocytes, MOMast cells, ND= Not determined, 
NO=Not observed, 0=Observed, PAS=Periodic acid Schiff, POPlasma 
cells. 
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Fig 8.1: Micrograph of the human nasal mucosa, showing epithelium (E) 
forming intra-epithelial glands (IG), glands (G), blood 
vessels (B) and sinusoids (S). ТВ staining, x50. 
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âT^. 
Fig. 8.2: Micrograpii of the epithelium of the nasal mucosa of a control 
(A) and an allergic rhinitis (B) patient, showing basal cells 
(B), goblet cells (G) and ciliated cells (C). Ihe mast cells 
(MC) in the epithelium are characteristic for the allergic 
patients. Ihe hyperplasia of the epithelium occurs in allergic 
as well as control patients. ТВ staining, x500. 
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Fig. 8.3: Micrograph of the epithelium (A) and glands (B) in the nasal 
mucosa of a control patient, showing glycoproteins. AB/PAS 
staining, x500. 
8.5. Discussie« 
Various tissue components were present in specimens of nasal mucosa of 
control, chronic sinusitis and allergic patients. 
Most specimens of the controls contained pseudostratified respiratory 
epithelium, whereas other specimens contained stratified squamous 
epithelium. These observations are in agreement with other studies of 
human nasal mucosa (Mygind et al., 1974). In the pseudostratified 
respiratory epithelium, basal cells, ciliated and non-ciliated cells and 
goblet cells could be distinguished. These cell types have also been 
described in human (Rhodin, 1974; Mygind et al., 1982) and rat nasal 
mucosa (Klaassen et al., 1981). AB-PAS staining demonstrated red and blue 
secretory material in the goblet cells, indicating the presence of 
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neutral and/or acidic glycoproteins (Jones, 1978; Johannes and KLessen, 
1984). AB- and PAS-positive goblet cells have also been observed in human 
nasal mucosa (Itiaete et al., 1981). 
Ihe tubulo-alveolar glands in the lamina propria are scattered throuc^ iaut 
the respiratory area and drain by small excretory ducts. These findings 
are in agreement with those observed in human nasal mucosa by Bojsen-
Mjziller (1965) and by Tos and Mogensen (1977). Ultrastructural studies 
revealed that striated excretory ducts are absent in these glands 
(Jahnke, 1972). In all specimens the glandular tissue stained PAS-
positive, indicating the presence of glycoproteins in human nasal glands. 
The PAS-positive glands were AB-negative or -positive, indicating the 
presence of neutral or neutral admixed with acidic glycoproteins in the 
acini. Glycoproteins are responsible for the viscosity and gel forming 
properties of the mucus. It has also been suggested that glycoproteins 
exert a protective role by trapping microorganisms (Clamp et al., 1978). 
No different glandular areas could be distinguished on the basis of the 
AB/PAS staining in human nasal mucosa. In rat nasal glands, three 
different areas could be distinguished on the basis of this staining for 
glycoproteins (KLaassen et al., 1981). Ihaete et al. (1981) also 
observed PAS-negative and/or AB-positive glands in human nasal mucosa. 
The PAS-negative/AB-negative cells were also observed and described as 
serous cells, whereas the PAS-positive and AB-negative were described as 
mucous cells. However, a differentiation in mucous and serous cells 
cannot be made on account of their affinity for glycoprotein staining, 
because the secretory granules of both serous and mucous glands contain 
glycoproteins (Jones and Reid, 1978). 
Ihe histological structure of the nasal mucosa of the 2 patients with 
chronic sinusitis was comparable with the structure of the control 
individuals. Granulocytes were observed in the respiratory epithelium of 
1 chronic sinusitis patient, whereas no respiratory epithelium could be 
observed in the other. Increased numbers of inflammatory cells have been 
described in other studies. Hypertrophy of the nasal glands could not be 
observed in this study but has been described elsewhere (Greenberg and 
Ainsworth, 1966; Okuda et al., 1983). 
Specimens of patients with allergic rhinitis demonstrated basophilic 
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cells in the epithelium, whereas no basophilic cells could be observed in 
the controls. Ihe number of basophils in the lamina propria was also 
increased in allergic patients in comparison with controls. Bascphilic 
cells can be subdivided into blood basophilic leucocytes and tissue mast 
cells (Galli et al., 1984). Since the bascphilic cells were present in 
biopsies of the nasal mucosa, mainly mast cells are present in the 
specimens. An increased number of mast cells in the epithelium and the 
lamina propria has been reported in histological studies of biopsies 
(Mygind et al., 1974; Tos and Mogensen, 1977; Okuda et al., 1983; Ohtsuka 
et al., 1985), in nasal scrapings (Liu, 1988) or nasal secretions (Ukai 
et al., 1986). Activation of mast cells leads to the release of mast cell 
mediators such as histamine from the granules (Robinson and Holgate, 
1985; Wasserman, 1987). It has been suggested that the migration of 
basophilic cells to the surface is characteristic for allergy and that 
the total number and the histamine content of these cells are sufficient 
to produce the nasal manifestation of allergy (Okuda et al., 1983 ; 
Pipkom et al., 1988). 
Despite the increase in the number of basophilic cells in the epithelium 
and the lamina propria, no other histological changes have been observed 
in patients with allergic rhinitis in comparison with controls. Many 
histological changes in biopsies of the nasal mucosa from allergic 
patients have been reported; e.g. an increase in the number of goblet 
cells (Mygind et al., 1974; Okuda et al., 1983), hyperplasia of the 
epithelium (Tos and Mogensen, 1977), thickening of the basement membrane 
(Mygind et al., 1974), an increase in the number and density of the 
glands (Tos and Mogensen, 1977; Okuda et al., 1983), thickening of the 
wall of large and small blood vessels (Tos and Mogensen, 1977). Other 
studies have also reported no change in the number of goblet cells (Tos 
and Mogensen, 1977) or of the basement membrane (Mygind et al., 1974). 
These discrepancies of the observed histological structures may be due to 
differences in the site of the biopsy or differences in time of removal. 
In our study biopsies were taken frcm allergic patients with no acute 
clinical manifestation of the allergic rhinitis. 
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CTAFim 9 . 
ACŒRAnCïe OF MUSCARINIC АСЕГЯХЯОЫНЕ RBCEPTCBS Ш THE KASAL WXDSA OF 
АЕЫИЛС РАТШИВ IN OCMPARISON WTffl NCN-AUiKGIC INDIVIIJUAIS. 
Y.J.B. van M e g e n 1 ' 2 , A.B.M. KLaassen1, J . F . Rodrigues de Miranda 2 , C.A.M. 
van Ginneken2 and R. lh.R. Wentges 1. 
Departments of Otorhinolaryngology 1 and Pharmacology2, U n i v e r s i t y of 
Nijmegen, The Nether lands . 
9 . 1 . Abstract 
Cholinergic nasal hypertesponsiveness in nasal allergy may be due to 
changes of the characteristics in muscarinic cholinergic receptors. 
Radioligand receptor binding and in vitro autoradiographic studies of 
nasal mucosa in non-allergic and allergic patients were performed to 
investigate this hypothesis. The heterogeneous non-allergic group was 
subdivided into control, chronic sinusitis and vasomotor rhinitis 
patients. The ^H-l-QNB binding to muscarinic receptors in human nasal 
mucosa membranes was saturable and of high affinity in all groups. No 
significant differences could be demonstrated between the subgroups of 
the non-allergic patients. In allergic patients the equilibrium 
dissociation constants and receptor densities were significantly 
decreased in comparison with those of non-allergic and control 
individuals. No differences in agonist binding or coupling of the 
muscarinic receptor to the effector system via the G-protein could be 
observed in allergic patients. 
In vitro autoradiographic experiments demonstrated specific 3H-1-QNB 
labelling of the glandular acini in non-allergic and allergic patients. 
No specific labelling could be observed in the epithelium, blood vessels 
or connective tissue. 
In conclusion, the increased sensitivity and decreased receptor number 
may reflect the cholinergic induced hypersecretion in nasal allergy but 
are probably too small to explain the ocnplex allergic reaction. 
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9.2. Introduction 
Nasal hyperreactivity in allergie rhinitis may originate from an 
imbalance of the autonomic nerve regulation (Mygind, 1982). Cholinergic 
nasal hyperresponsiveness has been observed in allergic patients. 
Methacholine provocation resulted in a significant increased secretion, 
without changes in the nasal airway resistance in allergic patients in 
comparison with control individuals (Borum et al., 1983; Druce et al., 
1985; Corrado et al., 1986; Devillier et al., 1988). Cholinergic 
hyperresponsiveness has been explained in terms of changes in 
characteristics of muscarinic cholinergic receptors in the lewer airways 
of asthmatic patients (Raaijmakers et al., 1984; Nadel and Barnes, 1984; 
Barnes, 1986; Hahn, 1986). In contrast with the lewer airways, only 
limited quantitative data (receptor densities) of muscarinic receptors 
in the human nasal mucosa are available (Ishibe et al., 1983; Konno et 
al., 1987). In this study radioligand receptor binding studies were 
performed with the antagonist 3H-1-QNB to investigate muscarinic 
receptors in non-allergic and allergic patients in order to elucidate the 
supposed changes in the characteristics of these receptors in nasal 
hyperreactivity. Furthermore, the heterogeneous non-allergic group has 
been subdivided into control, chronic sinusitis and vasomotor rhinitis 
patients. The investigation of the muscarinic receptors includes not only 
the receptor density and sensitivity but also the agonist affinity states 
and the coupling of the muscarinic receptor to the effector system by 
G-proteins. In vitro autoradiographic experiments were performed to 
localize muscarinic receptors in the nasal mucosa of non-allergic and 
allergic patients. 
9.3. Materials and methods 
Materials 
3H-1-QNB (Quinuclidinylbenzilate) (spec. act. 33.1 Ci/mmol) was purchased 
from New England Nuclear, Doom, Ihe Netherlands. 1-QNB was a gift from 
Dr. G. lambredit, Wolfgang Goethe University, Frankfurt, West-Germany. 
Ifethylfurtrethonium was synthesized in our laboratory according to known 
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procedures. HEPES, IMSF (phenylmethylsulfonylfluoride), Gpp(NH)p (5·-
guanylylimidodifiiosfhate), leupeptin and pepstatin were obtained frcm 
Sigma, Chemical Company, St. Louis, M.O., U.S.A. Nuclear K2 emulsion was 
purchased fron Ilford, Amsterdam, The Netherlands. All other chemicals 
were of analytical grade. 
Patients 
Biopsies of human nasal mucosa frcm behind the inferior turbinate were 
obtained during sinus and septal surgery. Patients were classified into a 
non-allergic and an allergic group on the basis of the following 
parameters (Mygind, 1978; Passali, 1983); nasal symptoms, family history, 
X-rays of the sinuses, serum IgE, blood and nasal eosinophils, RAST and 
skin-tests. Ihe non-allergic patients were further subdivided into 
control, chronic sinusitis and vasomotor rhinitis patients (table 9.1). 
The control group consisted of patients with a history of nasal trauma, 
with deviations of the septum and/or with cosmetic problems, and were 
characterized by lew serum IgE values, few eosinophils in the blood or in 
the nose and negative RAST and skin-tests. The X-rays of the sinuses of 
chronic sinusitis patients demonstrated an inflammatory change but the 
other characteristics were similar to the control group. The 
pathophysiology of the vasomotor rhinitis group resembles the 
pathophysiology of allergic rhinitis but an allergic camponent can be 
excluded. All these patients showed nasal obstruction and the other 
characteristics of this group were similar to those of the control group. 
Allergic rhinitis was diagnosed on high IgE values, an increase in 
eosinophils in the blood and/or the nasal mucosa and a positive RAST 
and/or skin-test for house dust mites, pollen and/or dander. 
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Table 9.1: Characteristics of non-allergic (NA) and allergic rhinitis (A) patients 
Homogenates 
η 
NA 
с 12 
s 3 
ν 3 
A 11 
Age 
32±8 
39±21 
26±1 
29±11 
M/F 
7/5 
3/0 
0/3 
8/3 
Medication 
Te(l) 
Vi(2)Be(l) 
Me(l)Pe(l)Ti(l) 
Sm 
7 
1 
0 
2 
skin-test 
neg(12) 
neg(3) 
neg(3) 
HM(9)Po(7) 
Da(8) 
IgE 
fU/ml) 
6-149(6) 
14(1) 
22-96(3) 
142-1235(7) 
Eo blood 
fxl06c/ml) 
45-265(5) 
70/150(2) 
110-180(3) 
34-1320(9) 
Eo nose 
m 
0-5(5) 
0(1) 
0(3) 
0-60(9) 
Autoradiography 
NA 2 
A 2 
59/67 
9/19 
2/0 
1/1 
Au(l)La(l) 
Lo(l) 
0 
0 
neg(2) 
HM(2)Po(l) 
Da(l) 
ND 
440(1) 
ND 
200/1900 
ND 
15/2 
A=Allergic rhinitis patients, Au=augmentine, Be=Beconase, c=control individuals, 
Da=human or animal dander, Eo=eosinophils, HM=house dust mite, La=Lanoxin, Lo=Lomudal, 
Me=methyrit, Pe=Penicillin, NA=non-allergic patients, ND=not determined, Po=Pollen, 
s=chronic sinusitis patients, Sm=smoker, Te=Tetracycline, Ti=Tinset, v=vasomotor 
rhinitis patients, Vi=Vibramycine, ( )=number of patients. 
Radioligand receptor binding to hcmoqenates of nasal mucosa. 
Biopsies from the nasal mucosae were immediately washed in 0.9% NaCl 
after removal. Ihe tissue was stored at -80oC for a maximum of 40 months 
(non-allergic 17±10 months; allergic 11±9 months). In rat nasal mucosa, 
no differences in binding parameters could be observed in fresh tissue in 
comparison with frozen mucosa. Similar binding parameters were obtained 
with human nasal mucosa stored for 40 months in carparison with 6 months. 
Ihe binding procedure to human nasal mucosa was analogous to the 
procedure as described for rat nasal mucosa (chapter 2). The tissue was 
homogenized in icecold HEPES-PI buffer (20 пМ HEPES, 120 пМ NaCl, 10 nM 
M3CI2, 1 irM IMSF, 1 irM EDTA, 0.01 irM leupeptin and 0.01 nM pepstatin) 
with an Ultraturrax for 2x10 sec. Ihe hanogenate was centrifuged at 
lOOOxg for 5 min and the supernatant centrifuged at 100,000xg for 1 hour 
(40C). The pellet was resuspended by Potter homogenization in HEPES-PI 
buffer. Protein determination was performed according to Bradford (1976) 
using bovine serum albumin as a standard. 
Radioligand receptor binding studies were carried out in conical plastic 
centrifuge tubes, containing 40 μΐ 3H-1-QNB, 40 μΐ HEPES buffer and 320 
μΐ tissue hanogenate (12.5 mg/ml). Non-specific binding was determined in 
the presence of 12 μΜ 1-QNB. After the incubation at 370C for 90 min the 
hotnogenates were centrifuged for 15 min at 18,000xg. Aliquots (250 μΐ) of 
the supematants were mixed with 10 ml Aqua luma (lumac) for determining 
free concentrations of radioligand. Ihe remaining supernatant was removed 
by suction. The tips of the centrifuge tubes were mixed with 10 ml Aqua 
luma. Ihe binding parameters were calculated by subjecting the data to a 
гюп-іілеаг least squares curve fitting procedure using the Gauss Newton 
algorithm (Fletcher and Pcwell, 1963). Inhibition curves were analysed 
according to a one or two binding sites model. 
Histology 
Specimens of human nasal mucosae were washed in 0.9% NaCl and fixed in 
2.5% glutardialdehyde in 0.1 M phosphate buffer (pH 7.0), dehydrated in 
ethanol and embedded in glycolmethacrylate (JB4 embedding kit, 
Polysciences Inc., Warrington, USA). Sections (2μιη) were stained with 
2.5% Toluidine Blue in 2.5% anhydrous sodiumdicarbonate. 
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In vitro labelling of muscarinic receptors in cryostat sections and 
autoradiography 
Biopsies fron the nasal mucosae were immediately washed in 0.9% NaCl 
after removal. The tissue was rapidly frozen using isopentane cooled in 
liquid nitrogen and stored for a maximum of 2 months for in vitro 
autoradiography. 
Binding characteristics were examined before autoradiographic experiments 
were performed as described for rat nasal mucosa (van Megen et al., 
1988). In summary, cryostat sections (10 μτη) were thaw-mounted on glass 
slides coated with gelatin/chrome-alum. ihe sections were air dried and 
stored at -SO'-t. Before incubation the sections were dried again at гост 
teitperature and fixed at A0C in 0.5% glutardialdehyde in Tyrode buffer 
for 30 min. Subsequently, the sections were rinsed in buffer at 40C for 
30 min and further processed for either radioreceptor assays or 
autoradiography. Several non-mounted parallel sections were collected for 
protein determination according to Inwry et al. (1951) with bovine serum 
albumin as a standard. Protein determination was performed after 
solubilization of the sections in 0.1 N NaOH at 100oC (boiling water-
bath) for 15 min. Parallel sections were stained with methylgreen 
pyronin (1%) for histological verification of the tissue quality. 
For the radioreceptor assay the tissue sections were overlayed with 150 
μΐ 3H-1-QNB in lyrode buffer and incubated at З?"^ for 90 min in a humid 
atmosphere. Non-specific binding was measured in the presence of 12 μΜ 
1-QNB under the same conditions. After the incubation, 75 μΐ of the 
incubation buffer was mixed with 10 ml Aqua Luma (Packard) to determine 
the concentration of radioligand. The remaining incubation buffer was 
removed by rinsing the sections in fresh buffer (3x4 min). Ihe slides 
were broken, transferred to vials and the sections were solubilized 
overnight in 1 ml Soluene-350 (Packard) at З ^ . Instagel/0.5 N HCl (9:1) 
18 ml, was added and the samples were counted in a liquid scintillation 
counter (1215 Rackbeta, 1KB). Ihe binding parameters were calculated as 
described for homogenates. 
For the autoradiography, 10 μπι sections of human nasal mucosae were 
incubated with 0.06 riM 3H-1-QNB. Adjacent sections were incubated with 12 
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μΜ 1-QNB in addition to 3H-1-QNB to determine the non-specific binding. 
After incubation, the sections were rinsed in Tyrode buffer (room 
temperature) then briefly in distilled water to remove the buffer salts. 
The specimens were coated with 0.5% gelatin/chrcme-aluin and covered with 
nuclear K2 emulsion. After an exposure time of 6 months (4ο0) the 
autoradiograms were developed in amidol (180C; 8 min), rinsed in 
distilled water, fixed in 30% sodiumthiosulphate (180C; 8 min), 
thoroughly washed in distilled water (15 min) and stained with 1% 
methylgreen pyronin. 
Statistical analysis 
Agonist inhibition curves were fitted to a one or two binding sites 
model. Preference was given to a two binding sites model when a 
significant diminution in the residual sum of squares was reached (F-
test). Differences in affinity values (negative logarithm of Kd) and 
receptor density (Ettax), which are kncwn to be normally distributed 
(Fleming et al., 1972; Hancock et al., 1988), were compared using the 
student t-test. Significance was accepted at p<0.05. 
9.4. Results 
Muscarinic receptor characteristics in human nasal mjcosa membranes 
Specific 3H-1-QNB binding to nasal mucosa membranes was saturable and of 
high affinity in non-allergic and allergic patients (fig. 9.1). The 
Scatchard plot of the specific binding (fig. 9.1) points to an 
hanogeneous class of binding sites. Analysis of the data of non-allergic 
patients demonstrated a mean dissociation constant (Kd) of 47.2±4.4 pM 
and a receptor density (Rnax) of 2.65±0.3 pmol/g tissue or 616±52 fmol/mg 
protein (n=18) (table 9.2). In allergic patients, the Kd-value and the 
Etnax, expressed in pioól/q tissue or fmol/mg protein, were significantly 
lewer than those determined in non-allergic patients. 
Ihe heterogenous non-allergic group was subdivided into control 
individuals (n=12), chronic sinusitis (n=3) and vasomotor rhinitis 
patients (n=3). Ihe Kd- and Bmax-values were not significantly different 
between these subgroups. In allergic patients, the Kd-value and the Bmax, 
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expressed in prool/g tissue or frool/mg protein, were significantly 
decreased in ccmparison with those determined in control individuals. Ihe 
Etnax, expressed in pmol/g tissue was significantly lewer in allergic 
patients in ccmparison with chronic sinusitis patients. No other 
significant changes in Kd or йпах could be observed in allergic patients 
in cxHiparison with chronic sinusitis and with vascsnotor rhinitis patients 
(table 9.2), probably due to the restricted number of these patients. 
Detailed analysis of the data revealed similar binding parameters fron 
individuals on medication in comparison to those without in the non-
allergic, control or allergic rhinitis group. Differences in binding 
parameters have neither been demonstrated between smokers in ccmparison 
with non-smokers in these groups. 
Bound 3H-I-QNB 
(fmol/mg protein) 
1500-
1000-
500 
9 
8 
0 
1 1 1 ' 
2 3 U 
3H-I-QNB free (nM) 
Bound/free 
(ml/mg protein) 
500 1000 
Bound (fmol/mg protein) 
Fig. 9.1: Left: Total (·, O) and specific binding of 3H-1-QNB to nasal 
mucosa membranes of non-allergic ( ) and allergic ( ) 
patients. Non-specific binding was determined in the presence 
of 12 μΆ 1-QNB. Right: Scatchard plot of the specific part of 
the binding. Data shown are the means of triplicates from 
representative experiments. 
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Table 9.2: Binding parameters (raeantSEM) of 3H-1-QNB binding to 
muscarinic receptors in the nasal mucosa of non-allergic and 
allergic rhinitis patients. 
non-allergic 
control 
chronic sinusitis 
vasomotor rhinitis 
allergic 
Kd (pM) 
47.2±4.4* 
49.2±5.50 
39.3±9.4 
47.0+15.1 
35.0І5.5*0 
Bmax (t) 
2.6510.30* 
2.59+0.39° 
3.25±0.58# 
2.27+0.87 
1.56±0.29*o# 
Bnax (p) 
616152* 
661168° 
543+146 
449+51 
445+57*° 
η 
18 
12 
3 
3 
11 
Broax (t) in prool/g tissue, &nax (ρ) in fmol/mg protein, *o# p<0.05. 
Inhibition studies of 3H-1-QNB binding with the agonist 
methyl furtrethonium in the absence or presence of Gpp(NH)p were 
performed to investigate the agonist affinity states and the coupling of 
the muscarinic receptors to the G-proteins in non-allergic and allergic 
patients. The inhibition curve appeared to be biphasic in 2 non-allergic 
and 1 allergic patient and could significantly better be fitted according 
to a two binding sites model, indicating the presence of high and lew 
affinity states (table 9.3). However, in 2 other non-allergic and 1 
allergic patient the agonist inhibition curve displayed a monophasic 
character, which could not be significantly better fitted according to a 
two binding sites model (table 9.3). In the presence of 5.10~4 M Gpp(NH)p 
a shift of the monophasic inhibition curve was observed and a complete 
conversion of high into lew affinity sites was observed in the biphasic 
curves (fig. 9.2). No dianges in agonist inhibition or coupling to 
G-proteins could be observed in allergic patients (table 9.3). 
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Table 9.3: Inhibition of 3H-1-QNB binding by the agonist methyl-
furtrethonium in the absence and presence of Gpp(NH)p in the 
nasal mucosa of non-allergic and allergic rhinitis patients. 
non-allergic 
a l lerg ic 
43pp(NH)p 
K i i (μΜ) КІ2 (μΜ) %RH 
0 . 2 1 0 . 9 17 
1.3 1 1 . 2 18 
1 2 . 2 
2 9 . 5 
0 . 8 1 1 . 0 15 
2 6 . 2 
-K3pp(NH)p 
Ki (μΜ) 
2 4 . 3 
1 8 . 1 
4 1 . 0 
5 2 . 1 
2 0 . 5 
131 
Fractional 
3H-l-QNB 
08 
06 
0 4 -
0 2 -
V/-, 
specific — 
binding 
м »
А
м 
ras·» 
% 
i. 
-12 -10 -8 -6 -í -2 
Log cone Methy l fur l re thonium (M) 
Fig. 9.2: 
Inhibition of specific 3H-1-QNB binding to nasal mucosa membranes of a 
non-allergic patient by the agonist methylfurtrethonium in absence (0) or 
presence (·) of 5.10~4 M Gpp(NH)p. The curve in the absence of Gpp(NH)p 
could significantly better fitted according to a two binding sites model, 
whereas the curve in presence of Gpp(NH)p could adequately be fitted 
according to a one binding site model. 
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Histology 
Various tissue components were present in biopsies of human nasal mucosa; 
epithelium and the lamina propria with glands, blood vessels and 
inflammatory cells. Nervous tissue could not be observed. Biopsies of 
patients with allergic rhinitis demonstrated basophilic cells in the 
epithelium and an increased number of basophilic cells in the lamina 
propria in comparison with non-allergic patients. No other histological 
changes have been observed. 
Localization of muscarinic receptors in human nasal mucosa. 
Before the autoradiography, radioligand receptor binding experiments to 
cryostat sections of human nasal mucosa were performed. The saturation 
curves were used to determine the optimal free concentration radioligand 
for the in vitro autoradiography. Specific 3H-1-QNB binding to muscarinic 
receptors was saturable and of high affinity in cryostat sections of 2 
non-allergic individuals (Kä=340/400 pM; anax=45/40 fmol/mg protein) and 
2 allergic patients (Kd=240/90 pM; ftnax=32/25 fmol/mg protein). After 6 
months exposure the autoradiograms shewed labelling of the glandular 
acini with 3H-1-QNB (fig. 9.ЗА) in sections of non-allergic patients. 
Epithelium, blood vessels and connective tissue were devoid of silver 
grains. Autoradiographs made from sections incubated with an excess of 
unlabelled ligand in addition to 3H-1-QNB showed only a very faint 
homogeneous labelling of the glandular tissue (fig. 9.3B). Ihe 
autoradiographs showed similar specific labelling of the glandular acini 
in sections of the allergic patients. 
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Fig. 9.3: 
Autoradiograms of 0.5% glutardialdehyde-fixed cryostat sections (10 μιη) 
of the nasal mucosa of a non-allergic patient after incubation with 0.8 
nM 3H-1-QNB (A) or with an excess of 1-QNB in addition to the radioligand 
(B) followed by dipping in liquid nuclear emulsion. Ihe autoradiograms 
show specific labelling of the glandular acini (x800). Staining with 
methylgreen pyronin (1%). 
148 
9.5. Discussion 
Qiolinergic nasal hyperresponsiveness has been observed in allergic 
patients (Borum et al., 1983; Druce et al., 1985; Corrado et al., 1986; 
Devillier et al., 1988) and may be due to an imbalance of the autonomic 
regulation (Mygind, 1982). In this study, the hypothesis of changes in 
muscarinic cholinergic characteristics and localization have been 
investigated. In the first instance, the biochemical characteristics and 
the autoradiographic localization of muscarinic receptors have been 
investigated in rat nasal mucosa, because of the limited supply of human 
nasal mucosa (Rodrigues de Miranda et al., 1985; Klaassen et al., 1986; 
van Megen et al., 1988). 
The 3H-1-QNB binding to muscarinic receptors in membranes of the nasal 
mucosa of non-allergic patients was saturable and of high affinity. The 
Kd-values were in agreement with those observed in rat nasal mucosa 
(Rodrigues de Miranda et al., 1985; Klaassen et al., 1986), human trachea 
smooth muscle (van Koppen et al., 1985) or human lung (Joad and Cassale, 
1987). 3H-1-QNB binding has been demonstrated in human nasal mucosa 
(Kä=3.9 riM, Ishibe et al., 1983; Kä=1.54 nM, Konno et al., 1987). Ihe Kd-
values reported were considerably higher, partly due to the use of the 
racende 3H-QNB instead of the levorotatory isomer as used in the present 
study. 
The heterogeneous group of non-allergic patients was subdivided into 
control individuals, chronic sinusitis and vascmotor rhinitis patients. 
No significant differences in Ш-value or receptor density were 
demonstrated between these subgroups, probably due to the limited number 
of patients in the last 2 subgroups. The Kd-value and the receptor 
density were significantly decreased in allergic patients in comparison 
with non-allergic emd control individuals. Ihe increased sensitivity may 
reflect the cholinergic induced hypersecretion in nasal 
hyperreactivity. Hie decreased number of muscarinic receptors was 
somewhat surprising, since methacholine provocation resulted in a 
significant increased secretion in allergic patients. However, this 
decreased receptor number may reflect an adaptation of the effector cells 
to overstimulation or changes in density of inhibitory presynaptic 
149 
receptors. Inhibitory presynaptic muscarinic receptors have been 
demonstrated in lung (Fryer and Maclagan, 1984) and other tissues 
(Kilbinger, 1984). The small shifts in affinity and receptor density may 
reflect the cholinergic hyperreactivity in nasal allergy but are probably 
too small to explain the complex allergic reaction. A difference in 
sensitivity to methacholine of two glandular parts in the rat nasal 
mucosa was also accompanied by small shifts (factor 1.2) in receptor 
density and in affinity (Klaassen et al., 1987). No changes in the 
affinity but an increased density of muscarinic receptors have been 
reported by Japanese investigators (Isibe et al., 1983; Kònno et al., 
1987) in nasal mucosa of allergie patients in comparison with chronic 
sinusitis patients. The use of chronic sinusitis patients as controls may 
be responsible for the discrepancies between both studies, although no 
significant differences between control individuals and chronic sinusitis 
patients could be demonstrated in the present study. On the other hand, 
the discrepancy between both studies can possibly be explained by 
differences in the biopsy removal or medication. However, detailed 
analysis of the data revealed similar binding parameters from individuals 
with medication in comparison with individuals without medication in the 
non-allergic, control or allergic rhinitis group. 
The agonist inhibition curves of 3H-1-QNB binding to muscarinic 
receptors in homogenates of 2 out of 4 non-allergic and 1 out of 2 
allergic patients demonstrated high affinity sites (17/18% and 15% 
respectively). The Ki-values of the high and lew affinity sites were in 
agreement with those determined in rat nasal mucosa (chapter 2) or human 
tracheal smooth muscle (van Koppen et al., 1985). Generally, a 
heterogeneity of agonist binding has been a predominant feature of 
muscarinic receptors in a variety of tissues (Birdsall, 1984; McKinney 
and Richelson, 1984; Nathanson, 1987). Hcwever, the agonist inhibition 
curves of 3 patients demonstrated only lew affinity binding sites. Itie 
absence of the high affinity sites is probably not due to proteolytic 
activity since protease inhibitors (mSF, EDTA, leupeptin and pepstatin) 
were included. A small proportion (about 10%) of high affinity sites, 
admixed with lew affinity sites, might be present but not detectable in 
such experiments. It has been proposed that the high affinity complex 
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consists of agonist, receptor and G-protein (Birdsall, 1984; Nathanson, 
1987). In the presence of 5.10-4 M Gpp(NH)p a shift of the monophasic 
inhibition curve and a conplete conversion of high into low affinity 
sites in biphasic curves was observed in non-allergic and allergic 
patients. Ihis complete conversion has been demonstrated in rat nasal 
mucosa (chapter 2) and in other tissues (Birdsall, 1984; Nathanson, 
1987). Ihe increased sensitivity of allergic patients to cholinergic 
agonists might be reflected in the agonist binding. In the limited number 
of patients studied, no differences of agonist binding or coupling to the 
G-protein between allergic and non-allergic patients could be observed. 
In the lewer airways, differences in agonist binding or coupling to G-
proteins between chronic obstructive bronchitis patients and controls 
could neither be observed (Raaijmakers et al., 1984; van Koppen et al., 
1989) 
Binding of -'H-l-Qf'JB to human nasal mucosa cryostat sections was 
saturable and of high affinity. Ihe saturation curves were used to 
determine the optimal free radioligand concentration for the 
autoradiography. The Kd-value of 3H-1-QNB binding to the sections of 
human nasal mucosa is higher in comparison with the Kd-value of the 
3H-1-QNB binding to homogenates of human nasal mucosa. This phenomenon 
was also observed in rat nasal mucosa and it has been suggested that the 
affinity of the ligand for the receptor in more or less intact membranes 
of cryostat sections could be different fron that in homogenized 
membranes (van Megen et al., 1988). Ihe muscarinic receptor density in 
homogenates is hiçpier than in sections, probably due to differences in 
protein contents; hanogenates consist of a relatively pure membrane 
fraction, whereas sections contain all tissue constituents. 
After an exposure time of 6 months, the autoradiographs of 10 μια. sections 
of non-allergic patients showed specific 3H-1-QNB labelling of the 
glandular acini. This observation provides evidence for the presence of 
muscarinic receptors in human nasal glands, ihe findings are in agreement 
with the in vitro autoradiographic results of rat nasal mucosa (van Megen 
et al., 1988) and with histochemical studies in the human nasal glands 
(Ishii and Toriyama, 1972; Cauna, 1982, Vecerina et al., 1983). Ihe 
glandular acini produce (glyoo)proteins (Ihaete et al., 1981; chapter 7), 
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which are responsible for the viscosity and gel forming properties of the 
mucus (Clamp et al., 1978). Fran histochemical and autoradiographic 
experiments it may be concluded that the (glyco)protein production by the 
acini in human nasal mucosa is under parasympathetic control. 
Physiological studies reported also the cholinergic stimulation of nasal 
glycoprotein release in man (Ifctow et al., 1984). Histochemical studies 
demonstrated acetylcholine-esterase containing fibres in the sub-
epithelial plexus (Ishii and Toriyama, 1972) and blood vessels (Cauna, 
1982; Vecerina et al., 1983). Ihe autoradiographs in this study did not 
show specific 3H-1-QNB labelling of the epithelium or blood vessels. 
No differences could be observed in the localization of muscarinic 
receptors in autoradiographs of allergic patients in comparison with 
those of controls. Frcm radioligand and in vitro autoradiographic 
experiments it may be concluded that the number of muscarinic cholinergic 
receptors in the glandular acini are decreased in allergic patients in 
conparison with non-allergic and in comparison with control individuals. 
This changed receptor density may be a consequence of histological 
changes in the submucosal glands of allergic patients. Hcwever, no 
hyperplasia or hypertrophy of the nasal glands of the inferior turbinate 
could be observed in allergic patients in this or other studies (Mygind, 
1974; Tos and Mogensen, 1977). 
In summary, the increased sensitivity and the decreased number of 
muscarinic receptors may reflect the cholinergic induced hypersecretion 
in nasal allergy. No differences in agonist binding, coupling to G-
proteins or localization of muscarinic receptors could be demonstrated in 
nasal allergy. 
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AIHERAnœ OF NKEHOCEPKBS IN THE NASAL MUOQSA OF AEIERGIC РАИИЛБ IN 
OCMPAEOSCN WTffl NCN-MIfBGIC INDIVIDUÁIS. 
Y.J .B, van Megen 1 ' 2 , A.B.M. KLaassen1, J . F . Podrigues de Miranda2 , C.A.M. 
van Ginnèken2 and R. lh .R. Wentges1. 
Departments of Otorhinolaryngology1 and Pharmacology2 Un ive r s i t y of 
Nijmegen, The Nether lands . 
10 .1 Abs t rac t 
Nasal hyperreactivity in nasal allergy may be due to changes of the 
characteristics in adrenergic receptors. Radioligand receptor binding 
studies with the antagonists 3H-Rrazosin (а^), 3H-Rauwolscine (o^), 
1251-(-)-С?£Р (β) were performed in homogenates of nasal mucosa of 
allergic and non-allergic patients to investigate this hypothesis. The 
heterogeneous non-allergic group was subdivided into control, chronic 
sinusitis and vasomotor rhinitis patients. No significant differences in 
affinities or densities of ay and «2 -adrenoceptors could be 
demonstrated in allergic patients in comparison with non-allergic and 
control individuals. 
The /3-adrenoceptor density, was significantly reduced in allergic 
patients in comparison with control individuals. Neither changes in 
agonist binding or in the effect of Gpp(NH)p on the agonist binding to β-
adrenoceptors could be observed in allergic patients. The subtype 
selective antagonist ^гоЗ-ОЗО demonstrated the presence of an 
hanogeneous population of ^ -adrenoceptors in human nasal mucosa of both 
non-allergic and allergic patients. In vitro autoradiography demonstrated 
specific 125I-(-)-CYP labelling of the epithelium in non-allergic and 
allergic patients. No specific labelling could be observed in the glands, 
blood vessels or connective tissue. 
In conclusion, no changes in the characteristics of а^- or tt2_ 
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adrenoceptors in the nasal mucosa could be demonstrated in nasal allergy. 
However, a decreased number of ß-adrenooeptors may reflect a ^ -adrenergic 
abnormality in nasal allergy. 
10.2 Introducticn 
Nasal hyperreactivity in allergic rhinitis may originate from an 
imbalance of the autoncmic nerve regulation in the nasal mucosa (Mygind, 
1982). Systemic adrenergic abnormalities have been observed in allergic 
patients. Isoprenaline (/3-agonist) infusion resulted in a significant 
decrease of pulse pressure and cAMP concentration in allergic patients 
in coniparison with controls (Kaliner et al., 1982; Shelhamer et al., 
1983). Intranasal administration of terbutaline (^-agonist) or 
phenylephrine (a^-agonist) caused no differences in nasal airway 
resistance in allergic patients (Svensson et al., 1980; Brooks et al., 
1988). Until now, the influence of ^-adrenergic agonists on nasal 
secretion in allergic patients in comparison with controls has not been 
investigated. Beta-adrenergic hyporesponsiveness and alpha-adrenergic 
hyperresponsiveness in the lewer airways have been explained in terms of 
changes in the characteristics of β- and α-adrenoceptors in patients with 
chronic airflcw obstruction (Szentivanyi et al., 1979; Barnes et al., 
1980; Kaaijmakers et al., 1987; Meurs et al., 1987; Barnes et al., 1988). 
In contrast with the lewer airways, only limited quantitative data 
(receptor densities) of ay- and /3-adrenoceptors in the human nasal mucosa 
are available (Ishibe et al., 1983; Konno et al., 1987). In this study 
radioligand receptor binding studies were performed with the antagonists 
3H-Prazosin, 3H-Rauwolscine and 125I-(-)-CYP to investigate otj-, 02- and 
/J-adrenoceptors respectively in non-allergic and allergic patients in 
order to elucidate the supposed alteration in characteristics of 
neuroreceptors in nasal hyperreactivity. Furthermore, the heterogeneous 
non-allergic group has been subdivided into control individuals, chronic 
sinusitis and vasomotor rhinitis patients. Ihe investigation of the 
^-adrenoceptors includes not only the receptor density and sensitivity 
but also the presence of /3-adrenoceptor subtypes, agonist affinity states 
and the coupling of this receptor to the effector system by the G-
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protein. In vitro autoradiography was performed to localize 
^-adrenoceptors in the human nasal mucosa of non-allergic and allergic 
patients. 
10.3 Materials and methods 
3H-Prazosin (specific activity 18.8 Ci/irmol), 3H-Rauwolscine (specific 
activity 73.5 Ci/mmol) and 125I-(-)-CYP (125I-cyancpindolol) (specific 
activity 2200 Ci/mmol) were purchased fron New England Nuclear, Doom, 
The Netherlands. (±)-propranolol was a gift from ICI Ltd., Alderly Park, 
England; (±) -isoprenaline and Ы<203-030 u&œ gifts frcan Boehringer 
Ingelheim, FRB and Sandoz, Basel Switzerland respectively. Phentolamine 
was a gift from Ciba-Geigy, N.J. Gpp(NH)p (S'-guanylylimidodiphosphate) 
and FMSF (phenylmethylsulfonylfluoride) were cbtained from Sigma Chemical 
Co., St. liouis, M.O., U.S.A. Nuclear K2 emulsion was purchased from 
Ilford, Amsterdam, The Netherlands. All other chemicals were of 
analytical grade. 
Patients 
Biopsies of human nasal mucosa from behind the inferior turbinate were 
obtained during sinus and septal surgery. Patients were classified into 
a non-allergic and allergic group on the basis of the following 
parameters (Mygind, 1978; lassali, 1983); nasal symptoms, family history, 
X-rays of the sinuses, serum IgE, blood and/or nose eosinophilia, RAST 
and skin-tests. The non-allergic patients were further subdivided into 
control, chronic sinusitis and vasomotor rhinitis patients (table 10.1). 
Ihe control group consisted of patients with a history of nasal trauma, 
deviations of the septum and cosmetic problems, and were characterized by 
lew serum IgE values, few eosinophils in the blood or in the nose and 
negative RAST and skin-tests. Ihe X-rays of the sinuses of chronic 
sinusitis patients demonstrated an inflammatory change but the other 
characteristics were similar to the control group. The pathophysiology of 
the vasonotor rhinitis group resembled the pathophysiology of allergic 
rhinitis but an allergic component could be excluded. All these patients 
shewed nasal obstruction and the other characteristics of this group were 
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Table 10.1: Characteristics of non-allergic (NA) and allergic rhinitis (A) patients 
ß-adrenoceptors 
η 
NA 
с 13 
s 3 
V 2 
A 14 
Age M/F 
31±9 5/8 
40±25 2/1 
26/28 0/2 
23±4 9/5 
Medication 
Bi(l)Be(l)L(l) 
Be(l) 
Vi, Tr(l)Be(l) 
Ve(2)Be(3)Ti(2) 
sm 
4 
0 
0 
2 
skin-test 
neg(13) 
neg(3) 
neg(2) 
HM(10) 
Po(10)Da(10) 
IgE 
fU/mll 
6-149(8) 
28(1) 
110(2) 
155-4650(12) 
Eo blood 
fxl06c/mll 
45-165(8) 
50/226(2) 
110/180(2) 
60-685(11) 
Eo nose 
0-5(8) 
0(1) 
0(2) 
0-9(11) 
а^-adrenoceptors 
NA 
С 5 
S 1 
V 1 
A 6 
29±12 2/3 
17 1/0 
26 0/1 
22±6 4/2 
Be, Ot(l) 
no 
Vi, Tr(l) 
Be(l)Ro(l)Ti(l) 
1 
0 
0 
0 
neg(5) 
neg(l) 
neg(l) 
HM(5) 
Po(4)Da(4) 
6-49(4) 
ND 
22(1) 
226-1110(3) 
90-165(4) 
ND 
110(1) 
100-685(3) 
0-3(4) 
ND 
0(1) 
0-5(3) 
a2-adrenoceptors 
NA 
с 8 
s 3 
ν 3 
A 9 
32±7 4/4 
33±15 2/1 
30±6 0/3 
26±9 6/3 
Be, Ot(l) 
Te(l) 
Vi,Tr(l)Be(l)L( 
Me(l)Pe(l)Ti(l) 
3 
2 
1)0 
1 
neg(8) 
neg(3) 
neg(3) 
HM(7) 
Po(6)Da(5) 
10-44(4) 
51(1) 
22-96(3) 
226-1235(5) 
80-120(3) 
70/80(2) 
110-273(3) 
286-1320(7) 
0-3(3) 
0/70(2) 
0-25(3) 
0-60(7) 
A=allergic rhinitis, Au=augmentine, Be=Beconase, Bi=Bisolvon, c=control, Da=human or 
animal dander, Eo=eosinophilia, HM=house dust mite, La=Lanoxin, L=Lomudal, Me=methyrit, 
NA=non-allergic, ND=Not determined, Ot=Otrivin/ Pe=Penicillin, Po=Pollen, Ro=Ronnisol, 
s=chronic sinusitis, Sm=smoker, Te=Tetracycline, Ti=Tinset, Tr=Triludan, v=vasomotor 
rhinitis, Ve=Ventolin, Vi=Vibramycine, ( )=number of patients. 
similar to those of the control group. Allergic rhinitis was diagnosed 
on high IgE values, an increase in eosinophils in the blood and/or the 
nasal mucosa and a positive RAST and/or skin-test for house dust mites, 
pollen and/or dander. None of the allergic patients demonstrated an acute 
clinical manifestation of the allergic rhinitis. 
Radioligand receptor binding to horoogenates of nasal mucosa 
Biopsies from the nasal mucosae were immediately washed in 0.9% NaCl 
after removal. The tissue was stored at -80oC for a maxiraun of 43 months 
(non-allergic 18±12 months, allergic 17±7 months). In rat nasal mucosa, 
no differences in binding parameters could be observed in fresh tissue in 
craparison with frozen mucosa. Similar binding parameters were obtained 
with human nasal mucosa stored for 36 months in comparison with 7 months. 
The binding procedures to human nasal mucosa were analogous to the 
procedures as described for rat nasal mucosa (van Megen et al., 1989 ; 
chapter 4 and 6). In summary, the tissue was homogenized in ice cold 
buffer with an Ultraturrax for 2x10 sec. The honogenate was centrifuged 
at lOOOxg for 5 min, the supernatant centrifuged at 100,000xg for 1 hour 
(40C) and the pellet was resuspended by Potter homogenization. Protein 
determination was performed according to Bradford (1976) using bovine 
serum albumin as a standard. 
Radioligand receptor binding studies were carried out in glass tubes 
containing 40 μΐ radioligand, 40 μΐ buffer and 320 μΐ tissue honogenate. 
The different incubation conditions for the various receptors are listed 
in table 10.2. Instead of the buffer, unlabelled ligand was added for the 
determination of the non-specific binding. Incubations were terminated by 
rapid dilution with 2x2 ml ice cold buffer and filtration throuç^ i Whatman 
GF/C filters under vacuum, follcwed by 3x5 ml rinses of the filter with 
buffer. Radioactivity collected an each filter was measured in a 
gammacounter (NE1612, MEN) at 78% counting efficiency in case of the 
125I-ligand, whereas 3H-radioactivity was counted in a liquid 
scintillation counter. Ihe binding parameters were calculated by 
subjecting the data to a non-linear least square curve fitting procedure 
using the Gauss-Newton algorithm (Fletcher and Powell, 1963). Inhibition 
curves were analysed according to a one or two binding sites model. 
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Table 10.2: Incubation conditions for receptor assays of a- and 
/3-adrenoceptors (R= drenoceptor). 
Ligand R Buffer Incubation Non-specific binding 
3H-Prazosin ai Tris/HCl 40 min, гб'-'С 12 /ІМ píientolamine 
3H-Rauwolscine о^ Tris/EDIA 20 min, 250C 12 μΜ phentolamine 
^^-(-J-CYP β TyrcidefO.01% BSA 90 min, З?"^ 2 μΜ (±)propranolol 
Histology 
Specimens of human nasal mucosae were washed in 0.9% NaCl and fixed in 
2.5% glutardialdehyde in 0.1 M phosphate buffer (pH 7.0), dehydrated in 
ethanol and embedded in glycolmethacrylate (JB4 embedding kit, 
Polysciences Inc., Warrington, USA). Sections (2μιη) were stained with 
2.5% Toluidine Blue in 2.5% anhydrous sodimdicarbonate. 
In vitro labelling and autoradiography of ß-adrenoceptors in cryostat 
sections. 
Biopsies fron the nasal mucosae were immediately washed in 0.9% NaCl 
after removal. The tissue was rapidly frozen vising isopentane cooled in 
liquid nitrogen and stored for a maximum of 2 months before in vitro 
autoradiography. 
Binding characteristics were examined before autoradiographic experiments 
were performed as described for rat nasal mucosa (van Megen et al., 
1988). In summary, cryostat sections (10 /an) were thaw-mounted on glass 
slides coated with gelatin/chrome-alum. Ihe sections were air dried and 
stored at -SO^. Before incubation the sections were dried again at room 
temperature and fixed at 40C in 0.5% glutardialdehyde in Tyrode buffer 
for 30 min. Subsequently, the sections were rinsed in buffer at 40C for 
30 min and further processed for either radioreceptor assays or 
autoradiography. Several non-mounted parallel sections were collected for 
protein determination according to l£jwry et al. (1951) with bovine serum 
albumin as a standard. Protein determination was performed after 
solubilization of the sections in 0.1 N NaOH at 100oC (boiling water-
bath) for 15 min. Parallel sections were stained with methylgreen 
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pyronin (1%) for histological verification of tissue quality. 
For the radioreceptor assay, the tissue sections were dried and overlayed 
with 150 μΐ 125I-(-)-CYP in Tyrode buffer (with 0.01% BSA) at various 
concentrations radioligand. Subsequently, the sections were incubated at 
370C for 2 hrs in a humid atmosphere. For the measurements of the non­
specific binding, parallel incubations were performed in the presence of 
2 ¡M (±)-propanolol at the same conditions. After the incubation, 75 μΐ 
of the incubation buffer was counted to determine the free concentration 
radioligand, the remaining incubation buffer was removed by rinsing the 
sections in fresh buffer (r.t.) during 4x15 min. The radioactivity in the 
sections was counted by gamma counting (NE1612 gammacounter, MEN). The 
binding parameters were calculated as described above. 
For the autoradiography, sections were incubated with 0.02 riM 
125I-(-)-CYP according to the method described above. After washing the 
slides in buffer, they were rinsed in distilled water to remove salts. 
Ihe specimens were coated with 0.5% gelatirv/chrcme alum, air dried and 
dipped in liquid emulsion (Nuclear K2 emulsion, Ilford) diluted with 
distilled water (1:1). After 2 months exposure (40C) the autoradiographs 
were developed in amidol (180C, 8 min), rinsed in distilled water, fixed 
in sodium thiosulphate (30%) at 180C for 1-3 min, thoroughly washed in 
distilled water (15 min) and stained with 1% methylgreen pyronin. 
Statistical analysis 
Agonist inhibition curves were fitted to a one or two binding sites 
model. Preference was given to a two binding sites model when a 
significant diminution in the residual sum of squares was reached (F-
test). Differences in affinity values (negative logarithm of Kd, Kjj and 
Kj), which are kncwn to be normally distributed (De Lean et al., 1982; 
Hancock et al., 1988) were ccnpared using the student t-test. 
Significance was accepted at p<0.05. 
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10.4. Results 
Histology 
Various tissue components were present in biopsies of human nasal mucosa; 
epithelium and the lamina propria with glands, blood vessels and 
inflammatory cells. Nervous tissue could not be observed in the 
specimens. Biopsies of patients with allergic rhinitis demonstrated 
basophilic cells in the epithelium and an increased number of basophilic 
cells in the lamina propria in comparison with non-allergic patients. No 
other histological changes have been observed. 
Alpha-adrenoceptors in nasal mucosa membranes. 
Specific binding of 3H-Prazosin and 3H-Rauwolscine to ai-adrenoceptors 
and 02-adrenoceptors respectively was saturable and of high affinity in 
non-allergic as well as allergic patients. Scatchard plots point to 
homogeneous classes of binding sites. Ihe binding parameters, equilibrium 
dissociation constant (Κα) and the receptor density (Bmax) are listed in 
table 10.3. No significant differences in binding parameters could be 
observed in allergic patients in comparison with non-allergic 
individuals. Ihe heterogeneous non-allergic group was subdivided into 
control individuals, chronic sinusitis and vasomotor rhinitis patients. 
Ihe binding parameters of 3H-Prazosin and 3H-Rauwolscine binding were not 
significantly different between these subgroups or between allergic 
patients and the subgroups. 
Beta-adrenoceptors in nasal mucosa membranes 
Specific 125I-(-)-CYP binding to ^-adrenoceptors was saturable and of 
high affinity in nasal mucosa membranes of non-allergic and allergic 
patients (fig. 10.1). The Scatchard plot points to an homogeneous class 
of binding sites. Similar binding parameters were obtained in allergic 
patients and non-allergic individuals. Ihe non-allergic group was 
divided in subgroups as described above. The /3-adrenoceptor density, 
expressed in fmol/mg protein, was significantly decreased in allergic 
patients in comparison with control individuals (table 10.3). 
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Table 10.3: Binding p a r a m e t e r s (meaniSEM) of JH-Prazosin, 
3H-Rauwolscine and 125I-(-)-CYP to o^-, 122- and ß-
adrenoceptors in the nasal mucosae of non-allergic and 
a l le rg ic rh in i t i s pat ients . 
a-, -adrenoceptors 
non-allergic 
control 
chronic sinusitis 
vasomotor rhinitis 
allergic 
on-adrenoceptors 
non-allergic 
control 
chronic sinusitis 
vasomotor rhinitis 
allergic 
0-adrenoceptors 
non-allergic 
control 
chmiic sinusitis 
vasomotor rhinitis 
allergic 
Kd fri№ 
0.4+0.1 
0.410.2 
0.5 
0.2 
0.310.1 
Kd fnM) 
2.710.5 
2.710.6 
3.711.4 
1.610.2 
2.310.4 
Kd fpM) 
2.710.2 
2.810.3 
2.910.2 
2.7/1.6 
3.1+0.4 
Bttax ft) 
0.77+0.14 
0.90+0.17 
0.35 
0.83 
0.80+0.11 
йпах ft) 
5.5311.04 
4.6110.87 
9.65+3.80 
3.86+0.59 
5.21+0.59 
игах ft) 
0.50+0.06 
0.4810.06 
0.67+0.20 
0.32/0.45 
0.4110.05 
Bmax (p) 
177+33 
195140 
80 
218 
244150 
Emax (p) 
11801127 
1070+119 
16301430 
1020+198 
1230+96 
Bmax fp) 
87111 
92+10* 
100+46 
42/30 
6316* 
η 
5 
3 
1 
1 
4 
η 
14 
8 
3 
3 
9 
D 
18 
13 
3 
2 
14 
unax(t) in pmol/g t i ssue, Bmax(p) in fmol/mg protein *p<0.05 
165 
No significant differences in binding parameters could be demonstrated 
in allergic patients in comparison with chronic sinusitis and vascrootor 
rhinitis patients (table 10.3). Further analysis of the data revealed 
similar binding parameters in individuals with medication and in 
individuals without medication of the non-allergic, control or allergic 
rhinitis group nor could differences in binding parameters be 
demonstrated betsjeen smokers in comparison with non-smokers in these 
groups. 
Bound 125I-(-)-CYP 
(fmol/mg protein) 
30 60 90 120 
1
" ] - [ - ) - C Y P free (pM) 
Bound/free 
(ml/mg protein) 
100 200 300 ¿00 
Bound (fmol/mg protein) 
Fig. 10.1: 
baft: Total (·, O) and specific 125I-(-)-CYP binding to /3-adrenoceptors 
in human nasal mucosa membranes of non-allergic ( ) and allergic ( ) 
patients. Non-specific binding was determined in the presence of 2 μΜ 
(±)-propranolol. Right: Scatchard plot of the specific part of the 
binding to nasal mucosa membranes. Data shown are the means of 
triplicates fron representative experiments. 
Ihe subtype selective /S^adrenergic antagonist 1^203-030 w a s used to 
define the relative proportions of 0і - and ßz-aarentxecfcars in human 
nasal mucosa. The inhibition curve was monophasic and could adequately be 
fitted according to a one binding site model in control and allergic 
patients (fig. 10.2). The low Ki-values (8.912.8 μΜ and 7.4±3.3 μΜ 
166 
respectively), indicated the presence of an homogeneous population of 
^-adrenoceptors in control individuals and allergic patients. 
Fractional specific -
125I-|-)-CYP binding 
10-І /-
0 8 -
0 6 -
0 4 -
0 2 -
-°τ
0
οϊοο* 
4f~\ 1 1 1 ! 1 1 1 1 1—^T 
-12 -10 -8 -6 - i -2 
Log cone LKJOJ.OJOIM) 
Fig. 10.2: 
I n h i b i t i o n of s p e c i f i c 
1 2 5I-(-)-CYP binding by the 
antagonis t 1*203-030· Horoo-
genates of nasal mucosa of 
non-a l le rg ic p a t i e n t s were 
incubated a t 370C for 120 min 
a t 16 pM 1 2 5I-(-)-CYP in the 
p r e s e n c e o r a b s e n c e of 
inhibitor. The inhibit ion curve 
could adequately be f i t ted by a 
one binding s i t e model. Data 
shown are t h e means of 
t r i p l i c a t e s from a represen­
tat ive experiment. 
Fig. 10.3: 
Inhibition of 125I-(-)-CYP 
binding by the agonist 
isoprenaline in absence (O) or 
presence of 5.10~4 M Gpp(NH)p 
(·). The curve in the absence of 
Gpp(NH)p could significantly 
better fitted according to a two 
binding sites model, whereas the 
the curve in the presence of 
Gpp(NH)p could adequately be 
fitted according to a one binding 
site model. 
Fractional specific -
,25l-(-)-CYP binding 
о 
1 0-W/-
0 8 
06 
0 4 -
02 
41-
V? 
0\ 
2 s . 
-12 -10 
-8 -6 -¿ -2 
Log cone Isoprenaline IM) 
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Inhibition studies of 125I-(-)-CYP with the agonist isoprenaline in the 
absence or presence of Gpp(NH)p were performed to investigate the agonist 
affinity states and the coupling of the /J-adrenoceptors to the G-proteins 
in human nasal mucosa (table 10.4). Ihe inhibition curve appeared to be 
biphasic in 4 out of 5 control individuals and 3 out of 4 allergic 
patients and could be significantly better fitted according to a two 
binding sites model, indicating the presence of 15±6% and 21±10% high 
affinity sites respectively. Monophasic inhibition curves were 
demonstrated in 1 control and 1 allergic patient. In the presence of 
5.10-4 M Gpp(NH)p a shift of the monophasic and a steepening of the 
biphasic curves was observed (table 10.4). In two biphasic curves (1 
control, 1 allergic patient) Gpp(NH)p caused a complete conversion of the 
high into the low affinity sites (fig. 10.3). No remarkable changes in 
agonist inhibition or coupling to G-proteins could be demonstrated in 
allergic patients. 
Table 10.4: Inhibition of 125I-(-)-CYP binding by the agonist 
isoprenaline in absence or presence of Gpp(NH)p in control 
(Co) and allergic rhinitis patients (Al). 
-GroiNHip 
Ki (μΜ) Кі (μΜ) RH(%) η 
Co 0.66 - - 1 
0.016±0.024 0.48±0.23 15±6 4 
Al 0.19/0.17 - - 2 
0.027+0.003 0.79+0.29 21+10 3 
+GppfNH)p 
Ki (μΜ) Ki (μΜ) RH*(%) η 
1.0 - - 1 
0.16±0.11 1.93±0.81 42±28 3 
0.36 - 1 
0.22/0.44 - - 2 
0.68±0.47 1.23/1.74 65/46 2 
0.60 - 1 
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Fig. 10.4: 
Autoradiograms of 0.5% glutardialdèhyde fixed cryostat sections (10 m) 
of the nasal mucosa of a non-allergic patient after incubation with 16 pM 
125I-(-)-CYP (A) or with 2 /JM (±)-propranolol in addition to the 
radioligand (B) followed by dipping in the nuclear emulsion. The 
autoradiograms show specific labelling of the nasal epithelium (x800). 
Staining with methylgreen pyronin (1%). 
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localization of fl-adrenoceptors in human nasal mucosa 
Before the autoradiography, radioligand receptor binding experiments to 
cryostat sections of human nasal mucosa were performed. Ihe saturation 
curves were used to determine the optimal free concentration radioligand 
for the in vitro autoradiography. Specific 125I-(-)-CYP binding to /3-
adrenoceptors was saturable and of high affinity in cryostat sections of 
non-allergic (Kä=4.3±2.4 pM; Bmax=3.7±2.8 fmol/mg protein; n=4) and 
allergic patients (Kd=6.3/5.8 pM; Bnax=6.3/3.5 fmol/mg protein; n=2). 
After 2 months exposure the autoradiographs shewed 125I-(-)-CYP labelling 
of the nasal epithelium of non-allergic as well as allergic patients 
(fig. 10.4). Autoradiographs made frem sections incubated in the presence 
of 2 μϋ (±)-propranolol in addition to the radioligand shewed only a 
faint homogeneous labelling of the nasal mucosa. Nasal glands, blood 
vessels, and connective tissue were devoid of silver grains. 
10.5. Discussion 
Nasal hyperreactivity in allergic patients (Kaliner et al., 1982; 
Shelhamer et al., 1983) may be due to an imbalance of the autonomic 
regulation (Mygind, 1982). In this study, the hypothesis of changes in 
adrenergic, а^-, аз- ^** /Э-adrenergic characteristics has been 
investigated. Changes of agonist binding, coupling to the G-protein and 
localization were only investigated for the /3-adrenoceptors due to the 
unfavourable ratio specific/non-specific binding in the a-adrenergic 
assays. In view of the limited amount of human tissue, the rat nasal 
mucosa has been used as a model to investigate the biochemical 
characteristics of adrenoceptors and the localization of /3-adrenoceptors 
(van Megen et al., 1988; chapters 4, 5 and 6). 
3H-Prazosin and 3H-Rauwolscine binding to a^- and «^-adrenoceptors in 
membranes of the nasal mucosae of non-allergic patients was saturable and 
of high affinity. The Kd-values were in agreement with those observed in 
rat nasal itucosa (van Megen et al., 1989; chapter 6) or other human 
tissues (Yamada et al., 1987; Muller and Noack, 1988). Ihe heterogeneous 
non-allergic group was subdivided into control individuals, chronic 
sinusitis and vasomotor rhinitis patients. Similar binding parameters of 
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the 3H-Prazosin and 3H-Rauwolscine binding were obtained in these 
subgroups. As high tissue concentrations (25 mg/ml) were required to 
observe specific 3H-Prazosin binding only a limited number of patients 
could be investigated. No significant differences in affinities or 
densities of ад- and a^-adrenoceptors could be demonstrated in allergic 
patients in comparison with non-allergic and control individuals. As far 
as the a^-adrenoceptors, these findings are in agreement with similar 
reactivity to o^-agonists in allergic and non-allergic patients (Brooks 
et al., 1988). In the lewer airways, α-adrenergic hyperresponsiveness has 
been explained by an increased density of aj-adrenoceptors (Barnes et 
al., 1980). 3H-Prazosin, but not 3H-Rauwolscine binding, has been 
demonstrated in human nasal mucosa (Ка=0.31 гіМ, Ishibe et al., 1983; 
RM.. 10 hM, Kbnno et al., 1987). These Japanese studies reported a 
decreased number of a^-adrenoceptors in the nasal mucosa of allergic 
patients in comparison with chronic sinusitis patients. Ihe discrepancy 
between both studies may be due to the use of chronic sinusitis patients 
as a control group or to differences in biopsy removal and/or in 
medication. In regard to the unchcinged affinities and densities of 
α-adrenoceptors demonstrated in this study, alpha-agonists do not seem 
to be the appropriate anti-allergic drugs. Bende and Laurin (1986) also 
suggested that α-agonists are adequate as decongestants but not as 
specific anti-allergic drugs. 
Ihe Kd-values of the 125I-(-)-CYP binding to /3-adrenoceptors in membranes 
of the nasal mucosae of non-allergic and allergic patients were in 
agreement with those ciaserved in rat nasal mucosa (chapter 4) and other 
human tissues (van Koppen et al., 1989). No significant differences of 
the binding parameters could be demonstrated in allergic patients in 
ccmparison with non-allergic individuals. However, if the non-allergic 
group was further subdivided, a significant decrease of the 
/9-adrenoceptor density, expressed per mg protein, could be demonstrated 
in allergic patients in catparison with control individuals. These 
findings emphasize the importance of an accurate diagnosis of the 
patients. The expression of the receptor density per mg protein is 
probably more accurate than the expression per g tissue. The decreased 
number of ^ -adrenoceptors may reflect a /3-adrenergic abnormality in nasal 
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allergy (Kaliner et al., 1982; Shelhamer et al., 1983). However, 
intranasal administration of terbutaline caused no changes in the nasal 
airway resistance in allergic patients in comparison with non-allergic 
patients (Svensson et al., 1980). Until now, the influence of ß-
adrenergic agonists on the nasal secretion in allergic patients in 
comparison with non-allergic patients has not been investigated. In the 
lower airways an infusion of terbutaline resulted in am increased 
mucociliary transport in asthmatic patients . The small shift in receptor 
density may reflect a possible /3-adrenergic abnormality in nasal allergy 
but is probably too small to explain the ccnplex allergic reaction. A 
decreased ^-adrenoceptor density has been reported in allergic patients 
in oomparison with chronic sinusitis patients with the antagonist 
3H-DihydrOalprenolol (Ishibe et al., 1983; Konno et al., 1987). In the 
present study, no significant difference in receptor density could be 
observed in allergic patients in comparison with chronic sinusitis 
patients, possibly due to the limited number of patients investigated. 
The discrepancy between both studies may also be explained by differences 
in biopsy removal and/or medication. Hcwever, further analysis of the 
data revealed similar binding parameters in individuals with medication 
and those without in the non-allergic, control or allergic rhinitis 
yroup. 
The agonist inhibition curves of 125I-(-)-C¥P binding to /3-adrenoceptors 
in nasal mucosa membranes of 4 out of 5 controls and 3 out of 4 allergic 
patients demonstrated 15±6% and 21±10% high affinity sites respectively. 
The Ki-values of the high and low affinity sites were in agreement with 
those observed in rat nasal mucosa (chapter 4) and human smooth muscle 
(van Kcppen et al, 1989). Generally, a heterogeneity of agonist binding 
has been a predominant feature of /9-adrenoceptors in a variety of tissues 
(Stiles et al., 1984; lÊvitzki, 1986). However, the agonist binding of 1 
control and 1 allergic patient demonstrated only low affinity sites. A 
small proportion (less than 10%) of hi^i affinity sites, admixed with low 
affinity sites, might be undetectable in such experiments. It has been 
accepted that the high affinity conplex consists of agonist, receptor and 
G-protein. Guanine nucleotides appeared to convert high affinity states 
into lew affinity states of the receptor (Stiles et al., 1984; Cheung et 
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al., 1989). In the presence of 5.IO-4 M Gfcp(NH)p a shift of the 
monophasic and a steepening of the biphasic agonist curves has been 
demonstrated. A complete conversion of the high into the lew affinity 
sites has been observed in 2 patients. Since the protease inhibitor HISF 
had no effect on the inhibition curve, proteolytic activity is probably 
not responsible for the incomplete conversion. Complete conversion has 
neither been demonstrated in rat nasal mucosa (chapter 4), bovine trachea 
smooth muscle (van Koppen et al., 1987) and rat heart (Christ et al., 
1988). A /3-adrenergic abnormality of allergic patients may be reflected 
in the agonist binding. Hcwever, no differences in agonist binding or in 
effect of Gpp(NH)p on the agonist binding between allergic and controls 
could be observed. The number of agonist inhibition curves must be 
extended for definite conclusions. In the lewer airways, differences in 
agonist binding could neither be ctoserved in patients with chronic 
airflow obstruction in comparison with controls (van Koppen et al., 
1989). Hcwever, allergen challenge of patients with asthma resulted in a 
reduced ^ -adrenergic agonist binding in lymphocytes (Meurs et al., 1987). 
The antagonist and agonist binding to in vitro antigen challenged nasal 
mucosa of allergic patients give probably more information on an 
autonomic disbalance in the more acute manifestation of allergic 
rhinitis. 
Ihe Kd-values of the ^2^I-(-)-CYP binding to cryostat sections of human 
nasal mucosa are similar to those observed in hemogenates. The 
/Э-adrenoceptor density in homogenates is higher than in sections probably 
due to differences in protein contents; homogenates consist of a 
relatively pire membrane fraction, whereas sections contain all tissue 
constituents. Ihe 125I-(-)-CYP saturation curve was used for the 
determination of the optimal free concentration radioligand in 
autoradiography. After 2 months exposure, the autoradiographs of both 
non-allergic and allergic patients shewed specific 125I-(-)-CYP labelling 
of the epithelium. The presence of adrenoceptors in the epithelium of 
human and rat nasal mucosa has been demonstrated before by histochemical 
and autoradiographic experiments (Vecerina et al., 1983; <ähapter 4). 
Beta-adrenoceptors in airway epithelium may play a role in the 
mucociliary transport, active ion transport or the production of 
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epithelium derived factors (Davis et al., 1979; Carstairs et al., 1985; 
Welsh, 1987). No specific 125I-(-)-CYP labelling could be observed in the 
nasal blood vessels, which is in agreement with other studies (Hall and 
Jackson, 1968). However, a small peculation of ^-adrenoceptors may be 
present (Malm, 1977). 
Inhibition studies with the subtype selective antagonist LK203-030 ^ 
homogenates and in vitro autoradiography indicated that the 125I-(-)-CYP 
labelling in the autoradiographs occurs to a homogeneous 02-
adrenoceptor population in epithelium of the human nasal mucosa. Ihe 
combination of radioligand receptor binding and in vitro autoradiography 
suggests a decreased /3-adrenoceptor density in the epithelium of allergic 
patients in comparison with controls. This finding is in agreement with 
quantitative autoradiographic results of the lower airways in chronic 
airflow obstruction (Raaijmakers et al., 1987). 
Histological examination of the biopsies demonstrated mast cells in the 
epithelium of allergic patients, whereas no mast cells could be observed 
in non-allergic patients. Clinical pharmacological studies refer to the 
anti-allergic effect of /3-agonists by inhibiting histamine release from 
mast cells (Kaliner and Austen, 1975). No specific 125I-(-)-CYP labelling 
of mast cells could be observed in non-allergic and allergic patients in 
this study. 
In surmary, no changes in affinities or densities of a^- or o^-
adrenoceptors in the nasal mucosa of allergic patients in comparison with 
control individuals could be demonstrated. The decreased number of /3-
adrenoceptors may reflect a ^-adrenergic abnormality in allergic 
patients. No differences in agonist binding, coupling to G-proteins or 
localization of ^ -adrenoceptors could be demonstrated in nasal allergy. 
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SUMRRY 
Nasal hyperreactivity in allergic rhinitis roay originate frcm an 
imbalance of the autonomic nerve regulation by changes in 
characteristics of neuroreceptors in the nasal mucosa. In this study, 
radioligand receptor binding and in vitro autoradiographic assays were 
developed to determine receptor densities, sensitivities, subclasses, 
receptor-effector coupling and/or localization of the neuroreceptors in 
the nasal mucosa of non-allergic and allergic patients. Initially, the 
rat was used as an experimental model so that the restricted amount of 
human tissue was not a limiting factor. 
Chapter 1 is a brief review of the anatomy, physiology and autonomic 
innervation of the nasal mucosa and also describes pharmacological and 
biochemical aspects of various neuroreceptors. Attention has also been 
paid to classification and mechanisms of nasal hyperreactivity. 
In chapter 2 and 3 the pharmacological characterization and the 
localization of muscarinic acetylcholine receptors in rat nasal mucosa 
is described. The muscarinic receptors were classified as M3 receptors on 
the basis of the selective antagonists AF-DX-116 and HHSiD. High and low 
affinity agonist binding sites could be demonstrated after the inclusion 
of protease inhibitors during the assay. In vitro autoradiography 
demonstrated the presence of muscarinic receptors in the glandular acini 
and to a lesser extent іл the excretory ducts. 
Chapter 4 describes the pharmacological characterization and the 
localization of the /3-adrenoceptors in homogenates and cryostat sections 
of the rat nasal mucosa. Conpetition experiments with the subtype 
selective antagonists 1^203-030 a n t i ICI118 551 demonstrated the presence 
of approximately 50% ßy- and ^ 2 _ a d r e n o c ^ ) t o r s ^1 hcmogenates as well as 
in cryostat sections. The agonist inhibition curves shewed 30% high 
affinity sites. Autoradiograms demonstrated the presence of /Эд- and 
^-adrenoceptors in the epithelium as well as in the glandular excretory 
ducts. 
ïhe pharmacological characteristics of a^- and o^ -adrenoceptors in rat 
nasal mucosa have been described in chapter 5 and 6. Because of the small 
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number of α^-adrenoceptors in the rat nasal mucosa, the characterization 
of these receptors was limited and the localization appeared to be 
impossible. Ihe selective antagonist WB4101 demonstrated a^-subtypes in 
rat nasal mucosa. The agonist inhibition curve had a monophasic 
character, indicating an homogeneous population of agonist binding sites. 
In first instance, the antagonist 3H-Rauwolscine appeared to bind to a^-
adrenoceptor subpopulations. The appearance of two binding sites was 
probably due to an inappropriate definition of the specific binding, 
caused by a non-linear non-specific binding. Inhibition of the 
3H-Rauwolscine binding with the subtype selective antagonist prazosine 
suggested the presence of o^-adrenoceptor subclasses. Ihe agonist 
inhibition curve showed high and low affinity binding sites. In the 
presence of guanine nucleotides high affinity sites were converted into 
lew affinity binding sites. Until now, localization of the o^-
adrenoceptors with in vitro autoradiograpihy was not succesful. 
Chapter 7 describes the characteristics of patients from whom we received 
a biopsy. Ihe following parameters were involved: nasal symptoms, family 
history. X-rays of the sinuses, eosinophils in the blood and in the nose, 
serum IgE, skin- and RAST-tests. Ihe patients were classified into a non-
allergic and allergic group. Furthermore, the heterogeneous non-allergic 
group has been subdivided into controls, chronic sinusitis and vasomotor 
rhinitis patients. Only 30% of the biopsies could be used for 
biochemical experiments because no clear distinction between non-allergic 
and allergic patients could be made in every case and/or because of the 
limited amount of tissue. 
A histological study of the rasai mucosa of non-allergic and allergic 
patients has been described in chapter 8. Ihe in glycol methacrylate 
embedded specimens of the nasal mucosa of most patients shewed various 
tissue oomponents; epithelium and the lamina prepria with glands, blood 
vessels and infiltrating cells. Ihe AB/PAS staining indicated the 
presenœ of neutral or neutral and acidic glyecproteins in goblet cells 
as well as in the tubulo-alveolar glands. In specimens from allergic 
rhinitis patients basophilic cells were observed in the epithelium, 
whereas no basophilic cells could be observed in control individuals. An 
incrreased number of basopihilic cells was observed in the lamina prepria 
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of allergic rhinitis in conparison with non-allergic patients. 
In chapter 9 the hypothesis of changes in characteristics of muscarinic 
receptors in the nasal mucosa of allergic patients is addressed. The 
heterogeneous non-allergic group was subdivided into subgroups as 
described in chapter 7. In allergic patients, the equilibrium 
dissociation constant and density of muscarinic receptors were decreased 
in comparison with non-allergic or control individuals. No differences in 
agonist binding or coupling of this receptor to the G-protein could be 
observed in allergic patients. In vitro autoradiography demonstrated the 
presence of muscarinic receptors in the glandular acini of non-allergic 
and allergic patients. The increased sensitivity accompanied by a 
decreased receptor density may reflect the cholinergic nasal 
hyperreactivity in nasal allergy. 
In chapter 10, the hypothesis of changes in characteristics of 
adrenergic, ctj-, o^- and ^-adrenergic, receptors in the nasal mucosa of 
allergic patients is addressed. Ihe heterogeneous non-allergic group has 
been subdivided into the subgroups as described above. No significant 
differences in affinities or densities of ctj- as well as o^-adrenoceptors 
could be demonstrated in allergic patients in comparison with non-
allergic or control individuals. Ihe /3-adrenoceptor density, expressed 
per mg protein, was significantly reduced in allergic patients in 
comparison with controls. No changes in agonist binding or guanine 
nucleotide coupling could be observed in allergic patients. Ihe subtype 
selective antagonist 1^203-030 demonstrated the presence of a homogeneous 
pcpolation of ^ -adrenoceptors in human nasal mucosa of both non-allergic 
and allergic patients. In vitro autoradiography showed the presence of 
^-adrenoceptors in the epithelium of both groups of patients. The 
decreased ^-adrenoceptor density in nasal allergy may reflect a 
/3-adrenergic abnormality in nasal allergy. 
In conclusion, the rat can be used as an experimental model to develop 
and optimize radioligand receptor binding and in vitro autoradiographic 
assays for investigating the pharmacological characteristics and 
local ization of various neuroreceptors in the nasal mucosa. Both 
techniques have been applied to human nasal mucosa in order to 
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investigate the supposed changes in the pharmacological characteristics 
of neuroreceptors in nasal allergy. The classification of patients into 
non-allergic and allergic patients as well as the subdivision of the non-
allergic group into controls, vasomotor rhinitis and chronic sinusitis 
patients appeared to be of prime importance. An accompanying histological 
study helped to interpret the biochemical studies. The combination of 
radioligand binding studies and in vitro autoradiography indicated the 
presence of muscarinic acetylcholine receptors in the nasal glands and an 
homogeneous peculation of ^ -adrenoceptors in the epithelium of the nasal 
mucosa of non-allergic as well as allergic patients. 
An increased sensitivity and a decreased number of muscarinic receptors 
have been demonstrated in the nasal mucosa of allergic patients in 
cctnparison with controls. These findings may reflect the cholinergic 
induced hypersecretion in nasal allergy. No differences in affinities or 
densities of α-adrenoceptors in the nasal mucosa of allergic patients in 
comparison with non-allergic individuals could be demonstrated. On the 
other hand, a decreased number of /5-adrenocep>tors have been demonstrated 
in allergic patients in comparison with controls, which may reflect a ß-
adrenergic abnormality. The small shifts in affinity and receptor density 
may reflect the cholinergic hyperreactivity and a /S-adrenergic 
abnormality in nasal allergy, but are probably too small to explain the 
complex allergic reaction. 
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айМЕИ ЙДТШЕ 
Nasale hyperreactiviteit bij allergische rhinitis wordt mogelijk 
veroorzaakt door een disbalans in de autonome regulatie van het 
neusslijmvlies door bijv. veranderingen in eigenschappen van 
neuroreceptoren. In deze studie werden radioligand receptorbinding en in 
vitro autoradiografische technieken ontwikkeld om de receptordichtheden, 
gevoeligheden, subtypen, receptor-effector koppelingen en lokalisatie van 
neuroreceptoren in het neusslijmvlies te bepalen. In eerste instantie 
werd de rat als proef diermodel gebruikt, zodat de geringe hoeveelheid 
humaan weefsel geen beperkende factor zou zijn. Vervolgens werden beide 
technieken toegepast op humaan neusslijmvlies van niet-allergische en 
allergische patiënten. 
Hoofdstuk 1 bevat een overzicht van de anatomie, fysiologie en autonome 
regulatie van het neusslijmvlies en bespreekt een aantal farmacologische 
en biochemische eigenschappen van verschillende neuroreceptoren. Tevens 
wordt aandacht gegeven aan nasale hyperreactiviteit. 
In hoofdstuk 2 en 3 worden de farmacologische karakterisatie en 
lokalisatie van muscarine cholinerge receptoren in het neusslijmvlies van 
de rat beschreven. Op basis van de selectieve antagonisten AF-DX-116 en 
HHSiD werden de muscarine receptoren in het neusslijmvlies 
gekarakteriseerd als M3 receptoren. Na toevoeging van diverse protease-
remmers, bleek het mogelijk hoge en lage affiniteitsbindingsplaatsen aan 
te tonen bij de verdringing van de antagonist binding met agonisten. In 
vitro autoradiografie toonde de aanwezigheid van muscarine receptoren in 
de acini en in geringe mate in de afvoergangen van de klieren. 
Hoofdstuk 4 beschrijft de farmacologische karakterisatie en lokalisatie 
van de /9-adrenoceptoren in homogenaten en vriescoupes van het 
neusslijmvlies van de rat. Uit verdringingsexperimenten met de selectieve 
antagonisten 1^203-030 e n ICI118 551 bleken ongeveer 50% ß-^- en /З2-
adrenoceptoren aanwezig in homogenaten maar ook in vriescoupes van het 
neusslijmvlies. De agonist verdringingscurve toonde 30% hoge 
affiniteitsbindingsplaatsen. Autoradiogranmen toonden de aanwezigheid van 
ßj- en ^2 - а (і г е п о с еР* : о г е п ^ het epitheel en in de afvoergangen van de 
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klieren. 
In hoofdstuk 5 en 6 worden de farmacologische kenmerken van а^- en oç-
adrenoceptoren in het neusslijmvlies van de rat beschreven. De geringe 
hoeveelheid a^-adrenoceptoren in het neusslijmvlies beperkte de 
karakterisatie en maakte de lokalisatie onmogelijk. De selectieve 
antagonist WB4101 toonde a^-subtypen in het neusslijmvlies van de rat. De 
verdringingscurve van de antagonist binding met agonist verliep 
monofasisch, wijzend op een homogene populatie agonistbindingsplaatsen. 
De antagonist 3H-Rauwolscine bleek in eerste instantie te binden aan 2 
subpopulaties van c^-adrenoceptoren. Het optreden van twee 
bindingsplaatsen werd mogelijk veroorzaakt door een onjuiste definitie 
van de specifieke binding wegens een niet-lineaire aspecifieke binding. 
Inhibitie met de selectieve antagonist prazosine suggereerde de 
aanwezigheid van o^-subtypen. De agonist inhibitie curve toonde zowel 
hoge als lage affiniteitsbindingsplaatsen. Na toevoeging van guanine 
nucleotiden werden de hoge affiniteitsbindingsplaatsen omgezet in lage 
affiniteitsbindingsplaatsen. Tot op heden bleek het niet mogelijk o^-
adrenoceptoren te lokaliseren m.b.v. de in vitro autoradiografie. 
Hoofdstuk 7 beschrijft het klinische beeld van de patiënten, van wie een 
neusbiopt verkregen werd voor het humane deel van het onderzoek. Hierbij 
werden de volgende parameters gehanteerd; symptomen, familie 
achergronden, foto's van de sinus holten, eosinofiele cellen in het bloed 
en in de neus, IgE gehalte in het serum, RAST en huid-testen. De 
patiënten werden geiklassificeerd in een niet-allergische en allergische 
groep. Vervolgens werd de heterogene niet-allergische groep verdeeld in 
controle individuen, chronische sinusitis en rhinitis vasomotoria 
patiënten. Slechts 30% van de verkregen biopten bleek bruikbaar voor 
biochemische studies wegens de geringe hoeveelheid verkregen weefsel of 
omdat niet altijd een duidelijk onderscheid gemaakt kon worden tussen 
niet-allergische en allergische patiënten. 
Een histologische studie van de neusbiopten van niet-allergische en 
allergische patiënten is beschreven in hoofdstuk 8. De plastic coupes van 
het neusslijmvlies van de meeste patiënten toonde diverse 
weefselcomponenten: epitheel en de lamina prepria met klieren, bloedvaten 
en bindweefsel. Neutrale en zure glycoproteinen bleken aanwezig in de 
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slijmbekercellen van het epitheel en in de tubulo-alveolaire klieren. In 
coupes van allergische patiënten werden basofiele cellen (mest cellen), 
waargenomen in het epitheel, terwijl deze cellen niet werden waargenomen 
in controle individuen. Tevens werd een verhoogd aantal basofiele cellen 
waargenomen in de lamina propria bij allergische patiënten t.o.v. 
controle individuen. 
In hoofdstuk 9 wordt de hypothese van veranderingen in de farmacologische 
kenmerken van muscarine receptoren in het neusslijmvlies van allergische 
patiënten getoetst. De heterogene niet-allergische groep werd verdeeld in 
subgroepen zoals hierboven beschreven. In allergische patiënten was het 
aantal muscarine receptoren verlaagd en de gevoeligheid verhoogd t.o.v. 
niet-allergische patiënten en controle individuen. Geen veranderingen in 
agonist binding en in de koppeling van de receptor aan het G-eiwit konden 
worden waargenomen in allergische patiënten t.o.v. niet-allergische 
individuen. In vitro autoradiografie toonde de aanwezigheid van muscarine 
receptoren in de acini van de klieren in niet-allergische en allergische 
patiënten. De verhoogde gevoeligheid en een verlaagd aantal muscarine 
receptoren reflecteert mogelijk de cholinerge hyperreactiviteit bij 
allergische patiënten. 
In hoofdstuk 10 werd de hypothese van veranderingen in kenmerken van 
adrenerge receptoren, UI-» <*2~ e n 0-adrenoceptoren, in het 
neusslijmvlies van allergische patiënten getoetst. De heterogene niet-
allergische groep werd gesplitst zoals hierboven beschreven. Geen 
veranderingen in gevoeligheden en/of receptordichtheden van 
a-adrenoceptoren konden worden waargencroen in allergische patiënten 
t.o.v. niet allergische en controle individuen. De /3-adrenoceptor 
dichtheid, uitgedrukt per mg eiwit, was significant verlaagd in 
allergische patiënten t.o.v. controle individuen. Geen veranderingen in 
agonist binding of koppeling van de /J-adrenoceptor aan het G-eiwit werden 
waargenomen in allergische patiënten t.o.v. niet-allergische patiënten. 
De ccmbinatie van radioligand binding met de selectieve antagonist 
LK203-030 en de in vitro autoradiografie toonde een homogene populatie 
/32_adrenoceptoren in het epitheel van het neusslijmvlies van zowel 
allergische als niet-allergische patiënten. Een verlaagd aantal 
/3-adrenoceptoren in het neusslijmvlies van allergische patiënten 
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reflecteert mogelijk een /3-adrenerge abnormaliteit bij allergische 
patiënten. 
Samengevat kan gesteld worden, dat de rat een goed proefdiermodel is om 
radioligand receptor binding en in vitro autoradiografische technieken 
te ontwikkelen en te optimaliseren. Beide technieken konden worden 
toegepast op humaan neusslijmvlies cm mogelijke veranderingen in 
neuroreceptoren bij nasale allergie te onderzoeken. De klassificatie van 
patiënten in niet-allergische en allergische individuen, maar ook de 
onderverdeling van de heterogene niet-allergische groep in controle, 
chronische sinusitis en rhinitis vasomotoria patiënten bleken van primair 
belang. De data van de biochemische studies konden beter geïnterpreteerd 
worden door hiernaast een histologische studie uit te voeren. De 
combinatie van radioligand receptorbinding studies en in vitro 
autoradiografie toonden de aanwezigheid van muscarine receptoren in de 
klieren en een hcmogene populatie ^ -adrenoceptoren in het epitheel van 
het neusslijmvlies van zowel niet-allergische als allergische patiënten. 
De verhoogde gevoeligheid en de verlaagde dichtheid van de muscarine 
acetylcholine receptoren in het neusslijmvlies van allergische patiënten 
in vergelijking met controle individuen reflecteert mogelijk de 
cholinerge hyperreactiviteit van allergische patiënten. Geen verschillen 
in affiniteit en/of dicihtheden van a-adrenoceptoren konden worden 
aangetoond in het neusslijmvlies van allergische patiënten t.o.v. niet-
allergische individuen. Het aangetoonde verlaagde aantal /3-adrenoceptoren 
in het neusslijmvlies van allergische patiënten t.o.v. controle 
individuen daarentegen, reflecteert mogelijk een /3-adrenerge 
abnormaliteit in allergische patiënten. Deze veranderingen in affiniteit 
en receptordichtheid verklaren mogelijk de cholinerge hyperreactiviteit 
en een /3-adrenerge abnormaliteit in allergische rhinitis patiënten, maar 
zijn waarschijnlijk te gering cm de complexe allergische reactie te 
verklaren. 
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